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Abstract: Small or large bone defects, can occur due to a variety of reasons: congenital 
disorders, infections, tumors, or traumas which can lead to significant disabilities. There 
is an assortment of bone grafting procedures, each having their own respective 
advantages and disadvantages and exhibiting certain essential characteristics.  Among the 
available grafts, autogenous (autograft), allograft, xenograft, and alloplasts, all exhibit a 
minimum of two-thirds of the essential characteristics and have been proven useful in 
fully or partially repairing skeletal defects.  However, different host-to-grafting material 
responses have been reported and should be taken into consideration when determining 
treatment options.  A large range of physical and chemical properties can be achieved 
with calcium phosphate based materials, which possess two of the ideal characteristics 
for grafting procedures: osteoconduction and osseointegration.  Calcium phosphate based 
scaffolds composed of hydroxyapatite (HA), β-tri-calcium phosphate (β-TCP), or a 
combination of both (HA/β-TCP) were investigated as materials for three-dimensional 
printing process to create layer-by-layer structures for use as bone regeneration scaffolds.  
Different calcium-phosphate phases will result in different degrees of in vivo dissolution 
and/or cell-mediated resorption.  There has been a growing interest in BCP because it has 
been shown that this material improves the formation of new bone inside the implanted 
scaffold.     The literature indicates that the faster dissolution rate of β-TCP would be 
greatly responsible of this enhancement.  However, in vitro tests indicate that fast 
dissolution can decrease the mechanical strength of BCP scaffolds.  Furthermore, studies 
reported that HA has higher mechanical strength and lower degradation rate than β-TCP.  
Therefore, the HA/β-TCP ratio is a key parameter controlling the performance of the 
scaffold for bone repair applications, since it determines degradation rate, calcium (Ca2+) 
and phosphate (PO4) release and mechanical properties of the material. 
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CHAPTER 1 
INTRODUCTION 
1.1 Overview  
 The motivation for this research was to advance a new technology, 3D printing of 
ceramics, to improve artificial bone scaffolds used in the repair of critical sized bone trauma or 
defects.  When a healthy bone is simply fractured, immobilizing with a cast allows the osteocytes 
to naturally mend the fracture.  However, when trauma, bone loss, or disease destroys a large 
section of bone, one must consider technologies that serve the triple purpose of supporting 
mechanical load, providing a physical scaffold for rapid and long-term bone formation and 
gracefully dissolving over time to allow natural bone to resume its function.  3D printing of 
ceramics offers significant fabrication advantages over the traditional forming techniques in that 
spatial variation of composition can now be controlled at a length-scale commensurate with the 
bone cell microenvironment. 
The human skeleton is a complex, living structure and bone wound healing is understood 
to include reconstruction of a collagen-mineral nanocomposite, porous, vascularized, spatially 
varied, hierarchical structure; the main work being done by osteoblasts, osteoclasts and 
chondrocytes, and the circulatory system.  For small bone defects (i.e., sub-critical) simple bone 
graft substitutes such as porous ceramic sponge materials with poor mechanical strength can 
significantly speed the bone repair process by providing a structure on which mesenchymal cells 
can operate.  For critical and super-critical defects (i.e., those where the osteyocytes will not heal 
the wound), there is a need to provide a scaffold that rapidly directs osteyocyte activity across the 
wound and begins the healing process.  The future of bone grafting will be a combination of 
materials, which have specific desirable properties (i.e. dissolution kinetics, pore size, surface 
area) and thus will compensate for the disadvantages of each separate material. 
This dissertation summarizes efforts to, design, fabricate, and characterize biphasic 
calcium phosphate (BCP) scaffolds for inducing bone regeneration across critical defects using a 
direct-write (DW), colloidal gel extrusion process.  A biphasic ceramic mixture consisting of 
hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP) was investigated for this research 
project.  The three main research questions were: 
  
 2 
Ø Is the composition and spatial distribution of the materials in the sintered ceramic 
scaffold able to be controlled? 
Synthetic HA and β-TCP are bone substitute materials approved by the United 
States Food and Drug Administration (FDA).  Implant manufacturers typically use 
these ceramics to make a porous scaffold by casting and sintering processes.  In 
addition to poor strength of scaffolds fabricated in this way, the implant manufacturer 
often faces the dilemma of choosing HA, which is virtually insoluble or β-TCP, 
which is too soluble.  Legeros et al, addressed the solubility issue by synthesizing so-
called bi-phasic calcium phosphate (BCP) by simply blending and co-sintering 
powders of HA and β-TCP.  The BCP has intermediate solubility; however, the 
impact of secondary phases, such as calcium pyrophosphate (Ca2P2O7), on solubility 
has not been fully understood.  In the new aqueous processing method studied here, 
the question of retaining the chemistry of the input ceramics in the final fabricated 
implant is important for understanding if the scaffold can be fabricated with the 
desired intermediate solubility. 
Ø Do the details of printing (i.e., pre-mixed composition ink, two-tip deposition of 
different ink compositions or blending inks with a mixing chamber while printing) 
affect the in vitro response of the scaffold on the macroscopic scale? 
Here, the term “ink” refers to the colloidal gel that is synthesized by dispersing 
and then controllably flocculating, high-concentration, aqueous ceramic slurries to 
create pseudo-plastic with yield stress rheology suitable for 3D printing.  The ink 
composition can be controlled by pre-selecting the composition (i.e., ratio of HA to 
β-TCP) in the dispersing step of the colloidal slurry synthesis or by controlling the 
deposition of separate HA and β-TCP inks from independent reservoirs.  Two-tip 
printing can create a binary OR filament (i.e., HA/β-TCP), while the mixing chamber 
method creates a binary AND filament (i.e., HA & β-TCP).  The mixing chamber 
method has the further advantage of controlling the HA:β-TCP ratio in the filament 
by simply controlling the flow rate of each stream.  This research question explores 
the effects of the printing process on dissolution and ion release behavior of scaffolds 
fabricate by these different methods. 
Ø Can 3D printing be used to tailor the scaffold to induce bone healing in long-bone 
defects, in addition to control of dissolution kinetics? 
Long cylindrical shaped scaffolds have been successfully fabricated and tested in 
vivo.  Although these scaffolds were successful, they were only done on a uniform 
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material composition throughout scaffold (i.e. 100% HA, 100% β-TCP, or some ratio 
of HA/β-TCP).  With improved tools/methods such as two-tip or mixing chambers, 
3D printing will allow for further tailoring of the scaffold.  In this case, one can tailor 
the cylindrical scaffold varying composition as a function of the radius, with having 
the more soluble material (β-TCP) concentrated on the inner radius and grading out 
to the outside shell composed of the slower resorbing 100% HA.  This may be ideal 
for the long bone design parameter or in a case where initial mechanical properties 
are desired as well as allowing for better control of dissolution/resorption. 
1.2 Project Overview 
The dissertation is divided into the following main areas of work: (a) beneficiation and 
characterization of commercial HA and β-TCP and synthesis of the colloidal gel ink with 
compositions of (i) 100% HA, (ii) 100% β-TCP, (iii) 15/85% HA/β-TCP, and (iv) 15/85% HA/β-
TCP (design mix), to verify their chemical properties and in vitro responses, (b) design the 
individual scaffolds in a innovative way (interchanging material on micro-scale level or create 
functionally graded structure to control their respective dissolution kinetics), (c) qualitatively 
investigate the Ca2+ and PO4 release in the initial implantation (via in vitro) times to better 
understand the kinetics to further incorporate into design process, and (d) ultimately creating a 
novel cylindrical scaffold for long bone regeneration.  
1.3 Dissertation Scope 
  The dissertation is organized into six chapters: Chapter 1 states the overview and main 
thesis of this project and its work.  Chapter 2 is a review of literature pertinent to bone repair 
techniques and materials with specific emphasis on the allograph approach (i.e., using artificial 
bone scaffolds to aid bone repair).  Chapter 3 addresses the first research question regarding ink 
formulation and observation of the printed scaffold quality in light of process variables.  Chapter 
4 addresses the second research question regarding the agile placement of HA, HA/β-TCP, or β-
TCP within a functionally graded scaffold by way of multiple deposition nozzles or an active 
mixing chamber.  Chapter 5 focuses on the third research question regarding how functionally 
graded long bone scaffolds in an in vitro environment behave and the subsequent qualitative 
analysis of the scaffolds.  Chapters 3, 4, and 5 all are organized to give a brief introduction, 
experimental section, results, discussion and conclusion.  Chapter 6 is the summarization from the 
entire work with its conclusions and additionally states a few recommendations for future work.  
Chapter 7 provides a list of references for this document. 
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CHAPTER 2 
REVIEW OF LITERATURE 
2.1 Bone 
2.1.1 Introduction 
Bone, composed primarily (Table 2.1) of osseous tissue, is a dynamic living organ, which 
is a complex, porous bio-composite that creates an environment for osteogenesis, osteolysis, 
hematopoiesis, while serving as a calcium reservoir for the body [1].   
• Collagen, mainly Type I 
• Hydroxyapatite 
• Non-collagenous proteins 
• Proteoglycans 
• Water 
• Blood vessels 
• Lymphatic vessels 
• Nerve Tissue 
Table 2.1: Primary components of the make up of bone. 
Bone is not a uniformly solid material, but organized according to location and function 
in the overall structure. Some medical terms to refer to sections of bone will serve us in this 
literature review are listed and briefly described in (Table 2.2).  Broadly, bone can be classified 
into two types: cancellous and cortical (Table 2.3).  Cancellous bone is also called spongy or 
trabecular bone due to the high porosity.  For example, in a cross sectional view of a limb bone, 
one observes a marrow space surrounded by cancellous bone composed of 50-90% volume 
porosity, and spongy in composition.  Surrounding the cancellous bone is cortical bone 
compromises the outer layer, which is more dense and contains c.a. 10% porosity by volume [2].  
Regardless of the bone type, cancellous or cortical, both undergo some extent of differentiation, 
remodeling, and resportion, which are controlled by various interactions between cells: osteocyte, 
osteoblast, and osteoclast [3, 4].  The intricate design of bone is further composed of trabeculae,
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 which range from 130 - 350 µm in diameter; the open porosity provides a route for 
vascularization and nutrient flow. 
Term Definition 
Superior (Cranial) Toward the head end or upper part of the 
structure or body; above 
Inferior (Caudal) Away from the head end or toward the lower 
part of a structure or the body; below 
Ventral (Anterior) Toward or at the front of the body; in front of 
Dorsal (Posterior) Toward or at the back of the body; behind 
Medial Toward or at the midline of the body; or the 
inner side 
Lateral Away from the midline of the body; or the 
outer side of 
Intermediate Between a more medial and more lateral 
structure 
Proximal Closer to the origin of the body part or the 
point of attachment of a limb to the body trunk 
Distal Farther from the origin of a body part or the 
point of attachment to the body trunk 
Superficial (External) Toward or at the body surface 
Deep (Internal) Away from the body surface; more internal 
Table 2.2: Orientation and directional terms commonly used in the medical field. 
 
• Cortical Bone = Compact Bone (80%) 
o Osteon 
§ Type I collagen, very organized, longitudinal 
§ Mineral deposits, hydroxyapatite 
§ Very dense and strong, reinforced concrete 
• Cancellous Bone = Spongy Bone (20%) 
§ Type I Collagen, less organized 
§ Mineral deposits, hydroxyapatite 
§ Less strong, more forgiving, shock absorber  
Table 2.3: Summary of the two primary bone types. 
Cells with a single nucleus, osteoblasts, are responsible for bone formation, these cells 
are differentiated and derived from mesenchymal stem cells.  These cells produce a mineralized 
osteoid, which is composed mainly of Type I collagen.  These osteoblasts are metabolically active 
cells that express soluble signaling factors such as bone morphogenetic proteins (BMPs), platelet-
derived growth factor (PDGF), transforming growth factor (TGF) or insulin-like growth factors 
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(IGFs) [5].  Osteoblasts trapped in the secreted mineralized matrix, either differentiate into 
osteocytes or result in apoptosis.  Osteocytes are networked together with long cytoplasmic 
extensions called canaliculi that occupy tiny canals in bone, which are used to connect the lacuna.  
In addition, osteocyte metabolic activity is important to maintain bone viability and homeostasis 
[5].  While the osteoclast is a large multinucleated cell associated with removal of bone (often 
referred to as bone resorption) [6].  Bone remodeling process involves osteoblasts (form bone) 
and osteoclasts (re-absorb bone), are in control of new bone formation and resorption of the old 
bone, respectively.  While bone is a resilient vital organ of the body, which due to the presence of 
both the osteoblasts and osteoclasts are two of the many factors in maintaining healthy bones [7], 
also the reason it has a great self-healing abilities with respect to small scales/length spans.  
However, trauma to the skeletal system due to: accident, osteoporosis, surgical removal of tumors 
or other diseases often overwhelm the ability of bone to self-heal at which an external 
intervention is necessary to facilitate the bone healing process [8, 9].   
2.1.2 Bone Defects and Abnormalities  
Bone defects, whether large or small, occur due because of congenital disorders 
infections, tumors, or traumas [10].  For instance, more than 2000 people are diagnosed with a 
bone tumor each year in the United States, while approximately 1 million skeletal defects are 
observed worldwide [11].  Irrespective of bone loss defect, an ideal rehabilitation would be full 
tissue regeneration; however, depending on location and size of the defect, full tissue 
regeneration may not be achievable [12].  While it is estimated that more than half a million 
bone-grafting procedures are performed annually in the United States alone, these numbers 
double on a world wide basis and indicating a shortage in the availability of musculoskeletal 
donor tissue traditionally used in these reconstructions (Figure 2.1). 
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Figure 2.1: U.S. trends in musculoskeletal tissue donors (Source: AATB Annual Survey). 
Trauma is a major contributing factor for large bone defects/fractures.  The leading 
causes of the majority blunt force trauma are automobile accidents, while others can be caused by 
work related accidents, recreational activities, or a simple fall [10].  Trauma may result in 
fractures with varied morphology and complexity degrees (Figure 2.2), ultimately requiring 
varied treatment approaches.  A fracture can heal naturally or with the help of supplemental 
procedures, as each patient will have a different response to a bone fracture.  For example, a 
young patient who is still in the process of growing will probably have fewer complications to 
repair/heal a fracture compared to an older individual as ones bone modeling/remodeling kinetics 
or quantity may have changed due to the aging process. 
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Figure 2.2: Schematic representation of various bone fractures of human tibia and spinal cord 
[13]. 
Different treatment options are currently available such as autografts and allografts.  
These options have proven successful but at times have their own respective limitations and 
drawbacks such as second surgical site or infection and viral transmission, respectively, hence 
focusing on a bone tissue engineering method to fabricate and/or regenerate bone, which in turn 
would restore and maintain its function [2, 11].  Scaffolds, which are three-dimensional (3D) 
biocompatible structures, are a pivotal element in bone tissue engineering.  These scaffolds have 
the ability to mimic extracellular matrix (ECM) properties such as mechanical support, cellular 
activity, and protein production while simultaneously providing a guide for cell adhesion and 
stimulation for bone tissue formation in vivo [11].  
Structurally, primary bone formation, or direct formation of new bone from damaged 
bone, without a cartilaginous intermediate (as in the endochondral bone formation seen in 
embryology and long bone fractures) is what is observed to grow into most scaffolds, and is the 
type of bone formation which is trying to be controlled. This type of bone ingrowth into a defect 
or wound site occurs as directional growth of new immature trabeculae, from the endosteal or 
periosteal layers of damaged cortical and cancellous bone into the wound site.  When an 
appropriate scaffold is present, these new trabeculae, as part of a phenomenon described as 
osteoconduction, will attach to and follow along the mesostructural elements of the scaffold.  This 
will only occur if the scaffold has suitable surface chemistry and microtexture.  Hydroxyapatite 
scaffolds, used in various forms such as packed synthetic particles, processed bone, or processed 
coral skeletons, have consistently had the proper surface chemistry and microstructure to show 
strong bone conduction. 
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2.2 Graft Materials 
Among the available grafts, autologous (autograft), allograft, xenograft, and alloplastic, 
all exhibit the essential characteristics and have been proven useful in fully or partially repairing 
skeletal defects.  However, different host-to-grafting material responses have been reported and 
should be taken into consideration while determining treatment options. 
2.2.1 Natural grafting materials 
 There is an assortment of natural bone grafting procedures, each having their own 
advantages and disadvantages.  Bone grafts should at least have these essential characteristics: 
osteoconduction - the capability to support the growth of bone over its surface;  osteogenesis - the 
process of extra cellular matrix deposition and subsequent minerializtion by osteoblasts,and 
osseointegration - the ability to intimately interact with bone without an extra layer of soft tissue. 
The autologous graft is the only one that is osteoinductive and provides the highest 
biocompatibility with the host compared to other grafting treatment options since it comes from 
the same patient.  A disadvantage in this procedure is that it requires at least two operating sites, 
lengthening surgical time and is often associated with moderate levels of pain for the patient [14-
16].  The autologous graft is often considered the “gold standard” for bone defect rehabilitation 
[11, 15].  Additionally, many patients may suffer from osteoporosis, weakened immune systems, 
etc. and autologous grafting is not a viable option. 
Allografting is similar to the autograft method but it is harvested from a cadaver.  The 
allograft has the same distinctiveness as the autograft with the omission of osteogenic cells [16].  
Allograft includes advantages such as availability and avoidance of a second morbidity site [10, 
16].  However, disadvantages of the allograft include but are not limited to fracture, non-union, 
infection, and viral transmission, which could possibly lead to lower degrees of biocompatibility 
and treatment success [14, 16].  
Another type of grafting is the xenograft, which is taken from species other than human 
(in most cases of bovine origin).  Concerns related to this type of grafting include disease 
transmission between the animal and patient [14]. 
2.2.2 Synthetic grafting materials 
Another grafting material group comprises of synthetic materials.  These grafts are/can be 
typically composed of a variety of materials such as polymers, metals, bioactive glasses, and 
bioactive ceramics such as hydroxyapatite (HA) and β tri-calcium phosphate (β-TCP), or a 
combination/mixture of materials [16].  As expected, each of these synthetic grafts has specific 
advantages and disadvantages. 
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Polymers have been used as scaffolds for bone defect regeneration.  Polymers like 
collagen, fibrin, chitosan, and starch, which are natural biodegradable polymers, have been shown 
to present acceptable biocompatibility but minimal osteoconductive properties [15].  These types 
of scaffolds have been widely used because of their versatility, as process dependent 
physicochemical properties ranging in size and shape and degradation rates which can be 
controlled [11].  The benefit of degradable implants is the fact that they eliminate an extra 
surgical procedure for device removal and allow for a slow transfer of the load to the healing 
bone [17].  However, a major disadvantage polymer-based scaffolds is their low mechanical 
stability [15, 18], rationalizing the utilization of other classes of materials in load bearing skeletal 
defects.  
Metals have also been utilized as an alternative solution to skeletal defects.  While metals 
provide instant mechanical strength at the defect site, they generally show poor integration with 
the tissue at the implant location (exceptions include Ti-based alloys among others) [11].  Metals 
have also been shown to fail due to infections or eventually fatigue loading [11].  Along with all 
of the disadvantages, metals do not show any resorption and from a biomechanical perspective 
often times lead to bone resorption due to stress shielding.  Thus, a limitation in the temporal 
physicochemical properties of polymer and metal-based materials has led to a large number of 
investigations on ceramic-based materials. 
Since the type of bonding at the material–bone interface depends on the nature of the 
material the interfacial strength between bone and implant material, is determined from push-out 
tests, it has been determined to be higher for the bioactive implant materials compared to 
materials such as titanium, zirconia or alumina (Table 2.4).  With respect to bioactive materials, 
fractures occur either within the material or bone but not at the interface; however with inert 
materials, the separation occurs at the interface.  This feature is attributed to the “bonding 
osteogenesis” occurring at the interface between bone and the bioactive materials, which is not 
present within non-bioactive materials.  This interface has been referred to as the “bonding zone”, 
described as being electron dense, having a mineralized organic structure. 
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Materials Fracture Strength Bone Contact Fracture 
Bioglass®* 28.9 MPa 92.9% Cohesive 
Hydroxyapatite* 19.6 MPa 95.4% Cohesive 
Titanium** 1.9 MPa 59.5% Interfacial 
Zirconia** 1.3 MPa 33.3% Interfacial 
Strengths per unit area after 24 weeks; *Bioactive; **Non-bioactive 
Table 2.4: Comparative Properties of Biomaterials [19].  
Therefore a large range of physical and chemical properties can be achieved with 
ceramic-based materials.  For instance, introduced in the early 70’s, bioactive glasses present 
osteoconductive properties along with rapid in vivo dissolution rates [16, 20].  These materials 
have been used as pre-formed implants and have shown considerably greater mechanical strength 
in comparison to other bioceramics used for grafting purposes (Table 2.5) [16].  However, their 
utilization fell from favor compared to other materials, as bioactive glasses do not always attach 
to the skeleton and their low resistance to drilling and shaping due to their brittle nature [11, 16].  
Alternative to bioglasses, calcium phosphate (CaP) based bioceramics possess two of the ideal 
characteristics for grafting procedures: (1) osteoconduction and (2) osseointegration [16].   
 
 
Table 2.5: The table compares the properties of synthetic grafting materials to cancellous and 
cortical bone in addition to giving information on other materials being used currently for tissue 
regeneration [11, 16].  
2.2.2.1 Calcium Phosphates 
Calcium phosphate (CaP) consists of minerals that contain calcium (Ca2+) combined with 
phosphate group (PO4
3-) (Table 2.6).  Calcium found in bovine milk and blood is primarily 
constituted from calcium phosphate.  Two of the primary CaP groups make up our bioceramics 
which will be focused on stoichiometric (1) hydroxyapatite (HA), Ca10(PO4)6(OH)6 which is also 
the principle mineral component of bone and (2) tri-calcium phosphate (TCP), Ca3(PO4)2, which 
occurs in alpha (α) and beta (β) phases.  Hydroxyapatite accounts for almost seventy percent of 
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bone and nearly ninety percent of tooth enamel.  The Ca to P ratio of bone ranges from 
approximately 1 to 1.67, while HA and TCP have ratios of 1.67 and 1.5, respectively.  In terms of 
dissolution among the CaP groups each have their own respective solubility and their rate of 
dissolution with respect to Ca is in the order of TTCP>α-TCP> β-TCP>HA.  While regarding 
dissolution of the phosphate the order was as follows: α-TCP>β-TCP>HA. 
Until recently, pure hydroxyapatite has been used as a graft primarily that it has 
outstanding osteoconductive properties in addition to chemical composition comparable to the 
inorganic component of bone [9, 21].  The advantage of HA is its high initial compressive 
strength while a disadvantage is its low dissolution kinetics in vivo (with rates of 1-2% per year or 
no evidence of change after more than five years of implantation) [10, 16].  Hydroxyapatite with 
a solubility product (Ksp) of ~2.4x10-59 mol/kg resorbs slowly under physiological conditions due 
to its biochemical stability, it will slowly remodel when placed in a bony area  
  As a result of the slow degradation rates of HA, β-TCP ceramics were developed [22].  
While it has been shown that β-TCP (Ksp=2.8x10-30 mol/kg) goes through resorption over a 6 to 
18 month period, it can be argued that it may have too rapid of a biodegradation/dissolution [16, 
22].  Therefore, numerous research projects have attempted blending HA and β-TCP in various 
ratios, coining the new product a biphasic calcium phosphate (BCP) in order to better control the 
bioactive ceramic material degradation/dissolution properties [10].  
HA and β-TCP are both biocompatible and bioactive.  They each possess the excellent 
properties of a nontoxic, biocompatible, osteoconductive, bioactive, nonimmunogenic agent 
while having the ability to form a direct chemical bond with living tissue [23].  These particular 
CaP bioceramics are bioactive (directly bonding with bone) and osteoconductive, but innately not 
osteoinductive, ability to form bone in non-bony sites, although there have been instance reported 
of this happening for both the HA and β-TCP [24, 25].  Specifically sintered HA is very 
important not only for tooth root replacement, bone reparation, augmentation of alveolar ridges 
and maxillofacial reconstruction [26].  In the past researchers have pointed out that the trend in 
the bioceramic field will be focused on solving the limitations of CaP materials, specifically HA 
and β-TCP ceramics, to improve their biological properties and applications [27].  Due to their 
well-researched and studied properties, both are approved as biomaterials by the USFDA.  
Various products that contain either HA, β-TCP, or a combination of both are readily found on 
the market in various forms. 
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2.2.2.2 Biphasic Calcium Phosphate 
The preparation of BCP ceramics which was described in 1986 by R. LeGeros consists of 
a ratio mixture of HA and β-TCP [28].  The sintering of the mixture is carried out at temperature 
where the diffusion of Ca from rich to poor regions is slow and the two phases remain distinct.  
The in vivo properties of the BCP ceramic were characterized by G. Daculsi, and colleagues [29, 
30].  According to these studies, BCPs as biomaterials have controlled dissolution, and due to the 
material’s chemical composition, the bone ingrowth is done at the expense of ceramic.  BCPs are 
obtained when a quantity of biological calcium deficient apatite is sintered at temperatures above 
700°C.  The BCPs’ reactivity is determined by the HA/β-TCP ratio: the lower the ratio the higher 
the reactivity [31].  Degradation and resportion along with its respective 
mechanical/physiological properties will be dependent on ratio of HA/β-TCP, the higher the 
amount of HA the lower the dissolution.  As HA ratio decreases, the BCP ceramic will have more 
bone bonding, β-TCP will resorb facilitating bone formation.  The BCP materials in vitro and in 
vivo have the ability to produce responses from bone cells that are the same as bone material: cell 
attachment and proliferation [32]. 
Irrespective of the ratio of HA to β-TCP, the bone to tissue reaction proceeds in a similar 
healing pattern, which is observed in the typical fracture healing.  In this process, first is the 
formation of the hematoma, followed by inflammation, vascularization, resorption of osteoclasts 
and ultimately new bone formation.  This is a natural occurring process in bone, therefore 
permitting the bone remodeling process [33]. 
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Name and Chemical Formula Abbreviation Structural characteristics 
(unit-cell dimensions in 
angstrom(Å)) 
Density 
(g/cm3) 
β-tricalcium phosphate 
(Ca3(PO4)2) 
β-TCP Trigonal R3ca 
a = 10.439; b 37.375 
3.07 
α-tricalcium phosphate 
(Ca3(PO4)2) 
α-TCP Monoclinic P21/a 
a = 12.887; b = 27.280;  
c = 15.219; β = 126.20 
2.86 
Tetracalcium phosphate 
(Ca3(PO4)2O) 
TTCP Monoclinic P21 
a = 7.023; b = 11.986;  
c = 9.473; β = 90,90 
3.05 
Phospho-calcium hydroxyapatite 
(Ca10(PO4)6(OH)6) 
HA Hexagonal P63/mc 
a = 9.418; b 6.881 
3.16 
Table 2.6: Main calcium phosphate compounds. aHexagonal settings, cThe structure of pure HA 
at room temperature is monoclinic, while in biomaterials the hexagonal form is primarily seen [34, 
35]. 
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Composition (wt%) Enamel Dentin Bone HA β-TCP 
Calcium 36.5 35.1 34.8 39.6 38.8 
Phosphorus 17.7 16.9 15.2 18.5 19.9 
Ca/P (molar ratio) 1.63 1.61 1.71 1.67 1.5 
Sodium 0.50 0.60 0.9 - - 
Magnesium 0.44 1.23 0.72 - - 
Potassium 0.08 0.05 0.03 - - 
Carbonate (CO32-) 3.5 4.6 7.4 - - 
Fluoride 0.01 0.06 0.03 - - 
Chloride 0.30 0.01 0.13 - - 
Crystallographic properties: lattice parameters 
a-axis (Å) 9.441 9.421 9.410 9.430 10.439 
c-axis (Å) 6.880 6.887 6.890 6.981 34.375 
Table 2.7: Concentration of the inorganic components of enamel, dentin, bone, and stoichiometric 
HA and β-TCP [36].  The lattice parameters are the mean ±0.003Å.  
 
Figure 2.3: Partial calcium oxide phosphorus pentoxide (CaO – P2O5) phase diagram [37-39]. 
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2.3 Scaffold Fabrication Technology 
Due to recent improvements in bioactive ceramics processing as well as their structure-
property relationship, a substantial increase in their utilization has been observed over the last 
decade [15].   
Numerous techniques have been developed for the production of bioactive ceramics for 
tissue engineering and bone grafts [40].  However, these fabrication technologies had limitations 
as to the material composition and achievable physical dimensions [40].  Among the first 
techniques were fiber bonding, solvent casting, and melt molding [11, 41].  However, complex 
designs/geometries could not be created using these standard-manufacturing procedures. 
2.3.1 Conventional Scaffold Fabrication Techniques 
Currently there are various fabrication techniques to assemble porous scaffolds, with 
some of the most common ones being: electrospin casting, foam-gel technique, particulate 
leaching, emulsion freeze drying, thermal phase separation, fiber bonding, membrane lamination, 
melt molding, fused deposition modeling (FDM), and solid freeform fabrication (SFF) [41-46].  
Each technique has its own limitations such as but not limited to poor meso-pore size control, 
limited structure composition design capabilities, and uncertain pore interconnectivity to name a 
few. 
For example FDM assembles three-dimensional (3D) models by extrusion, patterning, 
and solidification of a molten polymeric filament.  The deposition speeds are fairly slow and 3D 
pore architecture is difficult to control.  Furthermore the large polymer content quantity requires 
extended binder burnout steps especially when producing structures composed of ceramic oxide.  
While another considerable disadvantage of FDM is the fact the process requires high operating 
temperatures.  Thus the fabrication of certain biological materials is impeded [17, 47-49].   
While stereolithography is not suitable for use with sensitive materials, such as growth 
factors, due to the use of UV laser to crosslink the scaffold, it is still feasible to fabricate a 
ceramic scaffold [50].  Although it requires an extra step, such as making a mold from a polymer, 
making a ‘negative’, with this extra step, not only is that a factor but also extra cost, time, and 
reproducibility.  Aside from the cost and extra step, the reproducibility and resolution, makes this 
method undesirable. 
2.3.2 Three-dimensional printing - Direct Write (DW) - Robocasting 
In an attempt to improve on processing and design, the utilization of computer-aided 
programs for materials design has gained popularity.  From computer-aided design (CAD) and 
computer-aided manufacturing (CAM), technological advancements of 3D-printing in the form of 
robocasting.  Among different 3D production methods, ‘robocasting’ allows for the building of 
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ceramic-based scaffolds without the need for a mold.  Direct-write or robocasting is grouped as a 
SFF method, which utilizes a colloidal gel to fabricate an intricate 3D structure through 
deposition without the need for a cast or mold [37, 38, 51, 52].  According to the ink flow 
behavior, direct-write (DW) techniques can be categorized into two different categories: (1) 
droplet-based, and (2) filament-based ink approach [53].  In droplet-based, the ink is delivered in 
the form of droplets to fabricate a 3D structure while the filament-based direct-write technique is 
favorable due to their material flexibility, low cost, and capability for self-supporting features 
[54-57].  The filament-based technique allows for the creating of advanced composites with the 
utilization of single or multi-material colloidal gels.  It has shown to be a useful tool for tissue 
engineering to fabricate bone scaffolds for bone regeneration.  
 
Figure 2.4: Flow diagram representing the DW process based on filament extrusion technique 
[53]. 
The flow diagram of filament-based direct-write procedure for SFF of 3D structures is 
presented in Figure 2.4.  First, 3D virtual structures are generated through computer aided design 
(CAD) model tools.  Then, the operation parameters, such as deposition speed, applied pressure, 
nozzle diameter, and spacing height, should be specified.  Next, process relevant ink properties, 
like material types and composition, should be determined.  The computer numerical control 
(CNC) software processes the designed CAD model, operation conditions and ink properties, and 
conveys them to three-axis motion system and ink delivery system simultaneously.  Three-axis 
motion system controls the accurate tool path for the deposition process.  The ink delivery system 
supplies appropriate volumetric flow rate of inks along the tool-path lines.  Based on the 
cooperation of these two systems, the real 3D structures can be created.  
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The ink delivery system is the most important component in the whole filament-based 
DW process.  It depends on the ink properties, and desired 3D structures and determines the 
quality of the final products.  It commonly consists of three components, propeller, reservoir, and 
deposition head.  The feedstock colloidal gels are stored in reservoirs; the displacement part 
extrudes inks through a deposition head at desired volumetric flow rate (Figure 2.5).  For example, 
in robocasting, the plunger can be mechanically displaced on the ink reservoir at the constant 
speed to drive the ink out of the nozzle.  Figure 2.6 illustrates the schematics of the robocasting 
machine and multi-nozzle arrays for parallel printing of discrete ink materials and mixing nozzle 
system for multi-material mixture printing [52, 58]. 
 
Figure 2.5: Schematic of robocasting fabrication process (Dimensions not to scale).  The ceramic 
part is built layer-by-layer from a computer design.  A three-axis robotic arm moves the injection 
syringe while pressing the ceramic ink through the conical deposition nozzles, immersed in an oil 
bath, to create a self-supporting 3-D network [38]. 
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Figure 2.6: Representation of the robocasting machine used for the fabrication of scaffolds (a) 
represents the entire gantry and setup of robocasting machine, (b) representation of a multi-tip 
arrangement so allow for permitting with various materials, and (c) image of mixing nozzle 
attached to mixing motor and chamber [52]. 
Even though DW techniques have indicated their potential advantages allowing the 
ability to ‘print’ a variety of designs (Figure 2.7), there are still some challenges.  Firstly, the 
challenges in identifying new ink materials and their potential functions.  Further advances 
require science-based ink design method, instead of empirically formulating new inks by trial and 
error adjustments of inks composition.  Secondly the machine requires manufacturing precise and 
quality parts using these materials.  Ultimately with respect to the DW scaffolds the shape and/or 
deformation of structures during deposition, drying, and sintering is another important area to pay 
keen attention to, to further advance this technology.  Lastly is to how to apply these techniques 
from prototyping to large-scale production, and to shorten production time and lower cost for 
these parts [53]. 
In summary, for the robocasting process the following criteria, with respect to the 
colloidal gel, must be satisfied to successfully fabricate a scaffold [59]:  
1) The mixture must be homogenously mixed because the presence of 
agglomerates may lead to clogging, especially when working with smaller 
diameter tips. 
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2) The colloidal gels should be extruded through 100 – 500 µm diameter nozzle, 
while avoiding filter pressing as this would change the solids loading content 
and in turn have a negative affect on the shrinkage. 
3) The colloidal gel should have the ability to retain its shape as extruded, 
cylindrical, along with the ability to have shape retention once new lines are 
printed on top of each other in the subsequent layers. 
 
Figure 2.7: This image depicts various designs of scaffolds, compared to a penny, produced on a 
robocasting machine (3D Inks LLC, Tulsa, OK USA) [10, 54].  
2.4 Scaffolds for bone regeneration 
Bone tissue-engineering (BTE) strategies can be broken down into three primary 
components: (a) the extracellular matrix/scaffold, (b) the cells within that matrix/scaffold and (c) 
the environment within which the cells reside.  These principals can be manipulated in order to 
improve bony healing and regeneration.   
Bone extracellular matrix (ECM) sequesters and preserves osteogenic growth factors, and 
provides a malleable scaffold upon which cells may migrate, adhere, proliferate and differentiate.  
Many factors can impair successful bony re-ossification.  Information on bone development and 
repair mechanisms has been used to create artificial ECMs designed to overcome obstacles and 
guide bone regeneration.  Many materials have been used clinically (e.g., autologous bone grafts, 
allogeneic banked bone, ceramic scaffolds composed of calcium-phosphates, demineralized 
matrix pastes and polymers are reported in the literature. 
Tissue engineered scaffolds can be made up of natural or synthetic scaffolds and/or 
biologic tissue, which may be grown in vitro and in vivo.  A scaffold’s macro and micro-
structural property is essential for cell signaling, propagation, tissue response, and regeneration. 
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These properties affect cell survival, cell shape (which may affect differentiation status) and the 
rate of cell growth.  
The essential properties necessary for cell growth include: (1) macro-structure: the 
scaffold matrix should mimic the physiological functions of the extra cellular matrix (ECM) in 
order to maintain cell differentiation, (2) pore interconnectivity: and open-pore structure with 
highly porous surface and micro-structure that allows for cell in-growth.  Scaffold porosity 
provides adequate space for cells to infiltrate and attach to the scaffold and also facilitates ECM 
formation.  Additionally, high permeability of the scaffolds allows for the inflow of nutrients 
required for cell growth and the excretion of metabolic waste, (3) pore size: the optimal pore size 
needed for bone ingrowth is believed a range of c.a. 300 µm is optimal but pores as small as 20 
µm have resulted in bone ingrowth, (4) surface texture: studies have shown that smooth surface 
implants exhibited fibrous tissue growth and roughened surfaces displayed bone apposition, and 
(5) mechanical properties: the scaffold design should exhibit adequate mechanical properties 
which are needed to support and promote cell growth. 
 
Figure 2.8: Factors influencing cell adhesion in 3D scaffolds [19, 60]. 
Scaffolds require interconnected pore networks to not only stimulate osteoblast migration 
and osteoconduction, but also to permit sufficient nutrient support to the cells within the scaffold. 
With an open weave porous scaffold, trapped blood coagulates to produce a blood clot that can 
induce inflammation, potentially house an infection, and possibly result in rejection of the 
scaffold [61]. 
The structural pore size influences vascularization and cellular content within the 
material component of the scaffold and also mechanical strength.  Previous studies have shown 
that when constructing a scaffold, the minimum pore size can range from 20 to 200µm for the 
Biochemistry 
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osteoconduction and bone maintenance over time.  The conventional scaffold fabrication methods, 
such as solvent casting, particulate leaching, fiber meshing, melt molding have been unable to 
precisely control pore size and geometry.  This is mainly due to their inconsistent and inflexible 
processing procedures, such as molding to cast scaffolds.  Scaffolds require interconnected pore 
networks to not only stimulate osteoblast migration and osteoconduction [62] but also to permit 
sufficient nutrient support to the cells within the scaffold.  Ripamonte et al. [63] compared bone 
formation in porous hydroxyapatite (HA) lithomorphs and HA in granular form.  Despite the use 
of  “powerful” protein inducers of bone formation (bone morphogenic (BMP) and osteogenic 
proteins), morphogenesis is “partially controlled by, if not overruled by, the geometry of the 
scaffold” [63].  In grafted bone, the porosity, not the inherent properties of the graft, determine its 
survival [13]. 
Initial matrix mineralization leading to endosseous integration of implants occurs more 
rapidly (noticeable different by 8 days) with porous surfaced implants than with plasma-sprayed 
surfaces fabricated with the same materials [13].  A porous surface created by sintering Ti6A14V 
particles of 45 to 150 µm onto a machined substrate, resulted in a surface with pore size of 50 - 
200 µm, pore volume porosity of ~37%, and with three-dimensional interconnectivity between 
pores.  An alternate surface was created from the same material using plasma-spray, creating 
more irregularity and with lower porosity (5-10%) with little if any inter-pore interconnectivity.  
Bone response to the two surfaces was compared (in rabbit medial femoral condyles).  As early as 
8 days post implantation, substantially more mineralized tissue was formed within the pores and 
adjacent to the sintered particles of the porous-surfaced region than in the plasma-sprayed surface.  
Certainly, controlled porosity and uniform pore or channel size play and important role not yet 
well understood. 
Healing around an implant is dependent, in part, on the pore size [64], and endosseous 
integration can be promoted through porous structures that provide large areas that are “strain 
protected” [65].  An interconnecting porous architecture is one prerequisite for osteoinductivity 
but, by itself, may not be sufficient to influence bone response [66].  That, in turn, has lead to 
disagreement in “optimal” pore size with reported values ranging from 200 - 400 µm [67-69].  
Over long distances, porosity alone may not be sufficient for diffusion of nutrients. 
The influence on tissue response of the relationship between pore size, volume, and 
interconnectivity and the material, from which a substrate is fabricated, has yet to be established.  
“The relationship between geometry of biomaterials and host tissue response should be designed 
by principle rather than empiricism” [63].  One of the long-term objectives has been to clarify the 
interactions between the material, on the micro-, meso-, and macro-architecture scale of a 
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scaffold on bone response, leading to rational design of effective tissue-specific scaffolds so that 
we can ultimately predict combinations of material and scaffold on the micro- (1-20µm), meso- 
(20-1000µm), and macro- (1-100mm) scales with architectural features that will form 
fundamental building blocks to create structures for controllable bone response (Figure 2.9 and 
Table 2.8).   
 
 
Figure 2.9: This image shows the various scales (nano-, micro-, meso-, and macro-) the scaffolds 
are associated with along with their corresponding measurements [10]. 
Pore Size Biochemical effect/Function 
> 1µm 
Interaction with proteins 
Responsible for bioactivity 
1 – 20 µm 
Type of cells attracted 
Cellular development 
Orientation and directionality of cellular ingrowth  
100 – 1000 µm 
Cellular growth 
Bone ingrowth 
Predominant function in the mechanical strength 
> 1000 µm 
Scaffold functionality 
Scaffold shape 
Scaffold esthestics 
Table 2.8: Hierarchical pore size that an ideal scaffold should mimic to be successful. 
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CHAPTER 3 
QUALITATIVE ANALYSIS OF BIPHASIC CALCIUM PHOSPHATE (BCP) 
MATERIAL FOR SUBSEQUENT PHASES DURING DEGRADATION PROCESS 
3.1 Overview 
This chapter details the analysis of the starting materials as well as the finished ceramic 
product for bone scaffolds which was fabricated via 3D printing.  A brief review is given, 
followed by the materials and methods, with regards to the characterization steps followed for 
chemical characterization and in vitro analysis.  The results and conclusion are followed up for 
this section, with some expected results and the ability to be confident of the process and 
materials. 
3.2 Introduction 
Using these specific bioactive materials, HA, β-TCP or a ratio of the two (e.g., 15/85% 
HA/β-TCP), to achieve a wide range of physical and chemical properties can be achieved.  These 
specific materials have been used as not only as fillers but also as pre-fabricated implants and 
have shown promising results with respect to mechanical strength in comparison to other 
available calcium-phosphate (CaP) based ceramics used for grafting (Table 2.4). 
With regards to HA, it has proven to be useful due to its high initial compressive strength 
but its low dissolution kinetics (with a resorption rate of 1-2% per year or no evidence) [16] lead 
to the investigation and development of a β-TCP ceramic [22]. While β-TCP can resorb in as little 
as a 6 to 18 month period, this may be considered too rapid to act as a viable scaffold for bone 
regeneration [16, 22].  Scaffolds fabricated from a ratio of 15% HA and 85% β-TCP has been 
proven to provide enough initial strength while at the same time allowing resorption in an 
acceptable time frame [16, 22]. 
Aim #1 focuses on qualitatively analyzing the calcium-phosphate (CaP) based ceramic 
powders/materials for their phases during the degradation process.  The hypothesis in regards to 
degradation characteristics is that the scaffolds will degrade in vivo and in vitro as a function of 
the two primary phases: (1) HA and (2) β-TCP.  Intuition indicates that scaffolds with a higher β-
TCP content will dissolve faster.  Scaffolds with a higher fraction of the β-TCP phase will most 
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certainly give a faster time to resorb.  The experimental groups in this aim will include HA, β-
TCP, or a combination of the two and are as follows: (1) 100% HA, (2) 100% β-TCP, (3) 15/85% 
HA/β-TCP and (4) 15/85% HA/β-TCP (model) (percentages based on volume fraction).  The 
dissolution characteristics of the structures will be analyzed in vitro to observe the effect on the 
scaffolds, and additionally verify that no secondary or subsequent phases form during the process.  
Phases such as CPP (Ca2P2O7), calcium oxide (CaO), or α-TCP, to name a few are possibilities, 
which can be derived from the main ceramic components in the scaffold composition. 
The XRD spectrum collection of all the groups, including the individual raw materials 
that were used to fabricate the colloidal gels will be done to do an analysis for the phases.  The 
as-received materials prior to calcination (HA and β-TCP) have shown crystalline phases for the 
their respective primary phases.  However, in previous phase quantification analyses along with 
Rietveld refinement, small amounts of β-TCP, CPP, and calcium oxide (CaO) exist in for the as-
received HA material.  Also, minor fractions, <1%, of HA, CPP, and CaO can exist in the β-TCP 
starting material.  Given that the colloidal gels are primarily fabricated without considering the 
presence of minor quantities of other calcium-phosphate based phases, the beginning 
compositions of HA, β-TCP, or HA/β-TCP may not necessarily be the same in the final product 
[10]. 
The presence of Ca2P2O7 prior to calcination has previously been demonstrated to be 
possible following different HA and β-TCP synthesis routes: 
2CaHPO4 + 2H2O + Ca10 PO4 6 OH 2 → 2Ca3 PO4 2 + 2Ca2P2O7 + 2CaO + 6H2O 
or 
Ca10-x HPO4 x PO4 6-x OH 2-x Ca P =1.5  → 2Ca3 PO4 2 + 2Ca2P2O7 + CaO + H2O  
 
[10, 70, 71].  Additionally, the presence of Ca2P2O7 following high temperature preparation at 
long dwell times has been previously identified and quantified through Rietveld refinement [10, 
70].  The presence of the rapidly dissolving low stoichiometry phases such, CaO or Ca2P2O7, is 
usually not harmful with respect to the response of host to grafting material.  In previous studies 
[70], it was concluded that the secondary phase, might actually permit initially for rapid 
dissolution, which in turn may enable further opening of the pore network, allowing the release of 
Ca and P to the wound-healing site.  This would be beneficial because of enhanced transport of 
nutrients and oxygen; making conditions favorable for osseoconduction.  Alternatively, the 
release of considerable quantities of ions within a quick time frame may prove to be harmful or 
unfavorable to the continuously changing cells populating the wound-grafting area [19, 70].  Thus 
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making the chemical properties of the materials and its subsequent phases an important factor for 
grafting material purposes. 
 In consideration of the nucleation and formation of an apatite or apatite layer on bioactive 
materials, an international standard (ISO) was published to evaluate the apatite-forming ability on 
the surface of biomaterials in a model solution: simulated body fluids (SBF).  The SBF solution, 
proposed by Kokubo et al. contains mineral ions at concentrations comparable to that of human 
blood plasma (Table 3.6) [72-74].  It has been well documented that the apatite layer can be 
reproduced on the surfaces of material in SBF and the nanocrystalline apatite formed is quite 
analogous to the mineral found in bone.  This technique has been used to estimate the potential 
biological activity of a biomaterial and is useful for evaluating in a quantitative manner bone-
bonding ability of a biomaterial prior to an in vivo experimentation.   
 Two important factors, (1) biodeterioration and (2) biodegradation of bioceramic 
materials determine its durability.  Biodeterioration signifies when the modification of the 
implant is not essentially wanted while biodegradation is one of its advantages.  There are a few 
routes that contribute to biodeterioration and biodegradation: mechanical wear, spontaneous 
reactions of the implant materials with body fluids, and cell-mediated alterations.  Mechanical 
wear is of course occurring at the interface between mobile parts of a scaffold but it is also 
observed at the tissue–scaffold interface, and is primarily related to micromovements which 
results in wear residues along with possibility of an inflammatory reaction.  This is limited when 
there is a strong bond between the tissue and bioceramic scaffold.   
 The in vivo biodegradation rate is directly associated to the solubility behavior of the 
materials constituting the bioceramic [29].  The different CaP mixtures demonstrate solubility 
behaviors that vary from one another.  Several physical–chemical factors affecting biodegradation 
can be accounted for with one of the common ones being the de-cohesion of the material related 
to material with the higher solubility, thus leading to the release of crystals or particulates of the 
least soluble, more stable, phase.  This has been the case of HA plasma-sprayed coatings, and can 
be translated to the biphasic HA/β-TCP ceramics.  The size of these particles can prompt different 
body responses.  When the particles, which released are small enough, they can enter the process 
of phagocytosis eventually being eliminated.  However, if elimination is not possible, they may 
initiate an inflammatory response, which can possibly be harmful.  For example, if a material is 
not fully sintered or when a CaP bioceramic is combined with a rapidly absorbed matrix.  Recent 
CaP compounds developed can be modified by manipulating their respective component phase 
ratios.  As is seen in BCP compound, HA/β-TCP ceramics, where the degradation rate can be 
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specifically tailored by modifying the proportion of the β-TCP, more soluble phase, which 
degraded preferentially to HA upon cellular activity. 
 Comparably other physiochemical features have been known to influence the degradation 
rate of bioceramics in vivo (e.g., porosity and crystallinity).  Macroporosity (pore diameter in the 
range ~350µm) seems to be a key; especially in the case of ceramics made of insoluble CaP in 
body fluids.  The macropores permit cell invasion, in-turn, increasing the number of dissolution 
sites.  The effect of microporosity is difficult because initially the effect seems related to a lesser 
content in material while a resultant effect is related to the increase of the surface area and it 
relation to the dissolution rate.  So when considering the composition, highly microporous 
ceramics are faster absorbed in comparison to those of less porosity.  Additionally, crystallinity 
has been shown to be an important factor with the possibility of being related not only to the 
increase of the surface area but dissolution rate as well.   
3.3 Experimental Section 
3.3.1 Material Processing 
Commercially available powders of hydroxyapatite (HA) (Honeywell, Reidel-de Haën, 
Germany) Ca10(PO4)6(OH)2 and beta tri-calcium phosphate (β-TCP) (Sigma-Aldrich, St. Louis, 
MO) Ca3(PO4)2 are used as ceramic materials in this study.  The as-received powders were 
calcined in seperate alumina crucibles at 800°C for 11 hours.  After cooling, each powder was 
attrition milled (1.0 mm zirconia milling media, Union Process, Akron, Ohio) in distilled water 
(DI-H2O) for 30 minutes (Model L001 Attritor System, Union Process, Akron, Ohio).  The water-
ceramic suspensions were then separated from the milling media.  The ceramic slurries were 
placed in a low temperature oven (~80°C) for approximately 8 hours to allow the water to 
separate/evaporate and leaving the dried solid material.  The resulting solid materials were then 
transferred into a Nalgene bottles [10] charged with ~15 pieces of zirconia milling media (10mm 
diameter) which were then violently agitated for ~15 minutes in a paint shaker (1400 Classic 
Shaker, Red Devil Equipment Company, Plymouth, MN).  The powders were then stored in a in a 
dedicated containers in a desiccator cabinet. 
3.3.2 Colloidal Gel Preparation 
The previously calcined and milled ceramic powders were used for the colloidal gel 
formulation.  Concentrated HA, β-TCP, and HA/β-TCP suspensions for the four experimental 
groups (Table 3.1), where volume fraction (ϕceramics) of ceramic was ϕceramics= 0.42 to 0.5, were 
produced by mixing a pre-calculated (Equations (3.3.1-(3.3.7)) amount of ceramic powder and 
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ammonium polyacrylate dispersant (Darvan 821A®; RT Vanderbilt, Norwalk, CT) to stabilize the 
ceramic particles in DI-H2O.  Darvan 821A is a 40% aqueous solution of ammonium polyacrylate. 
The dispersant proportion per gram of ceramics was ~15 mg [10, 75].  First, about 25 g of milling 
media was added to the DI-H2O, then the dispersant, and then the ceramic powder in 3 parts 
(33.3% + 33.3% + 33.3%).  After each addition of powder, the suspension is mixed in the 
planetary mixer (Thinky AR-250; Thinky, Tokyo, Japan) for 1 minute.  Next, 
hydroxypropylmethylcellulose, also referred to as F4M, (Methocel F4M; Dow Chemical 
Company, Midland, MI) was added as the viscosifying agent.  The F4M is used in a 5% by 
weight aqueous solution with a proportion of 7 mg per milliliter of liquid phase (Table 3.2).  The 
suspension was then mixed for 1 minute followed by a defoaming step for 1 minute in the 
planetary mixer.  Finally, the suspension was gelled by adding ~150 mg per 30 mL of ink of 
polyethyleneimine (PEI) (Sigma-Aldrich, St. Louis, MO) 10% by weight solution.  Mixing and 
defoaming (1 minute and 30 seconds, respectively) after the final addition completed the ink 
preparation procedure.  An example of the necessary components and their corresponding 
calculations is presented below in Table 3.2 and Table 3.3.  The resulting colloidal gel needed to 
be printable through the desired size of the nozzle, which meant the paste needed to be not only 
stiff enough to maintain the shape of the extruded filament after deposition, but also soft enough 
to be extruded through the nozzle by applying pressure.  
Group Description Abbreviation 
1 100% HA HA 
2 100% β-TCP β-TCP 
3 15/85% HA/β-TCP BCP 
4 15/85% HA/β-TCP (mixed model) BCP (deisgn) 
Table 3.1: Experimental groups of colloidal gels/scaffolds for testing for Specific Aim #1. 
Substance Quantity (g) 
DI-water (H2O) 19.40 
Darvan 821A® 1.025 
β-TCP 54.55 
HA 9.45 
F4M (5%) 3.90 
PEI (10%) 1.25 
Table 3.2: ϕsolids=0.46 - HA(15%)/β-TCP(85%) 
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15/85% HA/β-TCP 
ϕceramic=0.46 
Vtotal=45mL 
ρβ-TCP=3.1
g
mL
 
ρHA=3.04
g
mL
 
Vsolid= Vtotal ·ϕceramic=20.7mL (3.3.1) 
Vliquid= Vtotal -Vsolid=24.3mL (3.3.2) 
Vβ-TCP= 0.85 · Vsolid =17.595mL· ρβ-TCP =54.545g (3.3.3) 
VHA= 0.15 · Vsolid =3.105mL· ρHA =9.439g (3.3.4) 
M821A= 0.016 · Vβ-TCP+VHA =1.024g (3.3.5) 
MF4M= 8mgmL ∙ 10-3 gmg∙ Vliquid 0.05 g∙molg∙stock solution =3.888g (3.3.6) MH2O= Vliquid-MF4M-M821A ≈19.4g (3.3.7) 
Table 3.3: Example calculation for colloidal gel formulation 
3.3.3 Fabrication of the 3D Scaffold 
The three-dimensional direct-write printer used a gantry robot with affixed syringe 
pumps to extrude the colloidal inks (Table 3.1) through a fine nozzle to build the three-
dimensional scaffold (Figure 3.1) [58, 75].  The three-dimensional disc-shaped scaffolds (10-mm 
diameter, 1-mm thickness, 330 µm struts, and 500µm pore size) (Figure 3.1) were designed on a 
computer-aided design (CAD) software (RoboCAD 4.1, 3D Inks, Tulsa, OK), which outputs x-y-
z motion commands along with the necessary coordination of syringe pumping commands to 
extrude the proper volume flow rate of ink.  The resulting machine code is suitable to be read by a 
U500 motion controller (Aerotech Inc, Pittsburgh, PA).  The syringe pumps are constant volume 
ram extruders rather than air pressure driven.  The ink layers are deposited sequentially, starting 
with the bottom layer.  The three-dimensional disc-shaped scaffolds were printed layer-by-layer 
at 10 mm/s deposition rate onto a flat ceramic substrate (ADS-96R, Coors Tek, Grand Junction, 
CO) in low-viscosity paraffin oil (Ultra-Pure lamp oil, Lamplight Farms Inc., Menomonee Falls, 
WI) to prevent drying of the structure during assembly.  Once a layer was finished, the nozzle 
was translated upward by ∆z = π 4 ·D, (D = inner diameter of the nozzle) and another layer was 
begun.  This was repeated until the desired height of the structure (i.e., 1 mm) was reached.  
Cylindrical nozzles (EFD Inc, Nordson, Westlake, OH) of 330 µm diameter (23 gauge, Part # 
7018314) are used for extrusion because the post-sintering diameter for bone scaffolds was 
designed to be ~267(±2) µm (Figure 3.2) [10].  The difference between the initial and final 
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dimension of the struts is known as shrinkage and occurs when the water and binder is lost and 
sintering occurs.  
 Designed  porosity = 
RW·Dtip - π4  · Dtip
2
RW·D
=1-
π·D
4·RW
 (3.3.8) 
 
  
Figure 3.1: Schematic of scaffold designed in RoboCAD 4.1 (3D Inks LLC, Tulsa, OK) (a) Iso 
view, (b) top and (c) front/side view. 
 
 
Figure 3.2: This SEM image displays the size of the rods as well as pore size and road width 
between each layer [10]. 
3.3.4 Heat treatment of fabricated scaffolds 
After the scaffolds were fabricated, the substrate was removed from the oil bath and 
allowed to dry in air for ~12 hours prior to the sintering process.  Heat treatment of the scaffolds 
a) 
c) 
b) 
5 mm 
h ≈ 1.98 mm 
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was performed utilizing an electric furnace (Model LHT 02/17, Nabertherm GmbH, Lilienthal, 
Germany) to enhance the mechanical strength for handling during the experiments (e.g., in vitro 
dissolution study) [75].  During the sintering processing, the green body ceramic was densified, 
and organic components were burned off.  The firing protocol began by heating at 2°C/min until 
400°C, dwell at 400°C for 2 hour, then heating until 900°C (~8°C/min), dwelling for 2 hours at 
900°C, heating at 3.3°C/min to ultimate temperature of 1100°C, dwelling at 1100°C for 4 hours, 
and finally a cooling at ~8.0°C/min until the samples cooled to room temperature (~30°C) (Figure 
3.3).  The binder burnout during the sintering process results in a predictable volumetric 
shrinkage (~20%) and can result in defects such as cracking and warping [76]. The sintering 
shrinkage of ceramics is an unavoidable step, and all dimensions of the designed geometric 
structure must be enlarged to account for this phenomena and to ultimately attain the final desired 
dimensions. 
 
Figure 3.3: Sintering temperature regime for the four experimental groups, with a ultimate 
sintering temperature equal to 1100°C. 
 
3.3.5 Density and Porosity Measurements 
The density and porosity of the experimental ceramic scaffolds was characterized using 
helium pycnometry (Accupyc 1340, Norcross, GA) to measure the true solid volume of the 
sample (Vsolid) by averaging across 10 independent measures per specimen (n=10 per group).  The 
length and diameter of each sample was determined by averaging three independent 
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measurements to calculate the volume of the bounding cylinder (Vcylinder).  This allowed 
computation of porosity as the void volume fraction as [10, 77]. 
 Void Volume Fraction= 1-
Vsolid
Vcylinder
 (3.3.9) 
 
 Wsolid=ρceramic·h·π·
D2
4  
(3.3.10) 
 
 Wporous=(1-ϕpore)ρceramic
·h·π·
D2
4
 (3.3.11) 
 
 ϕpore=1-
Wporous
ρceramic·Vcylinder
 (3.3.12) 
3.3.6 Inductive Coupled Plasma (ICP) 
Calcium (Ca) and phosphrous (P) concentrations were determined using ICP (Thermo 
Jarell Ash, Trace Advantage).  For this purpose, 10 milligrams of powder from each of the groups 
listed in Table 3.4 were dissolved in 1:1 HCl (35%) and made up to 100mL of double distilled 
water in a volumetric flask.  Suitable standard solutions for Ca (0, 20, and 40ppm) and P (0, 10, 
and 40ppm) and were prepared from 100 ppm standard solutions of the respective elements 
(Fisher Scientific, Pittsburgh, PA, USA).  Each specimen in solution and standard solutions was 
pumped through argon plasma, which was excited by 2kW, 27.12 MHz radio frequency generator 
[78]. 
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Group State 
100% HA 
Raw 
Calcined – 800°C 
Sintered – 1100°C 
100% β-TCP 
Raw 
Calcined – 800°C 
Sintered – 1100°C 
Table 3.4: The above table lists the six experimental groups, which were subjected to ICP 
analysis for Ca/P verification. 
3.3.7 Powder Characterization X-ray Diffraction 
The XRD (Bruker AXS D8 Discover, Madison, WI) was used to determine the 
crystalline phases present within the raw material and various experimental groups.  Three 
different spectra from each testing group were obtained (n=3 per group).  The diffractometer, 
using a curved crystal monochromator, operating at 45mA and 45kV, and scanned in the 2θ with 
a range from 20-65° [10], with a step size of 0.02° at 3 seconds per step. 
Rietveld refinement analysis used the data collected from X-Ray diffractometer, which 
subsequently converted data to “.xy” format.  The raw data was then input into, Material Analysis 
Using Diffraction (MAUD) software for quantitative analysis.  Rietveld analysis utilized the 
samples from previous XRD spectra (i.e., peak, heights, widths and positions).  This refinement 
method was used to quantify the percentage of each phase (HA, β-TCP, and other commonly 
observed phases in calcium- and phosphate-based materials such as calcium oxide, CaO) present 
in different calcination temperatures and sintering groups.  A least square fit approach was 
utilized to measured scans until replicating a theoretical scan (based on the structure in Inorganic 
Crystal Structure Data Base-(ICSD)) [79, 80].  The background, cell parameters, preferred 
orientation; peak asymmetry, atomic positions, site occupancy factors and global vibrational 
parameters were refined.  The calculated and observed patterns were plotted by least squares 
method until a minimum was reached.  Five iterations were utilized and the integrated intensities 
and the peaks heights were related to a scale factor.  The fraction of each phase was determined 
by 
 Wi=
Si ZMV j
Sj ZMVj
  (3.3.13) 
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where, Wi is the weight fraction of the phase, S is the scale factor, Z is the number of formulas 
per unit cell, M is the mass of the formula unit, V the unit cell volume, and i and j are the phase 
under analysis and j all phases in the system [10, 70]. 
3.3.8 Fourier Transform Infrared Spectrometer (FT-IR) 
The FT-IR (Varian 680, Agilent Technologies, Santa Clara, CA) analyses were made for 
the different experimental groups (n=3 per group).  Pellets were fabricated by mixing 1 milligram 
of the desired specimen with 250 milligrams KBr (IR grade, Thermo Scienctific).  A range of 
4000 to 400 cm-1 was scanned [10]. 
 
 HA β-TCP 
Pattern Number 09-0432 74-0566 09-0169 70-2065 
Crystal System Hexagonal Hexagonal Rhombohedral Rhombohedral 
Space Group P63/m P63/m R-3C R3C 
a (Å) (=b) 9.418 9.424 10.429 10.439 
c (Å) 6.884 6.879 37.38 37.375 
RIR None 1.06 None 1.25 
Table 3.5: The parameters utilized for reference patterns for XRD analysis, retrieved from PDF-
2® [81]. 
3.3.9 Differential scanning calorimetry (DSC) and Thermogravimetric analysis (TGA) 
After drying, the colloidal gels were individually heated in a differential scanning 
calorimetry/thermogravimetric analyzer (TGA) (STA 449 F1 Jupiter®, Burlington, MA) to 
characterize possible dehydration of Ca2+ and burnout behavior as a function of temperature.  The 
heating profile from 40°C to 1250°C was carried out with a ramp rate of 2.5°C/min in zero 
hydrocarbon air composed of 80/20 N2 O2 ratio (ZHCAir, Airgas USA, Radnor, PA) with flow 
rate set to 150mL/min. 
3.3.10 Dissolution analysis 
 Degradation of scaffolds was evaluated by determining the scaffold weight loss as a 
function of the immersion time in simulated body fluid (SBF) with a starting pH of ∼7.2 at 37°C, 
to mimic body conditions with ion concentrations approxiametly equal to those of the inorganic 
constituents of human blood plasma (Table 3.6).  The fluids were changed regularly, for time 
periods up 28 days (4 weeks).  Weight loss was measured regularly, and samples were fully 
characterized as weekly time points [82].  The composition of the SBF corresponds to the 
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corrected SBF solution previously published by Kokubo and Takadamaa [73].  A ratio of 1 g of 
scaffold to 50 mL of SBF was used for each test.  After removal from the SBF at selected times, 
the scaffolds were dried at ~70°C for 24 hours and weighed (XS Analytical, Mettler Toledo, 
Columbus, OH).  The weight loss was defined as: 
 ΔWt=
W0-Wt
W0
·100%  (3.3.14) 
 where W0 is the initial mass of the scaffolds and Wt is the mass at time (t) (t=1, 7, 14, 21, and 28 
days).  An initial dry weight of the scaffolds was recorded, and then samples are immersed in 
SBF for ~1 hour, blotted dry and weighed.  This value is considered the initial wet weight that is 
taken in consideration as W0 [76]. 
 Concentration (mmol/dm3) 
 Simulated Body Fluid (SBF) Human Blood Plasma 
Na
+
 142.0 142.0 
K
+
 5.0 5.0 
Mg
2+
 1.5 1.5 
Ca
2+
 2.5 2.5 
Cl
-
 147.8 103.0 
HCO3
-  4.2 27.0 
HPO4
2- 1.0 1.0 
SO4
2- 0.5 0.5 
Table 3.6: Ion concentrations of the SBF solution compared to that of human blood plasma. 
3.3.11 Scanning Electron Microscopy (SEM) 
A field emission scanning electron microscope (FE-SEM) (Hitachi S-4800, Santa Clara, 
CA) was used to observe the porosity and surface of the scaffolds.  Scaffolds from the four 
experimental groups and selected in vitro time points were mounted onto standard SEM pin stub 
mounts, (Product #: 16111, Ø12.7mm x 8mm pin height) (Ted Pella, Inc. Redding, CA), 
grounded with Graphite Conductive Adhesive 154 (Electron Microscopy Sciences, Fort 
Washington, PA), and mounted to a multi holder for 8 pin stubs (Product #: 15310-8) (Ted Pella, 
Inc. Redding, CA).  The multi holder was placed into the sputter coater (Edwards S150B Sputter 
Coater, Sanborn, NY) and coated with a thin layer gold for one minute and thirty seconds. 
3.3.12 Statistical analysis 
For statistical evaluation, analysis of variance (ANOVA) at 95.0% confidence interval 
using IBM SPSS Statistics ver. 22 (IBM Corporation Armonk, NY) was utilized considering 
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materials as independent variables.  Multiple comparisons between groups were performed by the 
Tukey’s post-hoc test. 
3.4 Results and Discussion 
The results for specific aim #1 are presented in the following sections, beginning with 
density/porosity results followed by the powder and scaffold characterization sections.  
Additionally, DSC and TGA data is presented in the following subchapter along with FTI-IR to 
give added value and characterization of the scaffolds and their respective material composition.    
3.4.1 Density and Porosity Measurements 
The theoretical densities of the ceramics used for ink formulations (i.e., 100% HA, 100% 
β-TCP, and 15/85% HA/β-TCP)are 3.16 g/cm3, 3.07 g/cm3, and 3.08 g/cm3, respectively.  The 
mixture of HA/β-TCP in both experimental groups (15/85% HA/β-TCP and 15/85% HA/β-TCP 
(design)) has a density based on a volume fraction of the weighted average of the individual HA 
and β-TCP densities.  The density measurement by He pycnometry match literature values for 
pure (100%) HA and β-TCP.  The as-sintered scaffold trend observed in Figure 3.6 indicated the 
amount of micro-porosity in the scaffolds decreases as sintering temperature increases.  Porosity 
decreases from 23.52% in the rods at 1100°C to 8.32% at 1125°C and disappears entirely at 
1250°C.  A parallel trend is followed by the total porosity while the meso-porosity remained 
relatively constant from 28.23% to 22.85% (within respective error limits). 
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Figure 3.4: SEM micrographs of the four experimental groups: (a) 100% HA, (b) 100% β-TCP, 
(c) 15/85% HA/β-TCP, and (d) 15/85% HA/β-TCP (design).  These images are taken post heat 
treatment to 1100°C for 4 hours.  The images were taken at 20kV and 5000x. 
 
(a) (b) 
(c) (d) 
10 µm 10 µm 
10 µm 10 µm 
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Figure 3.5:  Bar graph representing the four experimental groups’ density along with their 
respective standard deviation (S.D.). 
 
Experimental Group Mean (g/cm3) S.D. 
100% HA 3.288 ±0.016 
100% β-TCP 3.128 ±0.008 
15/85% HA/β-TCP 3.147 ±0.013 
15/85% HA/β-TCP (design) 3.126 ±0.006 
Table 3.7: The mean experimental density (g/cm3) of the four groups along with the 95% 
confidence interval. 
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Figure 3.6: SEM images of the surface of a 15/85% HA/β-TCP scaffold from Hitachi S3500N at 
15.0kV at 3000x.  (a) green state, (b) sintered to 900°C, (c) sintered to 1100°C, and (d) sintered to 
1250°C. 
Sintering Temperature Mean S.D. 
Green State 50.61a  ±5.18 
900°C 46.41b ±1.72 
1100°C 44.21c ±1.98 
1250°C 37.92d ±3.38 
Table 3.8: Percent porosity (mean ± 95% confidence interval) of 15/85% HA/β-TCP based on 
sintering temperature.  The letters represent statistically homogeneous groups. 
 
(a) (b) 
(c) (d) 
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Figure 3.7: Percent porosity (mean ± 95% C.I.) for 15/85% HA/β-TCP at green state and various 
sintering temperatures. 
 
Figure 3.8: Bar graph representing the four experimental groups’ (green state and sintered) mean 
percent (%) porosity along with their respective standard deviation (S.D.). 
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 Green State Sintered 
Experimental Group Mean S.D. Mean S.D. 
100% HA 74.33 ±1.36 75.07 ±3.3 
100% β-TCP 58.56 ±1.06 63.36 ±4.18 
15/85% HA/β-TCP 71.16 ±1.51 69.59 ±4.67 
15/85% HA/β-TCP (design) 68.97 ±1.18 68.82 ±3.95 
Table 3.9: The mean percent porosity (%) of the four groups, and their two states, green and 
sintered, along with the 95% confidence interval. 
 
Figure 3.9: (a) Green state and (b) sintered state 
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 πt πa πf 
10
0%
 H
A
 Green State 77.29% (±2.20) 
74.33% 
(±1.36) 
2.97% 
(±1.80) 
Sintered 76.69% (±2.23) 
75.07% 
(±3.30) 
1.63% 
(±1.18) 
10
0%
 β
-T
C
P 
Green State 73.69% (±0.02) 
58.58% 
(±1.06) 
15.11% 
(±1.06) 
Sintered 67.82% (±1.14) 
65.58% 
(±1.60) 
4.24% 
(±1.46) 
15
/8
5%
 
 H
A
/β
-T
C
P Green State 74.48% (±1.15) 
71.62% 
(±2.12) 
2.86% 
(±1.02) 
Sintered 71.95% (±4.21) 
69.59% 
(±4.67) 
2.37% 
(±0.64) 
15
/8
5%
  
H
A
/β
-T
C
P 
(d
es
ig
n)
 Green State 74.92% (±0.39) 
68.97% 
(±1.18) 
5.95% 
(±0.86) 
Sintered 66.65% (±0.59) 
64.68% 
(±0.97) 
1.98% 
(±0.52) 
Table 3.10: Table summarizing the closed, open, and total porosity, of the four experimental 
groups, in their respective green and sintered states. 
3.4.2 Calcium (Ca) to Phosphorous (P) ratio verification 
The ICP was completed to determine the Ca/P ratio of the two individual materials, in 
each of the 3 respective states: (1) raw, (2) after calcination at 800°C, and (3) post sintering 
1100°C.  The trend in the TCP group seemed to show a decrease from raw to after calcination 
step, but then an increase once sintered (Table 3.11 and Figure 3.10).  While the Ca/P ratio 
slightly increased while going from raw, to calcined, and ultimately sintered in the HA group 
(Table 3.11 and Figure 3.10).  The one-way ANOVA statistical analysis resulted in a p=0.0204 
and p=0.022, for HA and β-TCP respectively, indicating a significant effect due to the state of the 
material.  
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Figure 3.10: Mean ± 95% confidence intervals for Ca/P ratio depicting the two primary groups 
(HA and β-TCP) and their state.  
 HA β-TCP 
State Mean S.D. Mean S.D. 
Raw 1.60a ±0.02 1.36c ±0.02 
Calcined (800°C) 1.62a ±0.02 1.32d ±0.01 
Sintered (1100°C) 1.63a,b ±0.00 1.37c,e ±0.01 
Table 3.11: Mean ± 95% confidence intervals for Ca/P ratio depicting the two primary groups 
(HA and β-TCP) and their state.  The letters depict statistically homogeneous groups. 
3.3.3 Material Characterization X-ray Diffraction 
XRD spectra were collected of the individual raw materials (Figure 3.11) for crystalline 
verification.  Their spectra were matched to the theoretical HA and β-TCP.  After confirmation of 
the material was complete, and the experimental colloidal gels fabricated and subjected to 
sintering at 1100°C, XRD spectra were obtained from the groups for crystalline phase 
determination and verification.  The β-TCP phase is indicated by three high intensity peaks 
located at 27.9°, 31.2° and 34.4° while the highest peaks for HA are at 31.8° and 32.9° (Figure 
3.11).  High crystallinity was indicated by the narrow diffraction peaks described as sharp peaks.  
This result is in good agreement with other researchers’ works that found that biphasic mixing on 
a crystallite level is feasible [81, 83, 84].  The XRD refinement results were used to give an 
approximate Ca/P ratio by applying the following equation (3.4.1): 
Raw Calcined 1100°C Raw Calcined 1100°C
TCP HA
0.0
0.5
1.0
1.5
2.0
C
a/
P
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 Ca/P= wt%i×(Ca/P)i
2
i
  (3.4.1) 
 
Figure 3.11: This XRD spectrum is a comparison between the two basic components of the ink.  
The upper box represents the XRD spectra of hydroxyapatite (HA) group while the lower box 
represents the β-TCP group.  A few of the most intense diffraction peaks are shown on the spectra 
above. 
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Figure 3.12: This XRD spectrum is for Group #1: 100% HA and is a comparison among the six 
(6) time points in vitro: (a) Initial, (b) 1 day, (c) 7 days, (d) 14 days, (e) 21 days and (f) 28 days. 
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Figure 3.13: This XRD spectrum is for Group #2: 100% β-TCP and is a comparison among the 
six (6) time points in vitro: (a) Initial, (b) 1 day, (c) 7 days, (d) 14 days, (e) 21 days and (f) 28 
days 
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Figure 3.14: This XRD spectrum is for Group #3: 15/85% HA/β-TCP and is a comparison among 
the six (6) time points in vitro: (a) Initial, (b) 1 day, (c) 7 days, (d) 14 days, (e) 21 days and (f) 28 
days  
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Figure 3.15: This XRD spectrum is for Group #4: 15/85% HA/β-TCP (design) and is a 
comparison among the six (6) time points in vitro: (a) Initial, (b) 1 day, (c) 7 days, (d) 14 days, (e) 
21 days and (f) 28 days 
The 100% HA and 100% β-TCP materials from both the raw form and post sintered to 
1100°C were subjected to the Rietveld analysis using MAUD program for crystalline phase 
quantification.  The crystalline phases present in the raw materials, as-received, are represented 
above and the phase fraction mean and 95% confidence interval are listed in Table 3.12 along 
with a visual bar graph seen below in Figure 3.16. 
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Phase ê Raw Material è HA β-TCP 
%HA (±95%CI) 99.12a (±0.004) 0.017e (±0.03) 
%β-TCP (±95%CI) 0.87d (±0.004) 90.03b (±2.96) 
%Calcium Pyrophosphate (±95%CI) 0.00e (±0.00) 9.11c (±2.98) 
%Calcium Oxide (±95%CI) 0.00e (±0.00) 0.84d (±0.10) 
Table 3.12: Table indicating the percentage of each phase present in the raw materials as-received 
from the company.  The standard deviations are listed in parentheses.  The letters depict 
statistically homogeneous groups within each phase between all groups evaluated. 
 
Figure 3.16: Percentage of each phase (HA denoted using diagonal lined bars, β-TCP hatched 
filled bars, and calcium pyrophosphate (Ca Pyro) in boxed bars, and calcium oxide represented 
with solid black bars).  The raw materials prior to calcination as-received from company. 
 
The EDS was completed to evaluate the Ca/P ratio for scaffold materials of 100% HA, 
100% β-TCP, and 15/85% HA/β-TCP.  The ANOVA statistics summary is presented in Table 
3.13 and Figure 3.17.  The Ca/P ratios observed for the different groups were similar to what was 
expected aside from 100% HA, which seemed to be slightly on the lower end of the atomic value 
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of ~1.67.  The EDS was done as a supplemental quantitative measurement on the primary sample 
groups.  These values should not be taken as an estimate instead of final average of the groups; a 
better representation for the Ca/P ratio can be given by using inductive coupled plasma (ICP).  
 
Figure 3.17: Mean ± 95% confidence intervals for Ca/P ratio of the experimental groups. 
 
Group Mean Lower Limit Upper Limit 
100% HA 1.58 1.46 1.78 
100% β-TCP 1.52 1.40 1.58 
15/85% HA/β-TCP 1.49 1.37 1.58 
Table 3.13: Mean ± 95% confidence interval for the Ca/P values of the three primary groups.  
 
3.4.4 Fourier Transform Infrared Spectrometer (FT-IR) 
FT-IR was executed to explore the chemical groups molecular vibration, primarily due to 
the advantage of vibrational spectroscopies over XRD is the identification of fine structural 
details, especially those of apatites, such as the location of carbonate species on the different sites 
of the apatite structure, the presence of PO4
3- species, and at some instances the quantification of 
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the amount of OH− ions [85-87].  FT-IR allows for the identification of most calcium phosphate 
phases.  This method focuses on using the internal vibrational levels of molecules and ions, which 
may vary according to the short-range environments of these molecules, or ions.  Phosphate 
(PO4), carbonate (CO3), hydroxide (OH) ions, and water (H2O) molecules are the main groups 
detected by FT-IR.  The PO4
3- group has four main vibrational domains: ν1(at about 950 cm−1), 
ν2(400–470 cm−1), ν3(1000–1150 cm−1), ν4(500–620 cm−1).  While carbonate ions, have four main 
vibrational domains as well: ν1(~1050 cm−1), ν2(820–900 cm−1), ν3(1400–1550 cm−1), and ν4(650–
750 cm−1).  Carbonate ions are always present in biological apatites and they may occupy 
different types of sites.  With respect to the OH− ion, there is only one vibrational domain 
corresponding to the stretching of the O−H bond (3400–3650 cm−1).  However, a signal line, 
corresponding to a rotational energy level of the ion in the lattice, is also observed (630–750 
cm−1).  OH− bands are essentially detected in apatites and related compounds.  The OH− 
stretching and movements are extremely sensitive to hydrogen bonds, and it has been previously 
shown in apatites that the OH bands can be considerably shifted away from their position in HA.  
Table 3.14 below gives a better summary of indicative peaks, which are relevant in the FT-IR 
spectra, with phases of importance.  The most characteristic chemical groups in the FT-IR 
spectrum for HA are PO4
3-, OH-, CO3
2-, and at seldom HPO4
2-.  Figure 3.18a-d presents FT-IR 
spectra of four experimental groups sintered to 1100°C.  
Chemical group and phases Adsorption bands (cm-1) 
CO3
2- 875; 1385; 1419; 1457 
OH- 632; 3572 
PO4
3- (β-TCP)  435 
PO4
3- 1046; 1091 
PO4
3- (HAp) 472; 570; 602; 963 
PO4
3- (β-TCP)  944; 971; 1127 
P2O7
4- 725; 1210 
Table 3.14: Location of FTIR adsorption bands (cm-1) of certain phases and groups [85]. 
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Figure 3.18: The FTIR spectra are shown for the four experimental groups (a) 100% HA, (b) 
100% β-TCP, (c) 15/85% HA/β-TCP, and (d) 15/85% HA/β-TCP (design) 
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3.4.5 Differential scanning calorimetry (DSC) and Thermogravimetric analysis (TGA) 
 Using the DSC to verify whether any transformation was taking place, revealed two 
peaks (one endothermic and one exothermic) in all four experimental groups (Figure 3.19).  The 
first as seen in Figure 3.19 below, is one around 100°C, which is indicative of the water boiling 
off from the material.  The second peak, exothermic, is located at ~ 300°C, this is most likely 
indicative of other polymeric materials being removed from the colloidal gel. 
 
Figure 3.19: The above differential scanning calorimetry spectrum, is a comparison of the four 
experimental groups: (1) 100% HA – red; (2) 100% β-TCP – blue; (3) 15/85% HA/β-TCP – lime; 
and (4) 15/85% HA/β-TCP (design) – pink.  The circles highlight from left to right the 
endothermic and exothermic peaks, respectively.  
TGA results of as-dried colloidal gels are shown in Figure 3.20.  The pre-drying of the 
ink in air evaporates any residual water from the green structure and the remaining components in 
the initial state are the ceramic particles, Darvan 821A® dispersant, the F4M viscosifying agent, 
and PEI.  The TGA data indicates that burnout of the remaining material begins at ~75°C in air as 
a decrease can be seen in the data.  Loss of weight in the range from ~100°C to 150°C is 
presumed to be due to decomposition of polymeric additives.  The calculated weight fraction of 
ceramic gels in dried form is wsolids=~0.70.  The weight loss becomes steady beginning around 
200°C and remains consistent to the ultimate sintering temperature of 1100°C.  The 100% HA 
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group, as can be seen in Figure 3.20, has the most loss, based on percentage (%), due to the fact 
that when the colloidal gel was fabricated it had the lowest solids fraction value at ~ 40%.  
 
Figure 3.20: Thermogravimetric analysis graph above, gives a comparing of the four groups: (1) 
100% HA –►; (2) 100% β-TCP –○ ; (3) 15/85% HA/β-TCP –×; and (4) 15/85% HA/β-TCP 
(design) – ■.  The 100% HA shows the largest, nearly losing 30% of its mass during the process. 
The data from the DSC and TGA analysis was plotted together to give a better 
visualization of what is occurring while materials are being ‘burned’ off during the sintering 
process.  As can be seen in Figure 3.21A-D, the initial drop at approximately 100°C, where water 
would boil, there is also a significant endothermic peak.  While in all of the experimental groups 
there is an exothermic reaction taking place at ~300°C, which can be seen in both Figure 3.19 and 
Figure 3.21.  Figure 3.19 gives a better representation as showing an overlay of all experimental 
groups along with a better scale, shows that there is a slight difference in intensity among the 
groups with the 15/85% HA/β-TCP and 15/85% HA/β-TCP (design) group showing a similar 
trend, and the 100% HA showing the broadest exothermic peak, suggesting there may not be a 
significant reaction taking place. 
0 200 400 600 800 1000 1200
65
70
75
80
85
90
95
100
 
 
M
as
s P
er
ce
nt
 (%
)
Temperature (°C)
 TGA
 100% β-TCP
 15/85%  HA/β-TCP
 15/85%  HA/β-TCP (design)
  
 55 
 
Figure 3.21:  The figure above gives a representation and correlation between the DSC and TGA 
results for the four experimental groups: (A) 100% HA, (B) 100% β-TCP, (C) 15/85% HA/β-TCP, 
and (D) 15/85% HA/β-TCP (design). 
3.4.6 Dissolution analysis 
Immersion of bioactive glass in the SBF results in an initial partial dissolution of the 
material surface associated with a precipitation of a calcium phosphate that resembles the mineral 
phase of bone [88].  
The initial dry and soaked weights of the four experimental group of samples: (1) 100% 
HA, (2) 100% β-TCP, (3) 15/85% HA/β-TCP and (4) (3) 15/85% HA/β-TCP (design) are listed 
below in Table 3.15.  When comparing the two states of scaffolds (1) dry and (2) soaked, a 
p<0.001, was observed indicating a statistical significance.  Within the states the only statistical 
significance was that the 100% HA scaffolds were statistically (p<0.05) different in comparison 
to the other three experimental groups (100% β-TCP, 15/85% HA/β-TCP and 15/85% HA/β-TCP 
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(design)).  All percentages (%) reported are those compared to that of the weight of samples 
soaked for ~1 hour. 
 Dry 1 hour soak 
Experimental Group Mean S.D. Mean S.D. 
100% HA 0.083 ±0.003 0.104 ±0.005 
100% β-TCP 0.098 ±0.001 0.112 ±0.004 
15/85% HA/β-TCP 0.097 ±0.001 0.110 ±0.002 
15/85% HA/β-TCP (design) 0.096 ±0.001 0.109 ±0.002 
Table 3.15: Initial Weights of scaffolds used for the in vitro experimentation, both the dry 
scaffolds and those soaked in SBF for ~1 hour. 
 
Figure 3.22: The above plots are graphs for the amount of weight (g) remaining after x days in 
vitro and the corresponding weight percentage remaining for the experimental groups: (a) 100% 
HA, (b) 100% β-TCP, (c) 15/85% HA/β-TCP and (d) 15/85% HA/β-TCP (design).  
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Figure 3.23: The above image is a matrix of the experimental groups post in vitro.  The columns 
represent the material while the rows give the time point of the submerged in vitro time line. 
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Day (#) 1 7 14 21 28 
Experimental 
Group 
  
 
 
Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
100% HA 80.71% ±0.01 82.77% ±0.02 81.18% ±0.01 84.24% ±0.01 82.69% ±0.02 
100% β-TCP 88.92% ±0.01 90.78% ±0.01 90.18% ±0.01 90.25% ±0.01 90.04% ±0.00 
BCP 90.06% ±0.01 89.42% ±0.00 88.86% ±0.01 89.47% ±0.01 89.25% ±0.01 
BCP(design) 89.16% ±0.02 89.70% ±0.02 89.78% ±0.01 89.52% ±0.01 90.71% ±0.01 
Table 3.16: The above table gives the percentage (%) of materials remaining after set number of 
days in vitro (PBS solution).  The standard deviation (S.D.) is listed in % units.  (BCP=15/85% 
HA/β-TCP). 
3.5  Conclusion 
The present aim (Aim #1) concentrated on the qualitative analysis of the BCP ceramic 
which is primarily used for the regeneration of bone.  This aim focused on four general groups: 
(1) 100% HA, (2) 100% β-TCP, (3) 15/85% HA/β-TCP and (4) 15/85% HA/β-TCP (design).  The 
work was partial based on preliminary work done by group of authors (Witek et al 2011) focusing 
primarily on the bulk properties of 15/85% HA/β-TCP rods.  The material processing and 
subsequent colloidal gel fabrication was based on work done by Smay et al, and detailed in the 
methodology.  The scaffolds chosen here were of similar dimension and pore size of previous in 
vitro and comparable in vivo studies, allowing for near direct comparison of results.  The first 
steps of the characterization process were performed to verify, proper properties were achieved 
post sintering process (e.g., density).   
Porosity evaluation performed with helium pycnometry demonstrated that porosity 
decreases linearly from the green state scaffolds that were subjected to 900°C.  When the 
sintering temperature was increased to 1100°C, a decrease in porosity was observed followed by 
a significant increase in porosity when sintering temperature was raised to 1250°C.  The porosity 
results are in agreement with the scanning electron micrographs, which showed more open 
structures for samples sintered to 1250°C. 
Following the density experimentation, initial XRD scans were completed of the four 
groups to obtain their respective spectra.  These initial spectra were considered to be the baseline 
to compare them to the subsequent spectra post in vitro experimentation period of four weeks.  
The XRD spectra for the green state showed HA and β-TCP peaks for each in their respective 
experimental group.  Such observations were validated through phase quantification by Rietveld 
refinement where a substantial fraction of calcium pyrophosphate was observed following 
calcination at ~10%.  When phase transformation/evolution as a function of sintering temperature 
for materials was evaluated utilizing the green state phase fraction as baseline, a decrease in the 
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amount of HA from ~11% to less than 1% was along with a proportional increase in the amount 
of β-TCP and minimal changes in the amount of CPP (Ca2P2O7) was observed.  The functional 
group OH− in HA is possibly eliminated by a process called dehydration at a relatively high 
sintering temperature (~1100°C), but simultaneously while some of the HA is decomposing and 
forming into α-tricalcium phosphate (α-TCP), β-tricalcium phosphate (β-TCP) and tetracalcium 
phosphate (Ca4(PO4)2O ) (TTCP) [89, 90].  When the scaffolds were dehydroxylated via 
sinterting process, the HA lost OH− radicals upon heating [91] and longer hold times (≥ 4 hours) 
applied according to the Equation (3.5.1) [92, 93].  The hydroxyl ion-deficient product 
Ca10 PO4 6 OH 2-2xO2⊡x, is known as the oxyhydroxy-apatite, which is from research is known 
to form around 900°C [90].  
 Ca10 PO4 6 OH 2→Ca10 PO4 6 OH 2-2xO2⊡x+xH2O↑ (3.5.1) 
The chemical assessment to quantify Ca/P ratio or further verify the compositions of 
starting materials at the three various stages of colloidal ink development.  The theoretical Ca/P 
ratio for pure HA, β-TCP, and calcium pyrophosphate are 1.67, 1.5, and 1, respectively [94].  The 
ICP results obtained are not in 100% direct agreement with the theoretical Ca/P ratios of HA and 
β-TCP.  The bulk raw form of HA had Ca/P value of 1.598, approximately 5% lower than that of 
the theoretical 1.67, while the β-TCP material was about 10% lower from its theoretical Ca/P 
value of 1.5.  That leads to the conclusion that the β-TCP material utilized in this work, is calcium 
deficient thus further confirming the shifting of phase percentages remaining after the sintering 
process.  Additionally with the results of the ICP indicating the Ca/P values below the theoretical 
value lead to the molar ratio shifting away from 5/3 and 3/2 of Ca to P for the HA (Equation 
(3.5.2) and β-TCP (Equation (3.5.3), respectively, having a stoichiometric formula as seen below: 
 Ca4.79 PO4 2 OH  (3.5.2) 
 Ca2.72 PO4 2 (3.5.3) 
The presence of the rapidly dissolving low stoichiometry phases such CPP is typically 
not detrimental to the initial host to grafting material response.  Since the amount of secondary 
phase determined by Rietveld refinement was considerable (~10%), its initial rapid dissolution 
may enable further opening of the porous network, allowing the release of Ca and P to the 
wound-healing site along with larger diffusivity pathway for nutrients and oxygen, which are 
desirable features for osseoconduction.  On the other hand, the release of large quantities of ions 
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at short periods of time may be detrimental or toxic to the dynamically changing cell populating 
the wound-grafting material [95, 96].  Although the chemical properties are an important for 
grafting purposes they are not the only important property to consider when tailoring scaffold 
materials to patient and/or sites.  With respect to in vitro degradation analysis, there was no 
statistical significance among the four experimental groups.  Therefore it can be concluded that 
even when taking CPP into consideration, does not necessarily make a dynamic difference, which 
can be further translated into in vivo situation under the same assumption.  However, it should be 
taken into consideration that the presence of particles composed of two or more phases produced 
along with potential partial or full phase transformation may account for substantial changes in 
particle fusing, necking, and growth, thereby accounting for the observed microstructural 
evolution and kinetics [10, 97]. 
Following XRD and Rietveld analysis, material composition and chemical groups were 
further evaluated through Fourier Transform Infrared Spectroscopy prior to and after sintering.  
First, organic materials/remnants content was verified after calcination, and at both temperatures 
no organic content was present in the materials along with a low absorbance for H2O after both 
calcination and all sintering regimens, suggesting this fabrication route would not have an effect 
on the physicochemical properties. 
All the experimental groups (1) 100% HA, (2) 100% β-TCP, (3) 15/85% HA/β-TCP and 
(4) 15/85% HA/β-TCP (design) resulted in similar FTIR spectra, with exception of 100% HA.  
The group composed of 100% HA had the OH- peak present, thus indicating one of the primary 
differences between the spectra.  Additionally groups composed of the two phases, (i) HA and (ii) 
β-TCP, had peaks indicative of the CPP phase, and also lacked the definitive OH- peak.  These 
results are in agreement with phase quantification results, which were obtained from the XRD 
spectra.   
The primary goal of this aim was achieved and further confirmed with multiple analyses.  
The phase transformation or as referred in conclusion of HA transforming to β-TCP and small 
amounts of CPP, has been of interest in past, not with regards to possibly being detrimental to the 
host but more so of the ever so ‘disappearing’ Ca+ ion(s).  The results have shown and confirmed 
the HA decomposed into β-TCP from 100°C, thus making it indicative that HA in not fully stable, 
with colloidal inks containing a high amount of β-TCP.  It can be concluded that the presence of 
the TCP in composite colloidal inks is the stimulus for further decomposition of the HA phase 
through the process of dehydroxylation.  So the primary reason for the often so none matching 
Ca/P ratio value was due to taking TCP’s Ca/P theoretical value and not its experimental value.  
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Ca/P ratio is a relevant factor, as it is coupled to scaffold degradation once placed in vivo, so it 
will help better tailor the material, which ultimately becomes the scaffold. 
Ultimately the fabrication of 100% HA, 100% β-TCP, or a combination of both, BCP, is 
done by the sintering of the biologic or synthetic apatite.  The BCP composition after sintering is 
related to the calcium-deficiency of the not sintered apatite and then ultimately on the final 
sintering temperature.  These calcium deficient apatites are sintered at or above 700°C following 
the reaction: 
 
Ca10-xMx PO4 6-y HPO4 y OH 2 è 
 
Ca10 PO4 6 OH 2  + 
 
Ca3 PO4 2 
 
  (Calcium deficient apatite (CDA))          (HA)  (β-TCP)  
 The apatite is deemed to be calcium, Ca2+, deficient when the Ca/P ratio is determined to 
be lower than the stoichiometric value.  The M, in the formula is used to indicate other possible 
ions, which may show in the mixture.   
Biodegration, the process that occurs when a material breaks down into its smaller 
components, reduces the complexity of the matrix system by ‘eroding’ the material.  This process 
of degradation or resportion of the calcium phosphate material ultimately results in physical and 
chemical changes post introduction in to a biological environment, whether it be in vitro setting 
with fluids such as SBF or PBS, or implantation into the host.  The most obvious changes to this 
scaffold and its subsequent material will start with the breaking of the scaffold into smaller 
particles, whether it is naturally or due to movement.  With this being an issue the scaffold will 
endure a loss in its mechanical strength, and in due time it will incur a loss of density, as well as 
change in its porosity.  These aforementioned changes ultimately have an effect on the scaffolds 
size, volume, and weight.  With respect to the possible chemical changes, the local environment 
immediately around the implant its general vicinity may have a pH change which will facilitate 
the dissolution of the scaffold material.  The degradation or resorption has been linked to the 
bioactivity of the calcium phosphate (CaP) materials, which compose the scaffold.  These CaP 
materials, more specifically HA and β-TCP, have a unique feature to them, known as bioactivity.  
Bioactivity is defined as the ability to form a chemical bond with bone, which results in a bone-
scaffold interface and eventually leading to the formation of bone at this interface.  The 
dissolution properties of the CaP materials can be linked to their properties, which can include 
physical form, composition, crystal structure, and crystallinity.  These are factors that are directly 
associated with the material, while other factors such as pH or solution composition will also play 
a role in the process.  For example two scaffolds composed of 15/85% HA/β-TCP will have a 
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different dissolution rate if the density was altered to be different among them, i.e. the material 
with higher density will ultimately dissolve at a slower rate than that scaffold with a lower density.  
The calcium phosphate scaffolds composed of different materials or a combination of two, have 
different crystallographic structure, which results in different internal bond strengths, which are 
related to the solubility of the final ‘product’.  In certain instances even materials with the same 
composition but different structure, such as α-TCP and β-TCP, will vary in in their dissolution 
rate.  The order of solubility of a few commonly used CaP materials in scaffold fabrication is as 
follows: 
 ACP≫DCP>TTCP>α-TCP>β-TCP≫HA  
 (ACP = amorphous calcium phosphate; DCP = monetite, CaHPO4; TTCP = tetracalcium 
phosphate, Ca4P2O9; α- and β-TCP, Ca3(PO4)2; HA = hydroxyapatite, Ca10(PO4)6(OH)2). 
 β-TCP has shown in vitro to dissolve at a faster rate in comparison to HA, while the 
dissolution of the biphasic calcium phosphate (BCP) is based on the ratio of HA/β-TCP, with 
higher amounts of HA in comparison to β-TCP, slowing the rate.  In the past in vitro results have 
indicated that β-TCP was about 3 to 12 times faster in comparison to 100% HA.  These 
monophasic or biphasic calcium phosphate ceramics are osteoconductive but not osteoinductive.  
These osteoconductive ceramics provide the necessary factors that allow for “vascular ingress, 
cellular infiltration and attachment, cartilage formation and calcified tissue deposition” [98, 99].  
While the osteoinductive property of the materials’ “stimulate uncommitted cells, such as 
mesenchymal stem cells, to convert phenotypically to chondroprogenetor and osteoprogenitor 
cells” [98-101].  Although in some instances the osteoinductuve property has been linked to BCP 
ceramics, which are implanted subcutaneously (under the skin).  Even this has been observed in 
scaffolds composed of BCP material, in may not necessarily be linked its osteoinductive feature, 
but more along the geometry of the scaffold, with the incorporation of materials such as bone 
morphogenic proteins [25, 98, 101, 102].   
 The characterization of the calcium phosphate materials by appropriate methods cannot 
be overlooked for the proper interpretation of the in vitro and in vivo observations.  In terms of 
characterization XRD, supplemented by FTIR analysis would be the preferred method.  
Characterizing by calcium to phosphate ratio alone without XRD and FTIR may give misleading 
results especially when investigating the possible various phases (e.g. HA + TCP, HA + TCP + 
CaO, etc).  These CaP biomaterials, which are considered ideal candidates for bone replacement 
consist of HA, β-TCP, or combination of both.  These materials posses the advantage of having 
the ability to controlled.  
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CHAPTER 4 
CREATING A FUNCTIONALLY GRADED BIPHASIC CALCIUM PHOSPHATE 
(BCP) SCAFFOLD WITH THE UTILIZATION OF A NOVEL MIXING CHAMBER   
4.1 Overview 
Chapter 4 focuses the use of the 3D printer to build novel scaffolds for the potential bone 
replacement applications.  The focus is to show the capabilities of the 3D printer and how it can 
create custom tailored scaffolds on the micro and macro scale.  The work employs the use of 
alumina and zirconia to mimic the calcium phosphate system, as these two ceramics provide the 
ability to differentiate for a better analysis. 
4.2 Introduction 
Previously three basic periodic structures have been most widely assembled, including 
space filling layers, high aspect ratio walls, and spanning elements, as illustrated in Figure 4.1.  
Space filling volumes are built from solid layers requiring the deposited ink to be deposited in a 
pattern with no gaps between adjacent filaments.  To create a space-filling layer with a centerline-
to-centerline lateral (x-y) spacing of d, the layer-to-layer (z) spacing is 0.25⋅π⋅d, where d is the 
filament diameter.  While, high aspect ratio walls need the deposited filament have lateral spacing 
>d.  Spanning lattices have a lateral spacing of >d, but adjacent layers are rotated by an angle 
(typically 90°) and requires that the ink can bridge gaps in underlying layers.  In these structures, 
spanning lattices are especially important due to the versatile applications in the areas of 
electronics [103-105], composites [105-107], and biological science [108]. 
Computer-aided design (CAD) and computer-aided manufacturing (CAM), technological 
advancements in 3D-printing in the form of robocasting, fused deposition modeling (FDM), and 
selective laser sintering (SLS) have allowed for the advanced control of bioactive ceramic 
scaffold shape, size, and porosity [41].  Among the various 3D printing methods, robocasting 
allows for the building of ceramic-based scaffolds without the need for a mold and requires very 
little polymeric binder [38].  Robocasting builds (‘prints’) geometries by computer-controlled 
extrusion of colloidal pastes/gels (i.e., inks) [17].  3D printing methods can produce a variety of 
structures using CAD/CAM programs [34] that are adapted to reproducing/constructing a variety 
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of structures from various image/file sources (i.e., CT scans) (Figure 4.2).  One advantage of 3D 
printing is the ability to design specific shapes/objects to be used in bone replacement surgeries.  
The current state of the art 3D programs have produced a variety of designs, which have been 
produced with the SFF/RP system [11, 15, 41, 54, 109, 110].  
 
Figure 4.1: (a) space filling layers, (b) high aspect ratio walls, and (c) spanning elements [53].  
 
 
Figure 4.2: The images above represent a few examples of scaffolds, which can be fabricated 
using the robocasting system.  (a) Represents a quadranted scaffold with 3 different pore sizes, 
(b) a CAD cross-section of a cylindrical scaffold [111] and (c) scaffolds with a cap, used for in 
vivo studies, to prevent from falling thru a circular defect.  
An example of a design a ‘robocasting’ machines is represented in Figure 4.4.  The 
system uses positive displacement syringe pumps to dispense the ink in a pattern controlled by 
the x-y-z gantry robot.  For ceramics, the ink is typically deposited onto a ceramic substrate 
submersed in an oil bath.  For silicone materials, the ink is deposited directly onto the substrate in 
air (for silicone material printing).  For situations where HA/β-TCP scaffolds are desirable, the 
ink deposition must be done on a ceramic plate in an oil bath to prevent non-uniform drying [38].  
(b) (a) (c) 
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Figure 4.3: (a) Overall setup of the robocaster used for two-tip printing, (b) zoomed in image of 
the set up for the dispensing of the two “individual” materials.  The dashed circular shape in (b) 
indicates how exchanging the printing tip can customize the size of the rods. 
 
Figure 4.4: Schematic of robocasting machine currently in use at the Smay Lab Group (Oklahoma 
State University-Tulsa, Tulsa, OK), 3D Inks LLC (Tulsa, OK USA). 
Colloidal ink suspensions can be tailored to a variety of specific needs ranging from the 
concentration of HA or β-TCP (e.g., 15/85, 20/80, 35/65, and 60/40) to the size/shape of the 
scaffold that needs to be manufactured to the particular patient defect.  Therefore, such technique 
allows the possibility of unique chemistry arrangement within the structure, permitting further 
steps in bioactive ceramic material scaffold designing. 
(a) 
(b) 
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For example, from a macro-structural arrangement standpoint, robocasting of bioactive 
ceramic material rods allows distances between rods adjustment to be between 100µm and 
1000µm, potentially altering the host response to the scaffold.  Structural and within-material 
pore dimensions add another element to scaffold designing, as structural pore size influences 
vascularization.  In addition, establishment of cellular content and pore size within the material 
component of the scaffold affects its mechanical strength while yielding dissolution properties 
influences the ability to tailor the scaffold for a specific application.   
Depending on chemical composition and crystal structure, calcium phosphates exhibit 
different biodegradation rates in vivo (i.e., β-TCP>HA).  When two different calcium phosphates 
are properly mixed and subsequently sintered together, a functionally graded material having the 
two phases of the different dissolution rates can be prepared.   
The ultimate goal is to utilize the results from Specific Aim #1, to make sure that no 
unexpected phases arise during the degradation process, which can possibly be detrimental to the 
host.  This will help in establishing the extremes of using the mixing ratio of the various materials 
to be utilized.  As can be seen in Figure 4.5, two materials will be utilized to fabricate the 
structure.  The syringe reservoirs, labeled material #1 and #2 are loaded with a 100% β-TCP or 
100% HA, respectively, colloidal gel.  The first goal was to successfully create a functionally 
graded lattice-based scaffold, with the manipulation of each respective material controlled in the 
CAD design.  It is important to fully understand the mixing chamber and model it properly, using 
a CSTR design approach.   
Using an advanced feature, such as a mixing chamber, the scaffold can be tailored and 
enhanced to a specific site and for the individual patient.  When considering the multi (two)-tip 
technology currently being utilized to fabricate scaffolds, the variation in the scaffold is limited to 
interchanging between layers or mid layer (Figure 4.6a).  With the use of an already developed 
feature such as the mixing chamber, one can fabricate a functionally graded scaffold, truly 
tailoring the compositions, to the one, which would be deemed necessary at that location in the 
lattice-based scaffold.  The scaffold can be tailored in more of a 3D fashion as can be seen in 
Figure 4.6b.  The adjustment of the speed of the motor in combination of the mixing motor can 
create different rationed material from a combination of 2 to 4 different materials.   
This concept of mixing materials and co-extruding thru a single tip has been explored 
with a primitive mixing motor.  The results with the utilization of the first version of the mixing 
motor although successful, resulted in bad ‘mixedness’, and additionally presented a long time to 
fully change over from one material.  The delay to fully change over was seen and illustrated 
when printing silicone samples with red and blue dye as seen in Figure 4.8.  As can be seen, in 
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the array, that the sample starts at the top row in each column, but there is some remaining 
material, still being extruded, it is not until the last (third) structure (bottom row) does one see the 
complete change over.  With respect to the bad ‘mixedness’ that is shown in backscatter SEM 
micrographs as seen Figure 4.9, the mixing was not as uniform as it would be ideally.  This can 
be seen with the brighter/lighter shades being representative of the BaTiO3 material and the 
darker shades representing the SrTiO3. 
 
 
Figure 4.5: A schematic of the mixing nozzle (motor) to be used to mix to 100% colloidal gel 
pastes into a functionally graded structure (The mixer design is in Figure 4.12 and Figure 4.13). 
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Figure 4.6: (a) A schematic of the graded structure, indicating the change of material in different 
layers; (b) The new proposed use of a mixing nozzle to create a graded structure, with a higher 
content of HA on the outside, with a higher content of β-TCP on the inside while moving towards 
the center of lattice-based scaffold. 
 
Figure 4.7: Image showing a printed scaffold, using the multi-tip method, the two materials used 
were white and black silicone, and represents the schematic in Figure 4.6a. 
 
HA β-TCP 
a) 
b) 
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Figure 4.8: This array of silicone cubes represent the change over time, when co-extruding 
materials thru a single orifice.  All of the cubes with their respective ratio of blue to red were 
started at the top and printed until completion.   
 
 
Figure 4.9: The backscatter SEM (B-SEM) images represent a mixture of two materials using the 
first mixing motor designed in the Smay lab.  The binary array starts with a pure single material, 
(a) 100% BaTiO3, and decreases 25% in each subsequent step (b) 75/25, (c) 50/50, (d) 25/75, and 
ultimately reaches the other pure material, (e) 100% SrTiO3, being extruded [59]. 
 
Blue 100 80 60 40 20 0 
Red 0 20 40 60 80 100 
500 mm 
(a) (b) (c) (d) (e) 
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Figure 4.10: The above image gives a rendering of the CAD file, which was designed for a 
prototype experiment for a long bone study.  This cylindrical scaffold was fabricated from two 
materials (white = material #1 and black = material #2).  The image gives the reader four images 
to get a better visual understanding: (a) iso, (b) front, (c) top and (d) side. 
In this specific aim, aluminum oxide (Al2O3) (also known as alumina) and zirconium 
dioxide (ZrO2), referred to as zirconia, concentrated colloidal gels were used as model ink 
materials as they can differentiate in the SEM using backscatter mode.  The Al2O3 and ZrO2 
powders used are high purity, sub micrometer-size, and relatively monodispersed.  Al2O3 and 
ZrO2 powders were dispersed into an aqueous suspension with the addition of polyelectrolytes, 
several critical factors such as the pH, the surface chemistry of powders, the degree of 
polyelectrolytes dissociation, the molecular weight of polyelectrolytes, and the adsorption of 
polyelectrolytes must be understood and controlled [112-115].  After the stabilized suspensions 
were fabricated, the gel-based inks were prepared by adding appropriate amount of flocculants.  
During the extrusion, the colloidal gel needed to sustain the creep deformation caused by the 
extrusion pressure, which was induced shear stress.  
4.3 Experimental Section 
4.3.1 Materials 
Aluminum oxide (Al2O3 ) (AKP-30, Sumitomo Chemical Co., Tokyo, Japan) and 
Zirconia (ZrO2) (TZ-3Y, Tosoh Corporation, Tokyo, Japan) powders were utilized, with their 
properties listed in Table 4.1, as the ceramic phase. 
  
(a) (b)
(c) (d)
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 Al2O3 ZrO2 
Mean Particle Size (µm)  0.32 0.04 
Specific Surface Area (m2/g) 7.10 16.0 
Density (g/cm3) 3.97 6.05 
Table 4.1: Basic properties of aluminum oxide (Al2O3) and zirconia (ZrO2). 
4.3.2 Colloidal Gel Fabrication  
Concentrated Al2O3 and ZrO2 colloidal gels were prepared following a similar multi-step 
procedure as in Specific Aim #1.  First, Darvan 821A® (Darvan 821A®, R.T. Vanderbilt Co., 
Norwalk, CT), de-ionized water, and Al2O3 or ZrO2 powders were added sequentially into a 250 
mL sample cup containing ~25 grams of 3 mm diameter zirconia milling media.  The blend was 
mixed for 3 min in a non-contact mixer (Thinky AR-250; Thinky, Tokyo, Japan) to obtain a 
highly concentrated colloidal suspension.  Next, hydroxypropyl methylcellulose  (Methocel F4M, 
Dow Chemical Co., Midland, MI), a 5 wt% stock solution, was added at a 7 mg/mL aliquot 
followed by mixing for 90 seconds.  The suspensions were gelled with the addition of the 
flocculent, nonlinear polyethyleneimine (PEI50-100k) (with MW=50,000~100,000, Sigma-Aldrich, 
St. Louis, MO) 10% by weight solution.  In this specific aim the colloidal inks were fabricated 
with a solid fraction of ϕsolids=~0.47.  All samples were prepared in de-ionized water having a 
nominal conductivity of 5×10-4 Ω-1·cm-1. 
4.3.3 Viscoelastic property measurement  
Al2O3 and ZrO2 colloidal gels were compared to the BCP colloidal gel that is prepared 
by polyelectrolyte induced bridging-flocculation [10, 59, 116].  The rheological properties are 
measured using a controlled stress-strain rheometer (C-VOR 200, Bohlin Instruments, East 
Brunswick, NJ) fitted with a C14 cup and bob geometry (cup diameter = 16mm, bob diameter = 
14mm) with serrated walls to prevent wall slip.  Pre-conditioning of the samples was performed.  
For each measurement, a sample of 3.6 mL of colloidal gel is loaded into the measuring system 
and subjected to 30 min oscillatory pre-shear at 1Hz with a controlled shear stress at 0.02Pa.  
After pre-shear, the sample is kept undisturbed 30min for equilibrium.  All measurements are 
conducted at 25°C and a cover plate with filled water reservoir is used to minimize evaporation. 
The shear elastic modulus (G') is measured in oscillatory mode, where the stress 
amplitude is logarithmically increased from 1 to 2000Pa at an angular frequency of ω = 1Hz.  The 
yield “critical” stress (τy) of the gel is taken as the stress magnitude where G' drops to 90% of the 
maximum value during a stress sweep experiment starting from low stress.  The second set of 
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experiments measures the flow curve of carbon black gel.  In viscometery mode, the shear stress 
(Pa), τ, is recorded as a function of shear rate, (𝛾) in an ascending series of discrete steps (0.001 ~ 
100s-1) with a 1-minute equilibrium at each step.   
4.3.4 Fabrication of graded scaffolds (via two-tip method) 
Robocasting uses a gantry robotic control machine (Aerotech Inc., Pittsburgh, PA) to 
extrude colloidal ink through fine nozzles.  Printing was done with two materials (e.g.: colloidal 
inks or silicone).  The two-tip method was done out by using a separate nozzle for each material.  
The printing parameters were set in the design of the structure.  The ink delivery system is 
mounted on a z-axis mounted controlled stage for printing on a stationary platform.  The 3-axis 
(x-y-z) motion is independently controlled by a custom-designed, computer aided program 
RoboCAD (RoboCAD 4.2, 3D Inks LLC, Tulsa, OK).  Once a layer is ‘printed’, the gantry was 
translated up (∆𝑧) in the z-axis and the syringe is translated to with respect to the x-y axis, to 
allow for the printing of the secondary material, with the change between syringe #1 and #2 
occurring at pre determined geometrical locations as designed in the program per the design.  
This process is repeated until entire scaffold is printed.  This ∆𝑧 distance is a function of the 
deposition nozzle diameter (D) and for all structure design parameters the following correlation 
was used: in this project, a ∆z of (π 4) ·D.  The colloidal gel exits the nozzle as a continuous, rod-
like filament due to its rheological properties, which also aid in shape retention, allowing the rods 
to fuse together at points where they are in contact.  Interruptions of ink flow (e.g. air bubbles, 
clogs, etc.) during fabrication are not desirable.  Start-stop events were avoided as much as 
possible, but as this was a two-tip method, it was necessary when a change in tip (material) was 
indicated in the design parameter.  
4.3.5 Fabrication of mixed-material scaffolds (via mixing chamber) 
Stock inks of the prepared pure ceramics were loaded into individual reservoirs and then 
co-extruded through a mixing chamber to form samples with desired compositions by controlling 
the flow rate ratios of the two inks through the deposition nozzles.  Figure 4.11 shows a 
schematic for the intended application where a binary array is illustrated.  The ends in the array 
represent the two pure ceramic compositions and in between there is a systematic variation in 
composition from ‘pure material 1’ (Al2O3) to ‘pure material 2’ (ZrO2) as seen in Figure 4.5.  
The interior circles represent a binary mixture of the two pure components with ratios as follows: 
75/25, 50/50, 25/75 of Al2O3/ZrO2, respectively as seen in Figure 4.11.  Hence, if suitable pure 
inks are created, the entire composition range in the space may be rapidly processed in a single 
array printing experiment.  The samples are discrete, and the composition step size can be 
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adjusted to suit the experimenter's desires.  The pre-mixing of samples can be avoided and on the 
print properties can be tailored with real time mixing operations.  
 
Figure 4.11: The black shade represents the Al2O3 while the lighter “white” shade represents the 
ZrO2 material.  The 5 circular shapes represent a different ratio of Al2O3 to ZrO2 material ranging 
from 100% Al2O3, followed by 75/25, 50/50, 25/75, and ultimately 100% ZrO2. 
Aqueous stock inks of alumina (Al2O3 ) and zirconia (ZrO2 ) were prepared at 
ϕsolids=~0.45 volume solids loading such as those utilized and thoroughly explained in Specific 
Aim #1 (Chapter 3).  The colloidal gels were loaded into individual syringes and attached to the 
robocaster (3D Inks LLC, Tulsa, OK) device as shown in the inset in Figure 4.4. 
The mixing chamber was a custom assembly, which was designed and built to facilitate 
dynamic mixing of the two more colloidal gels immediately before extrusion.  Figure 4.12 shows 
the entire motor and mixing chamber schematic in addition to a cross section of the mixing 
assembly.  The mixed volume between the mixer body & mixing tip is stirred by a rotating 
mixing paddle.  The active mixing region (or dead/mixing volume) is < ~300 nL. 
Al2O3 ZrO2 
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Figure 4.12: (a) Overall schematic of the mixing motor assembly, (b) cross-section of the entire 
assembly from part (a) scaled at 2.5:1. 
 
Figure 4.13: A magnified view of the mixing chamber assembly.  Individual colloidal gels enter a 
common mixing chamber where they are mechanically mixed using a rotating paddle to produce 
a new mixed composite colloidal gel. 
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Figure 4.14: Digital image of mixing nozzle fully assembled, prior to printing silicone structures 
for analysis. 
 Positive displacement syringe pumps were used to push ink streams into the mixing 
chamber (Figure 4.12(c) and Figure 4.13) before being co-extruded as a single filament onto the 
substrate or underlying layers.  Agitator mixing speed was maintained at 2000RPM.  Four layer, 
space filled cuboid samples having square cross sectional area of 5 mm × 5 mm were written at a 
linear speed of 8 mm/s through a conical nozzle having a diameter of 337 µm (Eagle Stainless 
Tube and Fabrication, Inc., Franklin, MA).  The simply calculated Reynolds Number (assuming 
no agitator factor) for this system was ~ 1.14×10-5 (distance, D= 0.2 mm, velocity, V=8 mm/s, 
density, ρAl2O3=3.3 g/cm3 and ρZrO2=6.01 g/cm3 and viscosity, µ = 800 Pas at a shear rate γ= 
10 s-1) with an average residence time of 37.5 µs within the mixing chamber.   
 Reynolds Number = Re = 
ρVD
µ
 = 
VD
ν
 (4.3.1) 
V = mean colloidal gel velocity 
D = pipe diameter 
ρ = colloidal gel density 
µ = colloidal gel dynamic viscosity 
ν = colloidal gel kinematic viscosity 
The low Reynolds Number together with a short residence time (τ) warrants the use of a 
mechanical mixing agitator/paddle to assist in mixing of the colloidal gels.  Samples were then 
deposited onto an alumina substrate, which was immersed in oil.  After the fabrication process, 
substrates were removed from the oil tray, dried in air at room temperature, sintered to 1650°C 
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for 4 hours, embedded, thin gold coated, and then subjected to back scatter electron microscopy 
(B-SEM). 
 Residence time = τ = 
V
q
 (4.3.2) 
V = system capacity to hold a substance q = flow rate of the substance through the 
system 
 
Figure 4.15: This figure represents what the the shapes which will look like from a top view, 
these are CAD images rendered in RoboCAD 4.1: (a) 100% Al2O3, (b) 75/25 Al2O3/ZrO2, (c) 
50/50 Al2O3/ZrO2, (d) 25/75 Al2O3/ZrO2, and (e) 100% ZrO2.  
4.3.6 Heat Treatment of Scaffolds 
 Samples printed with a ratio of Al2O3 to ZrO2 ink were sintered in an air atmosphere 
furnace (Nabertherm LHT 02/17, Nabertherm GmbH, Lilienthal, Germany) for 2 hours at 1600°C, 
which was attained from room temperature.  The temperature increase rate was kept at 5°C/min, 
while two constant temperature steps at 80°C for 2 hour and 500°C for 4 hours were introduced 
before dwelling for 4 hours at 1650°C.  
4.3.7 Scaffold Characterization - X-ray Diffraction 
The XRD (Bruker AXS D8 Discover, Madison, WI) was used to determine the 
crystalline phase(s) present within the raw, green and sintered stages.  Three different spectra 
from each testing group were obtained (n=3 per group).  The diffractometer, using a curved 
crystal monochromator, operating at 45mA and 45kV, and scanned in the 2θ with a range from 
20-65° [10], with a step size of 0.02° at 3 seconds per step. 
Rietveld refinement analysis used the data collected from X-Ray diffractometer, which 
subsequently converted data to “.xy” format.  The raw data was then input into, Material Analysis 
Using Diffraction (MAUD) software for quantitative analysis.  Rietveld analysis utilized the 
samples from previous XRD spectra (i.e., peak, heights, widths and positions).  This refinement 
method was used to verify the phase(s) (Al2O3 or ZrO2) present in the individual colloidal gels at 
the different stages. 
100% Al2O3 100% ZrO2 Al2O3 ZrO2 
(a) (b) (c) (d) (e) 
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4.3.8 Back-scattered Electron Microscopy (B-SEM) 
Scaffolds of the different rationed groups were infiltrated and finally embedded using a 
methacrylate-based resin (Electron Microscopy Sciences, Fort Washington, PA) according to the 
manufacturer's instructions.  A field emission scanning electron microscope (FE-SEM) (Hitachi 
S-4800, Santa Clara, CA) was used to observe the ‘mixedness’ of the colloidal inks thru the 
mixing motor.  The polymerized sample blocks were then subjected to cut and grinding. The 
blocks were then cut in half by aiming the center of the scaffold along the axis with a precision 
diamond saw (Labcut 1010, Extec®, Enfield, CT).  The sections were then polished by means of a 
series of SiC abrasive papers (400, 600, 800, and 1200 grit) (Carbimet, Buehler, Lake Bluff, IL) 
using a grinding/polishing machine (Labpol 12-3DI, Extec®, Enfield, CT) under water irrigation 
[117]. A 1-µm polishing compound was used to remove residual scratches.  Scaffolds of the 
different rationed groups were mounted onto standard SEM pin stub mounts, (Product #: 16111, 
Ø12.7mm x 8mm pin height) (Ted Pella, Inc. Redding, CA), grounded with Graphite Conductive 
Adhesive 154 (Electron Microscopy Sciences, Fort Washington, PA), and mounted to a multi 
holder for 8 pin stubs (Product #: 15310-8) (Ted Pella, Inc. Redding, CA).  The multi holder was 
placed into the sputter coater (Edwards S150B Sputter Coater, Sanborn, NY) and coated with 
gold for one minute.  The back-scattered electron detector (BSE), work was performed at the 
Core Lab of Helmerich Research Center at OSU-Tulsa and was used to give a better 
representation of the mixing methods.  BSE microscopy is based on the larger atoms, those 
greater atomic number, Z, having a higher probability of producing an elastic collision because of 
their larger cross-sectional area.  Subsequently, the number of backscattered electrons reaching a 
BSE detector is proportional to the mean atomic number of the sample.  Therefore, a "brighter" 
BSE intensity is correlated with higher average Z in the samples, while the "dark" areas have a 
lower average atomic number, Z.  Thus, BSE images were helpful for obtaining high-resolution 
compositional maps of the mixing and to distinguish between the two phases [118-121]. 
4.3.9 Radial Distribution Function (RDF) 
In order to compare and describe the mixing modes (powder mix vs colloidal gel mix), a 
pair distribution function g(r), needed to be calculated.  The particle positions were located using 
a macro (Appendix C) along with the particle analysis function of ImageJ (National Institutes of 
Health).  The g(r) is represented mathematically with the following formula, 
 g r =
N(r)
4πr2(∆r)ρ
 (4.3.3) 
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where N(r) was the number of particles in an annular disc/shell of width, Δr, at a distance of a 
radius, r, drawn with a particle at center, ρ the number of particles per cm2 [122].  This correlation 
function, g(r), with respect to a two-dimensional image as shown in Figure 4.16(a) and (b), 
calculated based on pairs of particles relative to the reference particle.  This function ultimately is 
more so a qualitative expression, with regards of giving the probability of locating the center of 
one particle a specified distance from the center of another particle.  At short distances (r), the 
correlation will most likely be equal to zero while at greater radius values the g(r), converges to 1, 
which will give the indication of a uniform probability.  There were 3 experimental groups and 
each group had three RDF correlations compared to each other (Table 4.2). 
ê Experimental group Analysis Group/Area ê 
75/25% Al2O3/ZrO2 
Surface Area Powder Mixed Colloidal Gel Mixed 50/50% Al2O3/ZrO2 
25/75% Al2O3/ZrO2 
Table 4.2: Experimental groups used for determination of the radial distribution correlation 
among the experimental groups. 
  
 
Figure 4.16: (a) and (b) both represent the Radial Distribution Function as a probability of finding 
two particles at some distance or separation of radius, r [122]. 
4.4 Results and Discussion 
4.4.1 Rheological comparison Al2O3 and ZrO2 vs. BCP 
As illustrated in Figure 4.17 and summarized in Table 4.3, when the shear stress (τ) 
logarithmically increases from low to high values, the elastic modulus G' keeps constant as 
equilibrium elastic modulus Geq
'  until yield value, τy, after that, the elastic modulus G' decreases 
significantly.  The scaling of equilibrium elastic modulus Geq
'  and yield stress τy with solid 
fraction, ϕsolids, for the different materials are shown in Figure 4.17.  The results for of the Al2O3, 
r
dr 
(a) (b) 
  
 79 
BCP, and ZrO2 of similar ϕsolids loading varied by an order of magnitude in comparison to the 
BCP colloidal gel.  The trend as seen, increasing values in the Al2O3 and ZrO2, was expected, as 
for a fixed ϕsolids, the Geq
' , and critical stress τy increases with higher amounts of [PEI] wt%, 
resulting in a stiffer colloidal gels [53]. 
 
Figure 4.17: Experimental rheological data, shear elastic modulus, G', as a function of shear stress 
τ, for Al2O3 and ZrO2 compared to BCP colloidal gels of φsolids = ~0.47. 
Sample Al2O3 ZrO2 BCP 
G’
eq 
(Pa) 1,104,900 1,971,000 212,000 
(0.9) G’
eq 
(Pa) 994,410 1,773,900 190,800 
τ
x
 1082.23 2868.83 235.99 
δ (°) 45.0 45.0 45.0 
[F4M] (mg mL ) 7.0 8.5 8.0 
[PEI] (%) 6.0 6.0 5.0 
Φ
solids
 0.47 0.465 0.46 
Table 4.3: A summary of the pertinent information/results extrapolated from Figure 4.17 for the 
comparison of the 3 different collodial gels used for robocasting. 
The two tip fabrication method prints were done with either a white and black silicone 
combination (All Purpose Silicone GE112A 24C, GE Silicone, Huntersville, NC) or the 
combination of Al2O3 and ZrO2.  Figure 4.7 represents how the material is changed during a 
layer-by-layer design.  The advantage with a two-tip printing method is there is no need in taking 
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a change over of material into consideration, as is the case with the mixing chamber method.  The 
disadvantage is that with the two-tip printing apparatus you can print only 100% material ‘A’ or 
100% material ‘B’ at a time, while the challenge with the mixing chamber was to consider the 
residence time when adjusting the ratios of multiple materials during the printing process.  In the 
present study this was accomplished by a design feature of the mixing chamber, keeping the dead 
volume relatively low (<~300 nl). 
4.4.2 Material Characterization and Mixing method analysis 
The scaffolds were prepared two different ways: (1) ‘pre-blended’ to a certain ratio of 
Alumina to Zirconia (powder mixed) or (2) mixed from the colloidal gel via the novel-mixing 
nozzle.  In some instances silicone was used to give a better visualization of the results, whether it 
was printing with ‘pre-blended’ materials using the nozzle array or using ‘pure’ one phase 
colloidal gel blended with another ‘pure’ form to result in a predefined ratio.  Figure 4.7 shows 
what the capability of the nozzle array can print, from the macroscopic scale, giving the ability to 
vary materials in a layer-by-layer fashion.  While Figure 4.18, was printing using the mixing 
nozzle, and only using two materials, but were able to further customize on the go, by adjusting 
the ratio or material #1 to material #2 between layers.  This mixing nozzle method is beneficial by 
not limiting the user and structure to the ‘pre-blended’ materials that are loaded to print but 
allows for the customizability in various ratios. 
Both materials and their respective final products were also subjected to a density 
analysis, with the alumina, being about 99.2% dense with respect to its theoretical density of 3.97 
g/cm3, while the zirconia was about 97.5% of its theoretical density of 6.05 g/cm3.  The mixed 
materials were approximately 98.2%(±0.004) when compared to their average calculated 
theoretical density based on the densities of alumina and zirconia and their relative phase 
fractions (based on volume percent) (Figure 4.23 and Table 4.6). 
X-ray diffraction (XRD) spectra were collected of the individual materials (raw, green 
state, and sintered) (Figure 4.20).  Their spectra were matched to the theoretical Al2O3 and ZrO2.  
After confirmation of the material was complete the inks were fabricated and sintered to their 
respective protocols and XRD spectra (Figure 4.21) were then obtained for the experimental 
groups (Table 4.4) for crystalline phase determination.  The alumina peaks exhibited peaks of 
higher intensity in groups 1 and 2, but started to decrease as the amount of alumina started 
decreasing and zirconia began to increase, this is seen in Figure 4.21.   
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The Rietveld analysis for crystalline phase quantification of the experimental groups (2, 3, 
and 4) is represented in Figure 4.22 and the phase fraction mean and the 95% confidence interval 
are listed in Table 4.5.   
 
Group Components 
1 100% Al2O3 
2 75/25% Al2O3/ZrO2 
3 50/50% Al2O3/ZrO2 
4 25/75% Al2O3/ZrO2 
5 100% ZrO2 
Table 4.4: Table summarizing the 5 experimental groups analyzed and compared with different 
fabrication protocols. 
  
 
Figure 4.18: A digital image of a silicone square printed using the mixing nozzle, with the bar 
indicating the ratio of black and white silicone used in the program.  (a) shows the outside edge, 
showing the detail as can be visually indicated by seeing the hairpin turns in alternating layer and 
(b) the square was cut longitudinally and shown here is the cross-sectional area.  Each ratio 
printing 2 layers, starting at 100% white, 75/25% white/black, 50/50% white/black, 25/75% 
white/black, and ultimately ending with 100% black.  
 
100% Black 
100% White 
(a) 
(b) 
3 cm 
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Figure 4.19: Digital images of silicone box scaffolds printed using the nozzle array.  (a) the 
overall structure showing the interchanged layers and (b) cross-sectioned scaffolds to give a 
image of the continuity of the structure. 
 
 
Figure 4.20: X-ray diffraction spectra of the (a) alumina and (b) zirconia materials used for the 
mixing study to compare the two different methods.  Both materials had spectra collected for their 
raw state, green state, and following the sintering process for verification purposes. 
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Figure 4.21: XRD spectra of the 5 experimental groups, with three regions of interest indicated to 
visually show that the materials were being mixed and the spectra was able to determine the 
values of these. 
 
Figure 4.22: Percentage of each phase, Al2O3 and ZrO2, for the three experimental groups, along 
with their corresponding standard deviations.   
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Experimental Group ê/Phase è Al2O3 ZrO2 
75/25% Al2O3/ZrO2 74.79% (±0.65) 25.21% (±0.64) 
50/50% Al2O3/ZrO2 48.78% (±0.33) 51.22%(±0.32) 
25/75% Al2O3/ZrO2 23.13% (±0.96) 76.87% (±0.96) 
Table 4.5: Table indicating the percentage of each phase present in the experimental groups.  The 
standard deviations (±S.D.) are listed in parentheses. 
 
 
Figure 4.23: The above bar graph plots the mean densities and their respective standard 
deviations from the helium pycnometry analysis of the binary Al2O3 and ZrO2 scaffold system. 
Al2O3/ZrO2 
100/0 75/25 50/50 25/75 0/100 
3.94 (±0.04) 4.29 (±0.05) 4.63 (±0.06) 5.60 (±0.08) 5.90 (±0.09) 
Table 4.6: Table summarizing density analysis, giving the mean values in g/cm3, and their 
respective standard deviation (±S.D.) 
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Figure 4.24: The above micrographs are back scatter SEM images for the three methods and 5 
various experimental groups per method: (a) surface, (b) powder mixing, and (c) colloidal gel 
mixing, while ranging from (1) 100% Al2O3, (2) 75/25% Al2O3/ZrO2, (3) 50/50% Al2O3/ZrO2, (4) 
25/75% Al2O3/ZrO2, and (5) 100% ZrO2. 
 
 Using the SEM micrographs and ImageJ software, an analysis was performed to give a 
rough quantitative answer to the proportion oh each material (e.g.: Al2O3 or ZrO2).  Figure 4.25 
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and Table 4.7 both give a summary of the phases among the 3 experimental groups where the 
Al2O3/ZrO2, ratio was varied.  Looking at the results in Figure 4.25, and using the dashed line (--
----) as a point of reference for what the ratio was expected to be, it was concluded that the 
colloidal gel mixing gave results closets to the expected/designed values.  The only group which 
did not have any statistical significance (p>0.05) was the 25/75% Al2O3/ZrO2  
 
Figure 4.25: Bar graph representing the mean phase percentage of alumina (Al2O3) along with its 
corresponding standard deviation (±S.D.).  The dashed lines represent the volume % of the as 
fabricated structure/ink. 
 
Exp. Group è 
Area ê  
75/25% 
Al2O3/ZrO2 
50/50 
Al2O3/ZrO2 
25/75 
Al2O3/ZrO2 
Surface 
55.04(±0.6)/ 
44.96(±0.3) 
57.8(±3.5)/ 
42.2(±4.95) 
32.85(±1.5)/ 
67.15(±2.1) 
Powder Mix 
66.74(±1.8)/ 
33.26(±2.5) 
48.38(±0.8)/ 
51.62(±1.1) 
29.91(±1.8)/ 
70.09(±2.5) 
Colloidal Mix 
74.80(±2.7)/ 
25.2(±3.8) 
54.17(±2.7)/ 
45.83(±3.8) 
26.43(±5.0)/ 
73.57(±7.1) 
Table 4.7: This table corresponds to Figure 4.25, giving the average numerical phase percentages 
for both alumina (Al2O3) and zirconia (ZrO2) and with their respective standard deviations 
(±S.D.). 
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The radial distribution function (RDF) relates how the particles are packed together, 
relating the diameters of the particles, meaning that, the closest that two particles can be to one 
another will be equal to one diameter length.  At short distances (r), the RDF will be equal to zero, 
indicating the effective width of the particle, this holds to be true due to the fact that the particles 
which are considered as ‘hard spheres’ will not overlap one another.  The numerous peaks which 
can be seen in Figure 4.26, Figure 4.27, and Figure 4.28 indicate that the particles are packed 
around each other, with the occurrence of these peaks at larger radii being indicative of a higher 
degree of order.  Also while the radius grows larger the g(r), converges to 1, which will give the 
indication of a uniform value.  In all three experimental groups 75/25%, 50/50%, and 25/75% 
Al2O3/ZrO2, the powder mixing group showed the smoothest RDF results, with a continuous 
value hovering around RDF=1 (Figure 4.26(b), Figure 4.27(b), and Figure 4.28(b)).  The powder 
mixing group showed more organization and was visually seen that way too, when comparing the 
Al2O3 and ZrO2 phases as can be seen in the backscatter SEM micrographs (Figure 4.24). 
Taking for instance Figure 4.24(B.3) and Figure 4.24(C.3), powder mixed and colloidal 
mixed respectively, it is clearly seen that the mixing condition is different in comparison to one 
another.  One can see the distinction between the two phases (Al2O3 and ZrO2) but the continuity 
of the mixture is not a smooth, which when looking at the RDF results in Figure 4.26, Figure 4.27, 
and Figure 4.28, makes it evident that the powder mixing results in a better particle distribution.  
Although the mixing of particles was not as uniform in the colloidal gel mixing method in 
comparison to the powder mixing, the phase quantities were still near the designed values, 
indicating that the mixing nozzle and its corresponding parts did properly extrude the correct ratio 
of materials. 
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Figure 4.26: The radial distribution functions for 75/25% Al2O3/ZrO2, for (a) Surface 
measurement, (b) powder mixing measurement, and (c) colloidal gel mixing.  
 
Figure 4.27: The radial distribution functions for 50/50% Al2O3/ZrO2, for (a) Surface 
measurement, (b) powder mixing measurement, and (c) colloidal gel mixing. 
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Figure 4.28: The radial distribution functions for 25/75% Al2O3/ZrO2, for (a) Surface 
measurement, (b) powder mixing measurement, and (c) colloidal gel mixing. 
4.5 Conclusion 
The concept of functionally graded scaffold has led to the development of gradient 
porous biomaterials.  While there are not many examples of actual applications of the graded 
porous biomaterials or scaffolds, the interest of searching a new fabrication method of the 
materials still continues.  So far, few fabrication methods have been developed for producing 
functionally graded scaffolds.  The biomaterials can be made into a gradient porous material.  The 
structural features and mechanical properties of functionally graded/gradient porous scaffolds 
have not been characterized.  There are very few in vitro and in vivo studies of functionally 
graded scaffolds.  However, these functionally graded scaffolds are largely still in the stage of 
laboratory research.  While there are several patents on graded porous biomaterials, examples of 
clinic applications are scarce.  A possible hurdle may be the manufacturing cost, which will 
prevent the realization of the potential of functionally graded scaffolds.  For (bio)inert porous 
biomaterials, graded/gradient pore size and porosity will have obvious long-term benefit in terms 
of tissue ingrowth and minimization of stress shielding.  However, for these biodegradable porous 
scaffolds, the effect of graded/gradient micro-/macro- structures on the tissue ingrowth and 
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regeneration would be only in a short term.  While functionally graded scaffolds and their 
composites have optimized mechanical and cell/tissue ingrowth properties, there will still be 
room for enhancement.  Cost-effective methods are still needed to ensure suitable pore sizes and 
high pore interconnectivity.  With the current trend being in bone regeneration rather than tissue 
replacement, bioactive/biodegradable ceramic composites in the form of graded porous scaffolds 
will have their advantages compared to homogeneous porous biomaterials and compared to sole 
polymer or ceramic porous materials.  The pores in the functionally graded porous scaffolds can 
be tailored with the application of a coating (e.g., slurry dipping, sol-gel coating, or biomimetic 
coating (simulated body fluid (SBF)).  Furthermore coating with proteins or embedding with 
growth factors can also modify the porous scaffolds.  The macro-scaled pores can also be 
modified by filling or loading with biodegradable ceramic material such as calcium sulfate 
(CaSO4·2H2O), biodegradable polymers, or natural species like collagens, chitosan, or cells.  One 
promising case would be the development of porous bioactive/biodegradable composites with 
graded/gradient pore size, porosity, and composition and the modification of the composites with 
spatially distributed biochemical stimuli so that stem cells loaded into scaffolds would develop 
into complex tissues such as bone-cartilage tissue. 
With regard of printing these graded or functionally graded materials, certain parameters 
must be established to successful fabricate these with reproducible results.  Taking the scaffold 
graded on the macro scale, i.e. varying material between layers or struts, with the use of the 
nozzle array tool, the ability to control the on-off of the ink flow is critical.  The nozzle array 
allows for the use of multi-tips, extruding ‘pre-blended’ single or multicomponent ink, with 
distinct placement.  The volumetric flow rate, Q, is ~300 nl/sec and a start-stop volume of <6 nl is 
ideal.  Although those two parameters are crucial to fabrication, the precise alignment of the 
multiple tips is also a key factor.  While trying to fabricate scaffolds, which are functionally, 
graded the use of a mixing nozzle is necessary.  The premise of the mixing nozzle is to allow the 
ability to change material on the go while printing, allowing for even greater customizability on 
various scales.  Ideally the mixing nozzle would allow for quick change in composition, therefore 
a mixer volume, Vmixer, < 100nl is ideal.  Having a small dead volume, means that there is not 
much material, if any built up, so it is mixing and then being immediately extruded, so ideally this 
would permit to have a quick change over from one ratio to another.  Additionally, just as in the 
nozzle array, the on-off parameter is important, allowing for precise starts-stops.  With no less 
importance than the other parameters with regards to the mixing nozzle, the mixing efficiency is 
highly important.  This is important due to the fact that one would like to have an evenly 
distributed mixture.   
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From the backscatter SEM analysis, qualitative and quantitative, it was approximated that 
the correct ratios of the two materials, Al2O3 and ZrO2, (i.e. 100/0, 75/25, 50/50, 25/75, 0/100) 
was retained in the fabricated scaffold samples.  Although the ratios were within 5% of their 
designed ratio, the mixing of the colloidal gels in the mixing nozzle was not as ideal, when 
compared to the powder mixed, ‘pre-blended’ colloidal gels.  The cross sectional images of 
colloidal mixing method revealed large spots, ~10 µm, of phases in randomly oriented spots in 
the mixed phase scaffolds.  Even though from the surface micrographs the mixing looked to be 
uniform, the results from the RDF are not in entire agreement with the images.  In the past a 
similar result has been seen with using a similar protocol in mixing, and two primary factors can 
possibly be linked to the poor distribution, (1) the dead volume and residence time may be too 
small, with a quick mix and extrude, the gel is lacking the sufficient mix by the paddle; (2) the 
viscosities of the colloidal gels may be too large to permit for them to fully and uniformly mix 
thoroughly in the short amount of time and small amount of volume.  Three viable solutions may 
be to either (1) increase the size of the dead volume, (2) increase the mixing motor RPMs to great 
than 2,000, and/or (3) tweaking the viscosities of the colloidal gels. 
The benefit of the mixing nozzle has over the nozzle array, is maneuvering away from the 
fabrication of scaffolds using ‘pre-blended, multi-component’ ink (100% β-TCP, 15/85% HA/β-
TCP, or 50/50% Al2O3/ZrO2) and allowing the use of infinite compositions with grading in 1D, 
2D, and 3D.  To further the possibilities with these tools/accessories, combining the mixing 
nozzle with the nozzle array will allow for the printing of intricately designed functionally graded 
scaffolds with support material.  This is an important feature for various applications, especially 
in can be of use in the dental and orthopedic applications.  This will allow the ability to indicate 
and place at specific locations a particular ratio of material, allowing either zirconia toughened 
alumina (ZTA) or alumina toughened zirconia (ATZ).  This kind of customization will be ideal to 
the users as much as it will be to the recipients who will be getting the benefit of these 
biomaterial scaffolds.  Just as this will give the further customizability in non-bioresorbable 
ceramic scaffolds, it will be beneficial to the community of bioresorbable ceramics such as 
hydroxyapatite and β-tri-calcium phosphate.  With the utilization of this design of the mixing 
nozzle will allow the user to fabricate scaffolds which vary composition radially, in turn allowing 
even closer mimicking of the patients bone, when taking the long bone into account. 
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CHAPTER 5 
INNOVATIVE THREE-DIMENSIONAL BCP SCAFFOLDS FOR CRITICAL LONG-
BONE DEFECT REGENERATION 
5.1 Overview 
This chapter ties in the techniques and results from previous chapters and gives a more 
thorough in vitro analysis, and further provides some preliminary data towards the prototype 
critical sized long bone defect, using a long bone scaffold.  The results from the previous chapters 
as well as this chapter lay important groundwork to move forward in using these ceramics and 
mode of fabrication to help repair long bone defects or fractures.  
5.2 Introduction 
The repair of critical sized long bone segmental defects has been an interest in the 
orthopedic field due to its reconstructive complexity.  Attention is given to the defective site’s 
blood supply, with focus between bone and immune cells and mechanical reestablishment. 
Commonly, these defects are caused by trauma, or tumor resection. These issues may leave the 
patient with a critical size defect, which must be controlled with suitable dead space management 
followed by bony reconstruction using a graft material that is osteoconductive and degradable, 
minimizing complications and shortening the length of time of patient immobility. 
Bone wound healing is a complicated area of research and doctors, engineers, and scientist 
will continue searching for the most appropriate solutions.  Large, critical sized, defects or load 
bearing areas, there is not a viable or ideal solution on the market. The future of bone grafting is 
heading towards the combination of materials, which will have tailor-able properties.  After a 
series of in vitro and in vivo studies done by Ricci et al and others a reliable scaffold model with 
regards to material and pore size was verified.  Due to the drawbacks of traditional scaffold 
fabrication methods and tools, complex and intricate shapes have been limited, which in turn 
hindered the ability to fabricate scaffolds for more complex bone replacement sites. 
Three-dimensionally printed scaffolds fabricated from colloidal gel based inks have been 
successfully used to assemble space filling solid structures, (e.g., high aspect ratio walls and 
periodic lattices) however, cantilevered elements or unsupported structures in the past have been
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 difficult to fabricate due to a lack of an appropriate fugitive support material.  Ideally the fugitive 
support material would print and dry with similar characteristics as the previously mentioned 
ceramic colloidal gels, with the feature that it was removable during a sintering process.  
Therefore the support material must possess shear thinning with yield stress rheology and a shear 
modulus comparable to that of the ceramic based colloidal gel.  Additionally it should be aqueous 
for compatible printing with ceramic-based colloidal gels.  All while being stable enough in an oil 
bath during the printing process and resisting shrinkage upon drying. 
Ultimately Smay et al. developed an aqueous fugitive support material, carbon black 
(CB) colloidal gel.  The CB colloidal gel maintained its shape upon extrusion through the 
deposition nozzle and the drying of printed structures.  Upon heat treatment in air, negligible 
residual ash was observed in the printed sample structures as can be seen in Figure 5.4.  These 
characteristics suggest that the CB ink satisfies the printability requirements of the deposition 
process.  The compatibility with the calcium phosphate based inks suggested that the CB ink may 
be compatible with other ceramic compositions.  Furthermore, controllability of combustion rate 
via heating rate and oxygen partial pressure make carbon black inks appealing as a support for 
various structures.  The development of this support material is expected to benefit the 
practitioners of aqueous colloidal gel solid freeform fabrication (SFF) processes to fabricate more 
complex and intricate scaffold design.   
The stability of calcium phosphate (CaP) ceramics is known to be composition and 
structure dependent [123], and depending on the material (HA, β-TCP, or BCP) when implanted 
will undergo dissolution at different rates (HA < β-TCP) [31, 124].  When these CaP materials 
are implanted in vivo, induce a precipitation of a phase which is comparable to the HA like 
mineral found in bone [125].  While in some instances it has been seen that a bone apatite-like 
material was formed in a nonosseous site [124, 125].  Since one of the important factors with 
regards to bioactivity  (bone tissue formation rate and bone tissue bonding) is the dissolution 
produced from the CaP ceramics, which in turn may affect cellular activity, organic matrix 
deposition, or mineral deposition [126, 127].   
5.2.1 In Vitro dissolution release of Ca2+  
 Dissolution, in vitro, measurements are of value to determine or observe any possible 
phase changes that can possibly occur during the fabrication process or dissolution process.  [128, 
129].  In the past there has been work done to try to interpret as well as predict the long-term 
effects of the dissolution of CaP ceramics.  This study set out to determine the relative dissolution 
behavior of the four experimental groups (Table 5.1), specifically the mean concentration 
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(µg/mL) of Ca2+ and PO4 which were released from the experimental scaffold groups in a 
Tris(hydroxy)methylaminomethane-HCl buffer environment [125]. 
 
Group Description Abbreviation 
1 100% HA HA 
2 100% β-TCP β-TCP 
3 15/85% HA/β-TCP BCP 
4 15/85% HA/β-TCP (design) BCP (design) 
Table 5.1: Summary of the four primary experimental scaffold groups used for the in vitro 
evaluation of Ca2+ and PO4 release over a set amount of time. 
5.2.2 Chemical - Biological Factors 
Many scaffold designs at times can incorporate extra chemical or biological factors to 
enhance bone growth (Table 5.2) [130-133].  The choice of selecting which factors to integrate 
should be based on the ultimate goal of the scaffold is to enhance cell by (i) differentiation or (ii) 
proliferation, although these two are inversely proportional both are time dependent.  Each 
independent specific factor affects differentiation or proliferation differently with respect to tissue 
development [134].  Cells can be used as a factor for various purposes: (i) deliver a factor for 
tissue healing [135] or (ii) directly stimulate the cell population within the scaffold [134].  In 
certain instances the scaffold itself can be utilized as a release device for certain factors, such as 
having a material integrated into its macro pores [136] or it can be even filled with a carrier, such 
as calcium sulfate, CaSO4, (CS), that can release cytokine agent [137]. 
Growth factor  Abbreviation Functions 
Bone 
morphogenic 
protein 
BMP BMPs are osteoinductive.  Induces bone 
formation by causing the migration of 
mesenchymal stem cells and their differentiation 
into osteoblast.  BMPs do not initiate osteoclast 
activity. 
   
Transforming 
growth factor-β  
TGF-β  Causes proliferation and differentiation of bone 
by stimulating migration of osteoprogenitor cells, 
and regulating cell proliferation, cell 
differentiation and extra cellular matrix (ECM) 
synthesis.  Inhibits proliferation and 
differentiation of osteoclast progenitor cells. 
   
Fibroblast 
growth factor 
FGF Induces angiogenesis by increasing osteoblast 
proliferation, and also a potent stimulant for 
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wound healing 
   
Insulin-like 
growth factor 
IGF Stimulates osteoblast proliferation and bone 
matrix synthesis.  IGFs also stimulate 
osteoclasts. 
   
Vascular 
endothelial 
growth factor 
VEGF Induces angiogenesis during and 
permeabilization of capillaries bone formation.  
Regulates migration, proliferation and survival of 
endothelial cells by nutrient supply through the 
newly formed blood vessels. 
   
Platelet-derived 
growth factor 
PDGF A key regulator of wound healing/tissue repair.  
Stimulates bone cell proliferation and 
angiogenesis. 
   
Epidermal 
growth factor 
EGF Participates in wound healing process by 
regulating keratinocyte phenotype 
   
Placental growth 
factor 
PGF PGF, a member of VEGF family, stimulates 
angiogenesis. 
Table 5.2: Commonly used growth factors in tissue engineering for drug delivery applications 
[138-140]. 
5.2.3 Possibility of Cytotoxicity (Ca2+ and PO4) 
Phosphorus (P) is widely distributed in the body.  More than 80% of total phosphate (PO4) 
is present in the bone and teeth in the form of apatite.  The remaining phosphate is mostly present 
in the skeletal muscle, with trace amounts in the extracellular fluids (<0.1%) [141-144]. 
Intracellular phosphate ions are essential for oxidative phosphorylation and approximately 20% 
of cellular phosphate is present in the mitochondria.  Roughly 30% of total cellular phosphate is 
stored in the endoplasmic reticulum and is used in phosphorylation of various proteins.  The 
remaining cellular phosphate is present in the nucleus, Golgi complex and lysosomes.  
Transporting phosphate in and out of the cell according to the need of the body is a complex 
process and the exact molecular mechanisms of such sensitive transport are not entirely clear.  It 
is important to note that cells use PO4 to transport cellular energy through the formation of ATP 
by oxidative phosphorylation.   
With the aforementioned, phosphorus is an essential nutrient for the body and is routinely 
consumed through food.  After consumption, phosphorus binds with oxygen and exists as PO4 in 
the body.  Both organic and inorganic forms of PO4 are present in regularly consumed foods.  The 
amount of total PO4 ingestion can be significantly influenced by consumption of processed food 
and beverage, as there are phosphate metabolites additives in these items.  Following a meal, 
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inorganic phosphate can be rapidly absorbed across the small intestine and enter the blood stream 
causing an elevation in blood phosphate levels.  The net efficiency of intestinal phosphate 
absorption is double that of Ca2+ [145].  Taking into consideration just the amount of phosphate 
consumed and adding a calcium phosphate (CaP) based scaffold can lead to a potential toxic 
situation.  Phosphate toxicity due to excessive retention of PO4 in the body can cause a variety of 
cellular and tissue damage (Figure 5.1).  An example is seen with the higher occurrence of 
vascular calcification, encountered in patients with chronic kidney disease, is related to the 
increased retention of phosphate in the body [146, 147].  The normal range of PO4, should be on 
the order of 2.4 – 4.1 mg/dL, so this is of importance as when scaffold is placed in the system, the 
levels in the local region may be slightly higher than normal, but should not increase the over all 
levels to prevent any complications such as cell death, which in turn would lead to killing new 
bone cells. 
Inorganic phases Wt % 
Calcium orthophosphates (biological apatite) ~60 
Water (H2O) ~9 
Carbonates ~4 
Citrates ~0.9 
Sodium ~0.7 
Magnesium ~0.5 
Traces: Cl-, F-, K+, Sr+, Pb2+, Zn2+, Cu2+, Fe2+ balance 
Bioorganic Phase Wt% 
Collagen type I ~20 
Non-collagenous proteins: osteocalcin, 
osteonectin, osteopontin, thrombospondin, 
morphogenetic proteins, sialoprotein, serum 
proteins 
~3 
Other traces: polysaccharides, lipids, 
cytokines 
balance 
Primary bone cells: osteoblasts, osteocytes, 
osteoclasts 
balance 
Table 5.3: Biochemical composition of bone [147, 148] 
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Ca/P Compound 
Chemical 
formula 
Solubility 
at 25°C, 
−log(Ks) 
Solubility 
@ 25°C, 
g/L 
pH 
stability 
range  
in aqueous 
solutions 
at 25°C 
0.5 Monocalcium phosphate 
monohydrate (MCPM) 
Ca(H2PO4)2·
H2O 
1.14 ~18 0.0–2.0 
0.5 Monocalcium phosphate 
anhydrous (MCPA or MCP) 
Ca(H2PO4)2 1.14 ~17 c 
1.0 Dicalcium phosphate 
dihydrate (DCPD), mineral 
brushite 
CaHPO4·2H2
O 
6.59 ~0.088 2.0–6.0 
1.0 Dicalcium phosphate 
anhydrous (DCPA or DCP), 
mineral monetite 
CaHPO4 6.90 ~0.048 c 
1.33 Octacalcium phosphate 
(OCP) 
Ca8(HPO4)2 
(PO4)4·5H2O 
96.6 ~0.0081 5.5–7.0 
1.5 α-Tricalcium phosphate (α-
TCP) 
α-Ca3(PO4)2 25.5 ~0.0025 a 
1.5 β-Tricalcium phosphate (β-
TCP) 
β-Ca3(PO4)2 28.9 ~0.0005 a 
1.2–
2.2 
Amorphous calcium 
phosphate (ACP) 
CaxHy(PO4)z 
·nH2O, 
n = 3–4.5; 
15–20% H2O 
b b ~5–12d 
1.5–
1.67 
Calcium-deficient 
hydroxyapatite (CDHA or 
Ca-def HA)e 
Ca10−x(HPO4)
x(PO4)6−x 
(OH)2−x 
(0 < x < 1) 
~85 ~0.0094 6.5–9.5 
1.67 Hydroxyapatite (HA, Hap or 
OHAp) 
Ca10(PO4)6(O
H)2 
116.8 ~0.0003 9.5–12 
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1.67 Fluorapatite (FA or FAp) Ca10(PO4)6F2 120.0 ~0.0002 7–12 
1.67 Oxyapatite (OA, OAp, 
OXA)f 
Ca10(PO4)6O ~69 ~0.087 a 
2.0 
Tetracalcium phosphate 
(TTCP or TetCP), mineral 
hilgenstockite 
Ca4(PO4)2O 38–44 ~0.0007 a 
Table 5.4: Existing calcium orthophosphates and their major properties.  [a]These compounds 
cannot be precipitated from aqueous solutions. [b]Cannot be measured precisely. However, the 
following values were found: 25.7 ± 0.1 (pH = 7.40), 29.9 ± 0.1 (pH = 6.00), 32.7 ± 0.1 (pH = 
5.28). The comparative extent of dissolution in acidic buffer is: ACP >>α-TCP >> β-TCP 
>CDHA>> HA > FA. [c]Stable at temperatures above 100°C. [d]Always metastable. 
[e]Occasionally, it is called “precipitated HA (PHA)”. [f]Existence of OA remains questionable 
[148, 149]. 
 
 
Figure 5.1: List of possibly pathological events, which can be related phosphate toxicity as 
previously documented in animal and human studies [145, 150, 151]. 
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5.3 Experimental Section 
5.3.1 Support Material – Carbon Black 
 The carbon black ink (CB) formulation utilized uses an anionic dispersant in combination 
with a cationic flocculent molecule to control gel strength.  Carbon black (CB) (Monarch 120, 
Cabot Corporation, Billerica, MA) with specified particle density of approximately 1.8 g/cm3 and 
specific surface area of ~31.3 m2/g.  To disperse the CB, sulfonated naphthalene condensate, 
ammonium salt (NSC4AL) (AGNIQUE NSC4AL, Cognis, Cincinnati, OH), a 44% by weight of 
an aqueous solution of ammonium neutralized derivative of sulfonic acid, containing a 
naphthalene functional unit, is used to stabilize carbon black in water.  Subsequently, an aliquot 
of poly(ethylene glycol) (PEG) (Carbowax PEG-6000, Dow Chemical Company, Midland, MI) 
stock solution (10% by weight in water) was added at 5 mg/mL of ceramic and the suspension 
was again mixed for an additional 2 minutes at 2000 rpm.  Nonlinear poly(ethylenimine) (PEI) 
(ICN Biomedical, Aurora, OH) with Mw = 50 to 100 kDa is prepared in aqueous stock solutions 
with 10% by weight polymer and is used as a flocculant.  Deionized (DI) water (DI-H2O) 
wherever mentioned has a nominal conductivity 5×10-4 (Ω·cm)-1.  In the robocasting process, 
paraffin oil (Ultra-Pure, Lamplight Farms, Menomonee Falls, WI) is used as an oil bath to 
prevent drying during the printing process.   
 An example of CB gel of 30mL volume with a solids volume fraction of ϕCB = 0.37 is 
given in the following.  The amounts of each concentrated stock solution; carbon black and water 
for this example are given in Table 5.5.  First, the NSC4AL, along with carbon black powder is 
added to this aqueous solution in three equivalent aliquots and mixed for 1 minute after each 
addition using a non-contact, planetary mixer (Thinky AR-250; Thinky, Tokyo, Japan) and 
deionized water is added into a 250mL sample cup filled with 30g of 3 mm diameter zirconia 
milling media.  Next, the PEG is added to the carbon black suspension.  Finally the PEI flocculant 
is added to the carbon black suspension such that the weight ratio of PEI molecules to sulfonated 
naphthalene equals approximately 0.23.  The PEI is added in four steps with mixing for 1 minute 
after each addition. 
5.3.2 Thermogravimetric Analysis (TGA) 
After drying, the carbon black gel is heated in a Simultaneous Thermal Analysis (STA) 
(STA 449 F1 Jupiter®, Burlington, MA) to characterize its burnout behavior.  The heating profile 
from 25°C to 900°C occurs at a ramp rate of 2.5°C/min in zero hydrocarbon air composed of 
80/20 N2/O2 ratio (ZHCAir, Airgas USA, Radnor, PA) with flow rate set to 150mL/min. 
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 Carbon Black (CB) 
 ϕCB=0.37 
Vtotal=30mL 
ρCB=1.8
g
mL
 
PEG =10% 
 Vsolid= 45mL ·ϕCB=11.1mL (5.3.1) 
 Vliquid=Vtotal-Vsolid=18.9mL (5.3.2) 
 MCB= Vsolid · ρCB =19.98g (5.3.3) 
 MNSC4AL= 0.106 · MCB =2.12g (5.3.4) 
 
MPEI=
PEG · 10-3 gmg· Vliquid
0.055 g·molg·stock solution
=1.50g (5.3.5) 
 MPEG=
MPEI
MNSC4AL · MNSC4AL =2.318g (5.3.6) 
 MH2O= Vliquid-MNSC4AL-M8PEG-MPEI ≈10.11g (5.3.7) 
Table 5.5: The example calculation for the fugitive support material, carbon black (CB), based on 
a 37% solids loading (ϕsolids=0.37). 
 
Substance Quantity (g) 
DI-water ~10.11 
CB 19.98 
NSC4AL 2.12 
PEG 2.32 
PEI (10%) 1.50 
Table 5.6: Approximate values of necessary substances needed to make a 30mL batch of the 
fugitive support material, carbon black (ϕsolids=0.37). 
5.3.3 Carbon Black vs. BCP gel 
CB gel prepared is compared to the BCP colloidal gel that is prepared by polyelectrolyte 
induced bridging-flocculation [10, 59, 116].  The rheological properties are measured using a 
controlled stress-strain rheometer (C-VOR 200, Bohlin Instruments, East Brunswick, NJ) fitted 
with a C14 cup and bob geometry (I.D.cup = 16mm, O.D.bob = 14mm) with serrated walls to 
prevent wall slip.  Pre-conditioning of the samples was performed.  For each measurement, a 
sample of 3.6 mL of gel is loaded into the measuring system and subjected to 30 min oscillatory 
pre-shear at 1Hz with a controlled shear stress at 0.02Pa.  After pre-shear, the sample is kept 
undisturbed 30 minutes for equilibrium.  All measurements are conducted at 25°C with a cover 
and plate with filled water reservoir which is to minimize evaporation. 
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The shear elastic modulus (G') is measured in oscillatory mode, where the stress 
amplitude is logarithmically increased from 1 to 1000Pa at an angular frequency of ω = 1Hz.  The 
yield stress (τy) of the gel is taken as the stress magnitude where G' drops to 90% of the maximum 
value during a stress sweep experiment starting from low stress.  The second set of experiments 
measures the flow curve of carbon black gel.  In viscometery mode, the shear stress, τ, is recorded 
as a function of shear rate, (𝛾) in an ascending series of discrete steps (0.001 ~ 100s-1) with a 1-
minute equilibrium at each step.  The apparent viscosity (ηapp) of carbon black inks can be 
obtained as a function of the shear rate.   
5.3.4 In Vitro Ca2+ and PO4 release 
 The release of Ca and PO4 ions during dissolution of the CaP based scaffolds (Table 5.1) 
was measured using 0.05 mol/L Tris-(hydroxy)methylaminomethane-HCl (bioWORLD, Dublin, 
OH) solution with a pH of ~7.3 and maintaining a temperature of 37°C (in an incubator).  The 
weight of scaffold to volume of solution ratio was 1 mg/mL as recommended by Ducheyne et al. 
[125].  The time periods to be examined for the release of ions was 1 hour ranging to 2 weeks, 
with three samples measured for each time point.  The Ca2+ concentrations of the solutions were 
measured with the utilization of atomic absorption spectroscopy (AAS) (Varian AA240FS, Santa 
Clara, CA).  The phosphate (PO4) concentration of the solutions was measured as a 
phosphomolybdate complex [125, 152] in a UV-visible spectrophotometer (Cary 5000 UV-Vis-
NIR, Santa Clara, CA)  
5.3.5 Cell Alignment/Cytotoxicity/Protein Mapping 
Fluorescence microscopy images were taken of scaffolds stained 4',6-diamidino-2-
phenylindole (DAPI), additionally staining for proteins S-100β and p75LNGFR.  The S-100β is 
indicative of a vital nervous system sell cell cytosolic protein [153, 154]  while the p75LNGFR is a 
membrane receptor which is critical for binding certain growth ligands (e.g.: NT-3 and NGF) 
[154, 155].  The microscopy images were then analyzed using the angle tool in ImageJ [154, 156].  
Approximately 400 cells were measured for the two time points. For each cellular nucleus, an 
angle was drawn between the major axis of the elliptical nucleus and the corresponding line 
drawn through the predominating strut direction. The corresponding angle off the strut was then 
recorded, the angle drawing procedure is illustrated in Figure 5.13(a). 
5.4 Results and Discussion 
5.4.1 Rheological properties of CB gel 
The initial dispersion of CBG has a relatively low viscosity and gel behavior is only 
evident after the PEI flocculant, is added.  Figure 5.2 shows the oscillatory and steady flow 
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behavior of CB gel.  The elastic shear modulus (G') is graphed as a function of applied shear 
stress amplitude for the CB compared to the BCP colloidal gel.  The magnitude of G' for the CBG 
material is comparable to that for the BCP gel.  Three parameters may be used for comparison of 
the data: the plateau elastic shear modulus (G0
' ) is representative of the elastic nature of the 
colloidal gel network prior to rupture of the gel, the shear yield stress (τy) defined as the stress 
amplitude where G' G0
'  = 0.9 and the yield strain (γy) defined as the strain amplitude when 
G' G0
' = 0.9 [157].  These results are summarized in Table 5.7.  The latter is used as a more 
accurate representation of the physical process used in robocasting where the colloidal gel goes 
from rest in a reservoir and is then extruded through a tip.  The yield stress of the CBG is the 
higher of the two materials.  Likewise, the yield strain for the CBG gel is also higher, but BCP 
yield strain is lower.  Perhaps the more important comparison for the CB gel to the BCP gel is the 
plateau shear modulus. 
 
 
Figure 5.2: Rheology of BCP colloidal gel as compared to the fugitive support material, carbon 
black, illustrating the elastic modulus as a function of shear stress. 
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Sample BCP CB 
G’
eq 
(Pa) 212,000 204,640 
(0.9) G’
eq 
(Pa) 190,800 184,176 
τ
y
 32.38 46.06 
τ
x
 235.99 259.39 
δ (°) 45.0 45.0 
[PEG] - 5% 
M
[PEI]
/M
[NSC]
 - 0.23 
Φ
solids
 0.46 0.37 
Table 5.7: Summary of rheology results in comparing two printable gels, BCP and the fugitive 
support material carbon black. 
 
 
Figure 5.3: Digital image showing 3D printed cones from left to right: alumina, carbon black, and 
alumina. 
 
 
Figure 5.4: (a) A cubic window frame lattice structure printed with 100% β-TCP gel supported by 
the carbon black (CB) gel and (b) 100% β-TCP structure after sintering [59, 108].  
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Figure 5.5: Digital picture of a 3D printed 100% β-TCP scaffold, using a penny as a reference for 
size comparison. 
 
Figure 5.6: Three-dimensional reconstruction obtained through microCT of a 100% β-TCP long 
bone scaffold, the image is cut longitudinally.  
5.4.2 TGA Analysis of Carbon Black Burnout 
TGA results of as-dried CB ink are shown in Figure 5.7.  The pre-drying of the ink 
evaporates any residual H2O from the green structure and the remaining components in the initial 
state are the NSC4AL dispersant, the PEG gelling agent, PEI and carbon black particles.  The 
TGA data indicated that burnout of the remaining material begins at around ~260°C in air.  Loss 
of weight in the range from ~260°C to 345°C is presumed to be due to decomposition of 
polymeric additives.  The calculated weight fraction of CB in this dried ink is wCB=0.85.  This 
discrepancy likely indicates that not all of the polymeric additives are easily volatilized at these 
lower temperatures, but rather indicate that some of the polymer burns off at higher temperature 
along with the degradation of the CB particles.  Above 460°C, oxidation of carbon black 
accelerates and comes to completion by ~645°C.  Hence, it is determined that at ~625°C burnout 
of carbon black support may be carried out to completion at a reasonable speed in air, which is 
consistent with observation from other researchers [158]. 
10 mm 
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Figure 5.7: The plot illustrates the burn out process of carbon black, starting at room temperature 
(~20°C) until about 900°C.  As can be seen in the graph, that there is 0% remaining after ~615°C. 
5.4.3 Ca2+ and PO4 concentration analysis 
The calcium and phosphate concentration (mg\dL) of scaffold dissolution in Tris-HCl 
solution is summarized in Figure 5.8, Figure 5.9, Figure 5.10 and Table 5.8.  Figure 5.8 and 
Figure 5.9 are the representation of Ca2+ and PO4
3-, respectively.  The graphs initially start at time 
point 0 hours, which was used as initial, in analysis for both calcium and phosphate, for calcium 
the 100% HA scaffold groups show the greatest concentraion of Ca2+ ions (~1.9 mg/dL), but 
eventuially release at a slower rate, which can be seen at hour 336 (day 14), that the 100% HA 
scaffold have the least amount of calcium ions released.  On the other end of the spectrum, the 
100% β-TCP has the highest concentration released with approxiamtely 7.6 mg/dL measured 
(Table 5.8).  The 15/85% HA/β-TCP scaffold group, fell in between the 100% HA and 100% β-
TCP groups, and at day 14 had a Ca2+ ion release of approximately 5.95 mg/dL (Table 5.8). 
While the PO4
3- ion showed similar trends as those in Ca2+ the one apparent difference 
was with the 100% HA scaffold group.  There was almost 0 mg/dL of the phosphate ion released 
in the first 24 hours, in comparison to the how much Ca2+ ions released in that same time frame.  
The 100% HA group eventually did end up having a release of approximately 5.1 mg/dL at day 
14 but it was short of what the other three groups (100% β-TCP, 15/85% HA/β-TCP, and 15/85% 
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HA/β-TCP (design)) released in those same 336 hours.  100% β-TCP, 15/85% HA/β-TCP, and 
15/85% HA/β-TCP (design) followed the same trend, and at day 14, they all had an average PO4
3- 
ion concentration of ~8.61 mg/dL, with no significant differences between these three 
experimental scaffold compositions (Figure 5.9).   
 
Figure 5.8: Ca2+ concentration in 0.05 mol/L Tris buffer after immersion of 100% HA, 100% β-
TCP, 15/85% HA/β-TCP, and 15/85% HA/β-TCP (design) for time periods ranging from 1 hour 
to 336 hours (14 days). 
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Figure 5.9: PO4
3- concentration in 0.05 mol/L Tris buffer after immersion of 100% HA, 100% β-
TCP, 15/85% HA/β-TCP, and 15/85% HA/β-TCP (design) for time periods ranging from 1 hour 
to 336 hours (14 days). 
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  Time (hour(s)) 
Group Element(s) 1 12 24 72 168 216 288 336 
Monophasic  
HA 
Ca2+ 
1.864 
(0.13) 
1.971 
(0.24) 
2.015 
(0.04) 
3.874 
(0.05) 
2.463 
(0.62) 
3.659 
(0.48) 
4.540 
(0.31) 
4.469 
(0.04) 
(PO4)3- 
0.079 
(0.06) 
0.089 
(0.09) 
0.108 
(0.05) 
0.952 
(0.00) 
2.112 
(0.17) 
2.284 
(0.04) 
3.882 
(0.75) 
5.112 
(0.59) 
β-TCP 
Ca2+ 
1.485 
(0.08) 
2.015 
(0.31) 
2.256 
(0.28) 
5.250 
(0.76) 
5.675 
(0.15) 
6.129 
(0.31) 
7.349 
(0.23) 
7.632 
(0.65) 
(PO4)3- 
1.304 
(0.18) 
1.636 
(0.14) 
1.939 
(0.03) 
4.265 
(0.44) 
7.183 
(0.19) 
7.525 
(1.59) 
7.912 
(0.34) 
7.912 
(1.01) 
Biphasic  
HA/β-TCP 
Ca2+ 
1.044 
(0.03) 
1.318 
(0.08) 
1.606 
(0.13) 
3.601 
(0.38) 
4.245 
(0.03) 
4.621 
(0.62) 
5.510 
(0.16) 
5.947 
(0.16) 
(PO4)3- 
1.099 
(0.13) 
1.788 
(0.23) 
2.367 
(0.36) 
4.659 
(1.29) 
6.685 
(0.48) 
8.097 
(0.06) 
8.496 
(0.91) 
8.581 
(0.34) 
   HA/β-TCP               
   (design) 
Ca2+ 
0.770 
(0.03) 
0.914 
(0.04) 
1.215 
(0.01) 
2.555 
(0.03) 
3.465 
(0.14) 
3.426 
(0.26) 
4.038 
(0.27) 
4.437 
(0.16) 
(PO4)3- 
1.056 
(0.05) 
1.830 
(0.08) 
2.468 
(0.26) 
4.752 
(0.48) 
7.373 
(0.57) 
8.097 
(0.59) 
8.221 
(0.72) 
9.346 
(0.92) 
Table 5.8: Ca2+ and PO4
3-  mean concentration (mg/dL) as released from the mono- and bi-
phasic scaffold groups, the standard deviations (S.D.) are noted in parentheses. 
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Figure 5.10: Comparing the Ca2+ and PO43- concentration in 0.05 mol/L Tris buffer after 
immersion for time periods ranging from 1 hour to 336 hours (14 days) for (a) 100% HA, (b) 
100% β-TCP, (c) 15/85% HA/β-TCP, and (d) 15/85% HA/β-TCP (design). 
 
 The kinetic rate law for dissolution is: 
 dC
dt
=kD
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n
 (5.4.1) 
C = molar quantity being dissolved 
t = time 
kD = a constant 
n = kinetic rate order 
KSO-IP
KSO
 = relative under saturation 
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 log Ca = A0+ A1 log t (5.4.2) 
This equation is related to the rate equation: 
 d Ca
dt
=k  · tm (5.4.3) 
[Ca] = Ca2+ concentration in solution 
k = constant 
m = effective order of the reaction 
To followed by the equation: 
 Ca = k m +1 ·tm+1 (5.4.4) 
Or 
 log Ca = log k m +1 + m+1 · log t (5.4.5) 
 A0= log k m +1  
A1= m+1  
 
5.4.4 Scaffold Morphology and Schwann cell growth (in collaboration with Stanford University) 
Cell alignment data showed a correlation between cell orientation and the scaffold at two 
time points (7 and 14 days in vitro).  Cell directionality was derived from the angle of the cell 
nuclei measured in relation to the strut (Figure 5.11b).  It was found that the majority of cells on 
the scaffold grew at an angle between 0° and 30° off-parallel from the struts.  This parallelism 
with the scaffold’s internal configuration was seen to have a tight connection at day 7 and 14, 
where ~30% of cells were within 10° of parallel with the strut and nearly 55% of cells are within 
20° (Figure 5.13).  By day 14, the effect on directionality was still apparent by the scaffolds with 
the percentages within a similar range in comparison to the two time points.  The data (Figure 
5.13) and images ( Figure 5.12) suggest that the struts of the 3D printed scaffolds facilitate the 
movement of the cells along the surface.   
The cytotoxicity assay results ( Figure 5.12) indicated that the Schwann cells (SCs) 
propagated on the individual struts of the scaffold with a negligible amount of dead cells present 
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at the indicated time points in vitro,  in comparison to the control group.  While the staining for 
S100-β and p75LNGR proteins (Figure 5.14) presented positive results for both of the proteins.  The 
positive results suggest that the β-TCP does not affect the Schwann cells, ultimately meaning that 
these cells are capable of growing along the β-TCP struts, while still executing their functions 
[154]. 
 
Figure 5.11: (a and b) Digital image and SEM image, respectively, of a scaffold used for the cell 
directionality study.  (c and d) images which show intersection struts at 100 µm level and the 
surface at 25 µm level, respectively.    
 
Figure 5.12: Fluorescent images of the cytotoxicity assay at (a) 3 days, (b) 7 days, and (c) 14 days.  
The staining indicated directed cell growth along the struts and in some areas clustered growth. 
 
2 mm 
(a) (b) 
500 µm 
(c) (d) 
100 µm 25 µm 
(a) (b) (c) 
200 µm 200 µm 200 µm 
  
 112 
 
Figure 5.13: Results show the mean percentage of cells (and standard deviations) at a given range 
within a degree of the parallel scaffold struts.  Insert (a) gives an example of the method of 
measuring the angle between the cell axis in relation to strut [154]. 
 
Figure 5.14: The p75LNGFR was stained green and the S100-β in red.  Columns (a) and (b) are for 
the control and 100% β-TCP scaffold at 7 days, while (c) and (d) are at 14 days, respectively.  
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5.4.5 Preliminary In Vivo Work (in collaboration with New York University) 
Reconstructed microCT (µCT 40, Scanco Medical, Switzerland) images of the scaffolds 
of the scaffolds at various time points in vivo, were used to examine for new bone formation.  
Images found in Figure 5.15, are representative of scaffolds found at 2 weeks (Figure 5.15a) and 
24 weeks (Figure 5.15b) in vivo, respectively.  From the reconstructed image it is seen that there 
is a greater amount of bone formation, remodeling, and integration at the longer time point, 24 
weeks, in comparison to the 2 week time point.   
 
Figure 5.15: 3D microCT scans of 100% β-TCP scaffold at two time points in vivo: (a) 2 weeks 
and (b) 24 weeks. 
5.5 Conclusion 
The data and results from the aforementioned sections, as well as specific aim #1, with 
respect to dissolution results of the four experimental groups can vary.  It should be noted that the 
study of these ceramic scaffolds have been used in a variety of biological studies, and not always 
does the in vitro result directly translate into the in vivo condition.  The limitations of the in vitro 
testing should be reviewed and compared to the differences, which may be encountered in an in 
vivo environment since these in vitro experiments are modeled and constructed to simulate 
physiological conditions of the potential in vivo environment.   
(a) 
(b) 
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The data from the in vitro portion of this specific aim is in agreement with the findings in 
the overall scope of the dissertation.  Taking the 100% HA and 100% β-TCP as controls and the 
two 15/85% HA/β-TCP groups as the experimental, the results are similar to what was expected.  
Literature indicates the bulk or pressed powder properties of this two materials, but does not 
present the biphasic mixture release for Ca2+ or PO4  in an in vitro setting.  The results indicate the 
trend which, the rate of calcium and phosphate ion release should fall greater than 100% HA but 
beloe 100% β-TCP.  This can be seen when looking at the results and further identified with the 
extrapolation of data from previous bulk property results.   
The in vitro analysis of ion release in a SBF solution also has been collaborated with 
work done along with Yang et al, with regards to cytotoxicity.  The cytotoxicity assay results 
indicated that the 100% β-TCP material which is most commonly used did not have a significant 
effect or do much altering to the Schwann cells in vitro, nor did it have any negatively alter the 
expression of the p75LNGFR or S100-β proteins in those Schwann cells.  These findings lead to the 
conclusion that the 100% β-TCP material of which the scaffolds are fabricated from as a capable 
material to facilitate the stimulation of nerve related functionality into a ceramic bone scaffold.  
In addition the alignment data displays the scaffolds individualized struts ability to direct the 
Schwann cells along its surface with results yielding that nearly 10% of the cells are within 10° of 
being parallel with the strut.   
With the ability of the material (100% β-TCP) to support the alignment of the Schwann 
cells, in conjunction with its nearly nonexistent cytotoxicity, permitted for the next step of an in 
vivo experiment.  The alignment of the cells gives the evidence that when a scaffold is placed in a 
long bone critical sized defect model, the cells will move longitudinally from one end to the other 
and facilitate the bone growth process.  The ceramic phosphate based scaffolds needed to exhibit 
and mimic cellular regeneration as well as mechanical properties of the host to lead to a 
successful bone healing [2].  Scaffolds, which were implanted, showed minimal new bone 
formation at earlier time points in vivo, while longer time points (i.e. 24 weeks) showed moderate 
bone formation and integration.  These long bone scaffolds implanted as is showed promising 
results at their respective time points, but in the future these scaffolds can be either coated or 
filled with different components, which can be slowly released, such as a growth factor.  The 
combined results from the in vitro and in vivo portions give a better interpretation of the 
possibilities that can be achieved with utilization of 3D printed long bone scaffolds used with 
Schwann cells.  The alignment provided by the struts and in combination with the benefits of 
Schwann cells has the potential to advance the vascularization of calcium phosphate based 
scaffolds, in turn providing a quicker and more established angiogenesis [154].  
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CHAPTER 6 
CONCLUSIONS 
 Calcium phosphate based scaffolds composed of hydroxyapatite (HA), β-tri-calcium 
phosphate (β-TCP), or a combination of both (HA/β-TCP) were investigated as materials for 
three-dimensional printing process to create layer-by-layer structures for use as bone regeneration 
scaffolds.  Commercially available ceramic powders were beneficiated and combined with 
commercially available process additives to produce colloidal gels/inks.  These inks were printed 
and sintered to produce scaffolds.   
Chapter 1 of this dissertation introduced three research questions: 
1. Is the composition and spatial distribution of the materials in the sintered ceramic 
scaffold able to be controlled? 
2.  Do the details of printing (i.e., pre-mixed composition ink, two-tip deposition of 
different ink compositions or blending inks with a mixing chamber while 
printing) affect the in vitro response of the scaffold on the macroscopic scale? 
3. Can 3D printing be used to tailor the scaffold to induce bone healing in long-
bone defects, in addition to control of dissolution kinetics? 
Chapter 2 reviewed the literature relevant to selection of ceramic materials used for 
potential bone regenerative scaffolds.  The standard of medical care in the use of hydroxyapatite 
and β-TCP includes implant of porous, friable scaffolds.  As-such, current bone repair scaffolds 
are non-load bearing but do provide a microenvironment suitable for osteogenesis and resorption 
of the scaffolds.  HA and β-TCP have also been blended to create biphasic calcium phosphates, 
which have shown intermediate solubility between the solubility of the two components. 
Chapter 3 addressed an important, fundamental step in design of printable inks for the 
robocasting process.  Namely, does the beneficiation of the commercial powders and the 
subsequent processing change the physicochemical properties of the sintered ceramic parts?  The 
XRD and FT-IR spectra results show that indeed the final ceramic scaffolds have the same crystal 
structure and functional groups, respectively, as one would expect if simply blending the raw 
powders together at the same ratio.  There was some small deviation from the expected which 
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occurred in the BCP (15/85% HA/β-TCP) experimental group with the finding of trivial amounts 
of calcium pyrophosphate (CPP), which was confirmed with XRD and FT-IR analysis.  The CPP 
phase, although not detrimental to the host in small quantities, does have a speedy dissolution rate, 
which is greater than that of β-TCP.  With a faster dissolution such as that associated with CPP, 
the Ca2+ and PO4 ion release will occur at a faster rate.  The CPP phase is not present in the 
100% HA or 100% β-TCP scaffolds, leading to the conclusion that a reaction between the two 
phases at the higher heating temperatures leads to this by-product.  Therefore, it can be concluded 
that the robocasting process does not impact the physicochemical properties of these particular 
ceramics. 
Chapter 4 focused on the ability to adapt the 3D printing process and the colloidal pastes 
to create tailored scaffolds.  The primary focus of the chapter was the ‘mixedness’ of the 
materials, further looking into the powder mixing, which offers the ability to use multiple 
materials in a ‘pre-blended’ fashion.  In this part, alumina and zirconia, had to be substituted in 
place of hydroxyapatite and β-TCP, to allow for the imaging analysis, as HA and β-TCP are 
composed of the similar basic components there would be a difficulty in differentiation.  The 
results from the colloidal gels mixed in powder form, which yielded the pre-blended paste, were 
more evenly distributed across the sample area when compared to those mixed in their paste 
through the mixer prior to deposition.  The radial distribution function (RDF) confirmed what 
was visualized in the backscatterd SEM images.  Even though the RDF results indicated poor 
mixing and particle distribution the refinement results were found to be promising, the ratios were 
within 5% of their designed ratio.  These two approaches to fabricating the scaffold ((1) nozzle 
array and (2) mixing nozzle) offer further ability to tailor these scaffolds and print intricate 
designs to facilitate with the bone remodeling process.  The dispersion of the two basic materials 
to create a biphasic model allows for the tailoring of the dissolution of the material (HA<<TCP) 
in addition to the mechanical integrity (HA>>β-TCP). 
Chapter 5 merged the results from characterization and in vitro investigation while 
including some  preliminary in vivo data.  The in vitro data with regards to the calcium (Ca2+) 
and (PO4) results were in agreement with literature where β-TCP dissolves at a faster rate in 
comparison to HA.  These results of calcium and phosphate release were different and more 
apparent than the in vitro weight loss done in chapter 3, indicating that weight loss in a SBF is not 
a sufficient enough method to determine the overall success for in vivo.  Additionally the 
cytotoxicity assay results indicated that the CaP based materials which are most commonly used 
did not have a significant effect to the Schwann cells (SCs) in vitro, nor did it negatively alter the 
expression of the p75LNGFR or S100-β proteins in those Schwann cells.  These Ca2+/PO4 along 
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the cytotoxicity results in conjunction with the ability for the struts of the scaffold to conduct the 
cells nearly parallel along the surface gives the potential to successfully transport cells from one 
end of the scaffold to the other.  This promising result can narrow the gap and lead to numerous 
possibilities when it comes to fixing critical sized defects.  With the combination of the 
preliminary in vitro data and previous in vivo work, lead to the initial attempt of a critical sized 
long bone defect.  The primary histology and microCT data have shown bone formation along the 
surface of the long bone replacement scaffold as early as 4 weeks with significant bone growth at 
the 24 weeks in vivo. 
The work done within the scope of this dissertation and its aim to answer the three 
primary research questions, indicates that robocasting is a viable tool for the designing and 
fabrication of calcium phosphate based ceramic scaffolds to facilitate in the bone replacement 
process.  In conclusion this particular research led to an increase in knowledge in biological, 
chemical and scientific areas and provides a solid basis for future development and direction to 
further explore novel ideas in the area of 3D printing scaffolds for bone regeneration. 
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CHAPTER 7 
FUTURE RECOMMENDATIONS 
 Although the work done for the completion of the degree was thorough, a continued 
investigation is highly encouraged to further evolve the adaptability of this method and its 
materials.  The work done was a step in the right direction, with regards to the in vitro and 
preliminary in vivo study.  The results showed promise and also at the same time opened doors to 
other possibilities.  At the time more work needs to be completed into the mixing nozzle, as is 
evident in the RDF and SEM images, the mixing although quantitatively is there with two phases, 
while the mixing of particles is far from ideal.  It is of significance to further explore the mixing 
paddle, chamber, speed of printing, and potentially the properties of the colloidal gels.  This 
‘mixedness’ may be sufficient in its current state or possibly detrimental, a study focusing on 
comparing the current state of mixing in vitro with that of the powder mixing would give crucial 
information and direction with regards to the area of its future, while possibly leading to further 
realization of addressing the potential capability for angiogenesis.  
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APPENDIX A CIRCULAR SCAFFOLD 
;<HEAD> 
;MultiTip=False 
;<Syringe0Properties>, skip 
;syringe diam = 9.54, skip 
;backoff dist = 1.3, skip 
;Tip diam = 0.33, skip 
;Tip pos = (-13.752, 3.331, -8.964), skip 
#define v0 SY0Speed 
#define v10 SY0Stroke 
#define v11 T0X 
#define v12 T0Y 
#define v13 T0Z 
;</Syringe0Properties>;skip 
;<Syringe1Properties>, skip 
;syringe diam = 9.59, skip 
;backoff dist = 1, skip 
;Tip diam = 0.33, skip 
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;Tip pos = (-44.05, 3.48, -8.945), skip 
#define v1 SY1Speed 
#define v20 SY1Stroke 
#define v21 T1X 
#define v22 T1Y 
#define v23 T1Z 
;</Syringe1Properties>;skip 
;<Syringe2Properties>, skip 
;syringe diam = 9.59, skip 
;backoff dist = 2, skip 
;Tip diam = 0.33, skip 
;Tip pos = (0, 0, 0), skip 
#define v2 SY2Speed 
#define v30 SY2Stroke 
#define v31 T2X 
#define v32 T2Y 
#define v33 T2Z 
;</Syringe2Properties>;skip 
;Define variables for tip change motion 
#define v1 TM0 
#define v2 TM1 
#define v3 TM2 
BO1; 
PL1; PLANE 1 is motion plane 
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PR ME UN UN/SE; 
VELOCITY OFF; 
CM0; Modal, contour mode 0  
AC PL=300; Limit accel per plane to 300 mm/s^2 
RA 50; Set accel time to 50 ms 
EN X Y Z U; 
EN A; 
EN C; 
ER A,0,0; Turn off Error checking on stepper 
ER C,0,0; Turn off Error checking on stepper 
BO 2; setup board 2 
PR ME UN UN/SE; 
RA 50; Set accel time to 50 ms 
EN X Z; 
BO 1; 
;<Tip0da_Position> 
T0X = -13.752 
T0Y = 3.331 
T0Z = -8.964 
;</Tip0da_Position> 
;<Tip1da_Position> 
T1X = -44.05 
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T1Y = 3.48 
T1Z = -8.945 
;</Tip1da_Position> 
;<Tip2da_Position> 
T2X = 0 
T2Y = 0 
T2Z = 0 
;</Tip2da_Position> 
;</HEAD> 
;<BODY> 
;Initial Point=(0.247399, -4.993876, 0) 
;Initial Speed=10 
;<Layer 0> 
;<Ink On> skip 
 ;COMP=(1, 0, 0, 0, 0, 0) 
 ;Print Length= 156.137931 skip 
 ;Write Speed= 10 skip 
 SU :SY0PlungerDown ; skip 
 SY0Speed = 0.011966; skip 
 SY0Stroke = -0.185248; skip 
 SU :SY0Start ; skip 
;</End Ink On> skip 
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 CCW X-0.247398 Y-0.006124 I-0.247399 J4.993876 F10; 
LI X-0.000001 Y0.2508 Z0 F10; (SMALL CONN LINE) 
 CCW X4.7492 Y4.7492 I0 J4.7492 F10; 
 ;<Filled Arc:  ToCenter=(-4.7492, 0, 0), ToEnd=(-9.4984, 0, 0), d_InRad=0, n_Dir=1, 
Speed=10, [FillOptions:   FillType=Raster, FillDir=In, FillPeriodicity=Uniform, 
WindingDir=CCW, RW=0.6785, SpaceInCenter=False]> 
  VELOCITY ON; skip 
  CCW X-0.678457 Y2.446212 I-4.7492 J0 F10; 
  LI X0 Y-4.892424 Z0 F10; 
  CW X-0.678456 Y-0.877535 I-4.070743 J2.446212 F10; 
  LI X0 Y6.647495 Z0 F10; 
  CCW X-0.678456 Y0.573691 I-3.392286 J-3.323748 F10; 
  LI X0 Y-7.794879 Z0 F10; 
  CW X-0.678455 Y-0.393499 I-2.713829 J3.89744 F10; 
  LI X0 Y8.581879 Z0 F10; 
  CCW X-0.678459 Y0.26029 I-2.035371 J-4.29094 F10; 
  LI X0 Y-9.102458 Z0 F10; 
  CW X-0.678459 Y-0.14926 I-1.356914 J4.551229 F10; 
  LI X0 Y9.400978 Z0 F10; 
  CCW X-0.678458 Y0.048711 I-0.678457 J-4.700489 F10; 
  LI X0 Y-9.4984 Z0 F10; 
  CW X-0.678457 Y0.048711 I0 J4.7492 F10; 
  LI X0 Y9.400978 Z0 F10; 
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  CCW X-0.678456 Y-0.14926 I0.678457 J-4.700489 F10; 
  LI X0 Y-9.102458 Z0 F10; 
  CW X-0.678456 Y0.260289 I1.356914 J4.551229 F10; 
  LI X0 Y8.581879 Z0 F10; 
  CCW X-0.678455 Y-0.393499 I2.035371 J-4.29094 F10; 
  LI X0 Y-7.794879 Z0 F10; 
  CW X-0.678459 Y0.573694 I2.713829 J3.89744 F10; 
  LI X0 Y6.647495 Z0 F10; 
  CCW X-0.678458 Y-0.877537 I3.392286 J-3.323748 F10; 
  LI X0 Y-4.892424 Z0 F10; 
  VELOCITY OFF; skip 
  CW X-0.678457 Y2.446213 I4.070743 J2.446212 F10; 
 ;</End Filled Arc> 
;</End Layer 0> 
;<Layer 1> 
;<Ink On> skip 
 ;COMP=(1, 0, 0, 0, 0, 0) 
 ;Print Length= 156.571817 skip 
 ;Write Speed= 10 skip 
 SY0Speed = 0.011966; skip 
 SY0Stroke = -0.185767; skip 
 SU :SY0Start ; skip 
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;</End Ink On> skip 
LI X-0.244676 Y-0.247399 Z0.2592 F10; (SMALL CONN LINE) 
 CCW X-0.006124 Y0.247386 I4.993876 J0.247399 F10; 
LI X0.2508 Y0.000013 Z0 F10; (SMALL CONN LINE) 
 CCW X4.7492 Y-4.7492 I4.7492 J0 F10; 
 ;<Filled Arc:  ToCenter=(0, 4.7492, 0), ToEnd=(0, 9.4984, 0), d_InRad=0, n_Dir=1, 
Speed=10, [FillOptions:   FillType=Raster, FillDir=In, FillPeriodicity=Uniform, 
WindingDir=CCW, RW=0.6785, SpaceInCenter=False]> 
  VELOCITY ON; skip 
  CCW X2.446212 Y0.678457 I0 J4.7492 F10; 
  LI X-4.892424 Y0 Z0 F10; 
  CW X-0.877537 Y0.678458 I2.446212 J4.070743 F10; 
  LI X6.647495 Y0 Z0 F10; 
  CCW X0.573691 Y0.678456 I-3.323748 J3.392286 F10; 
  LI X-7.794879 Y0 Z0 F10; 
  CW X-0.393501 Y0.678459 I3.89744 J2.713829 F10; 
  LI X8.581879 Y0 Z0 F10; 
  CCW X0.260289 Y0.678458 I-4.29094 J2.035371 F10; 
  LI X-9.102458 Y0 Z0 F10; 
  CW X-0.14926 Y0.67846 I4.551229 J1.356914 F10; 
  LI X9.400978 Y0 Z0 F10; 
  CCW X0.048711 Y0.678447 I-4.700489 J0.678457 F10; 
  LI X-9.4984 Y0 Z0 F10; 
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  CW X0.048711 Y0.678457 I4.7492 J0 F10; 
  LI X9.400978 Y0 Z0 F10; 
  CCW X-0.149263 Y0.678467 I-4.700489 J-0.678457 F10; 
  LI X-9.102458 Y0 Z0 F10; 
  CW X0.260288 Y0.678455 I4.551229 J-1.356914 F10; 
  LI X8.581879 Y0 Z0 F10; 
  CCW X-0.3935 Y0.678456 I-4.29094 J-2.035371 F10; 
  LI X-7.794879 Y0 Z0 F10; 
  CW X0.573691 Y0.678456 I3.89744 J-2.713829 F10; 
  LI X6.647495 Y0 Z0 F10; 
  CCW X-0.877537 Y0.678458 I-3.323748 J-3.392286 F10; 
  LI X-4.892424 Y0 Z0 F10; 
  VELOCITY OFF; skip 
  CW X2.446211 Y0.678457 I2.446212 J-4.070743 F10; 
 ;</End Filled Arc> 
;</End Layer 1> 
;<Layer 2> 
;<Ink On> skip 
 ;COMP=(1, 0, 0, 0, 0, 0) 
 ;Print Length= 156.571817 skip 
 ;Write Speed= 10 skip 
 SY0Speed = 0.011966; skip 
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 SY0Stroke = -0.185767; skip 
 SU :SY0Start ; skip 
;</End Ink On> skip 
LI X-0.247399 Y0.244676 Z0.2592 F10; (SMALL CONN LINE) 
 CCW X0.247398 Y0.006124 I0.247399 J-4.993876 F10; 
LI X0.000001 Y-0.2508 Z0 F10; (SMALL CONN LINE) 
 CCW X-4.7492 Y-4.7492 I0 J-4.7492 F10; 
 ;<Filled Arc:  ToCenter=(4.7492, 0, 0), ToEnd=(9.4984, 0, 0), d_InRad=0, n_Dir=1, 
Speed=10, [FillOptions:  FillType=Raster, FillDir=In, FillPeriodicity=Uniform, 
WindingDir=CCW, RW=0.6785, SpaceInCenter=False]> 
  VELOCITY ON; skip 
  CCW X0.678457 Y-2.446212 I4.7492 J0 F10; 
  LI X0 Y4.892424 Z0 F10; 
  CW X0.678456 Y0.877535 I4.070743 J-2.446212 F10; 
  LI X0 Y-6.647495 Z0 F10; 
  CCW X0.678456 Y-0.573691 I3.392286 J3.323748 F10; 
  LI X0 Y7.794879 Z0 F10; 
  CW X0.678455 Y0.393499 I2.713829 J-3.89744 F10; 
  LI X0 Y-8.581879 Z0 F10; 
  CCW X0.678459 Y-0.26029 I2.035371 J4.29094 F10; 
  LI X0 Y9.102458 Z0 F10; 
  CW X0.678459 Y0.14926 I1.356914 J-4.551229 F10; 
  LI X0 Y-9.400978 Z0 F10; 
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  CCW X0.678458 Y-0.048711 I0.678457 J4.700489 F10; 
  LI X0 Y9.4984 Z0 F10; 
  CW X0.678457 Y-0.048711 I0 J-4.7492 F10; 
  LI X0 Y-9.400978 Z0 F10; 
  CCW X0.678456 Y0.14926 I-0.678457 J4.700489 F10; 
  LI X0 Y9.102458 Z0 F10; 
  CW X0.678456 Y-0.260289 I-1.356914 J-4.551229 F10; 
  LI X0 Y-8.581879 Z0 F10; 
  CCW X0.678455 Y0.393499 I-2.035371 J4.29094 F10; 
  LI X0 Y7.794879 Z0 F10; 
  CW X0.678459 Y-0.573694 I-2.713829 J-3.89744 F10; 
  LI X0 Y-6.647495 Z0 F10; 
  CCW X0.678458 Y0.877537 I-3.392286 J3.323748 F10; 
  LI X0 Y4.892424 Z0 F10; 
  VELOCITY OFF; skip 
  CW X0.678457 Y-2.446213 I-4.070743 J-2.446212 F10; 
 ;</End Filled Arc> 
;</End Layer 2> 
;<Layer 3> 
;<Ink On> skip 
 ;COMP=(1, 0, 0, 0, 0, 0) 
 ;Print Length= 156.571817 skip 
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 ;Write Speed= 10 skip 
 SY0Speed = 0.011966; skip 
 SY0Stroke = -0.185767; skip 
 SU :SY0Start ; skip 
;</End Ink On> skip 
LI X0.244676 Y0.247399 Z0.2592 F10; (SMALL CONN LINE) 
 CCW X0.006124 Y-0.247386 I-4.993876 J-0.247399 F10; 
LI X-0.2508 Y-0.000013 Z0 F10; (SMALL CONN LINE) 
 CCW X-4.7492 Y4.7492 I-4.7492 J0 F10; 
 ;<Filled Arc:  ToCenter=(0, -4.7492, 0), ToEnd=(0, -9.4984, 0), d_InRad=0, n_Dir=1, 
Speed=10, [FillOptions:   FillType=Raster, FillDir=In, FillPeriodicity=Uniform, 
WindingDir=CCW, RW=0.6785, SpaceInCenter=False]> 
  VELOCITY ON; skip 
  CCW X-2.446212 Y-0.678457 I0 J-4.7492 F10; 
  LI X4.892424 Y0 Z0 F10; 
  CW X0.877537 Y-0.678458 I-2.446212 J-4.070743 F10; 
  LI X-6.647495 Y0 Z0 F10; 
  CCW X-0.573691 Y-0.678456 I3.323748 J-3.392286 F10; 
  LI X7.794879 Y0 Z0 F10; 
  CW X0.393501 Y-0.678459 I-3.89744 J-2.713829 F10; 
  LI X-8.581879 Y0 Z0 F10; 
  CCW X-0.260289 Y-0.678458 I4.29094 J-2.035371 F10; 
  LI X9.102458 Y0 Z0 F10; 
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  CW X0.14926 Y-0.67846 I-4.551229 J-1.356914 F10; 
  LI X-9.400978 Y0 Z0 F10; 
  CCW X-0.048711 Y-0.678447 I4.700489 J-0.678457 F10; 
  LI X9.4984 Y0 Z0 F10; 
  CW X-0.048711 Y-0.678457 I-4.7492 J0 F10; 
  LI X-9.400978 Y0 Z0 F10; 
  CCW X0.149263 Y-0.678467 I4.700489 J0.678457 F10; 
  LI X9.102458 Y0 Z0 F10; 
  CW X-0.260288 Y-0.678455 I-4.551229 J1.356914 F10; 
  LI X-8.581879 Y0 Z0 F10; 
  CCW X0.3935 Y-0.678456 I4.29094 J2.035371 F10; 
  LI X7.794879 Y0 Z0 F10; 
  CW X-0.573691 Y-0.678456 I-3.89744 J2.713829 F10; 
  LI X-6.647495 Y0 Z0 F10; 
  CCW X0.877537 Y-0.678458 I3.323748 J3.392286 F10; 
  LI X4.892424 Y0 Z0 F10; 
  VELOCITY OFF; skip 
  CW X-2.446211 Y-0.678457 I-2.446212 J4.070743 F10; 
 ;</End Filled Arc> 
;</End Layer 3> 
;<Layer 4> 
;<Ink On> skip 
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 ;COMP=(1, 0, 0, 0, 0, 0) 
 ;Print Length= 156.571817 skip 
 ;Write Speed= 10 skip 
 SY0Speed = 0.011966; skip 
 SY0Stroke = -0.185767; skip 
 SU :SY0Start ; skip 
;</End Ink On> skip 
LI X0.247399 Y-0.244676 Z0.2592 F10; (SMALL CONN LINE) 
 CCW X-0.247398 Y-0.006124 I-0.247399 J4.993876 F10; 
LI X-0.000001 Y0.2508 Z0 F10; (SMALL CONN LINE) 
 CCW X4.7492 Y4.7492 I0 J4.7492 F10; 
 ;<Filled Arc:  ToCenter=(-4.7492, 0, 0), ToEnd=(-9.4984, 0, 0), d_InRad=0, n_Dir=1, 
Speed=10, [FillOptions:   FillType=Raster, FillDir=In, FillPeriodicity=Uniform, 
WindingDir=CCW, RW=0.6785, SpaceInCenter=False]> 
  VELOCITY ON; skip 
  CCW X-0.678457 Y2.446212 I-4.7492 J0 F10; 
  LI X0 Y-4.892424 Z0 F10; 
  CW X-0.678456 Y-0.877535 I-4.070743 J2.446212 F10; 
  LI X0 Y6.647495 Z0 F10; 
  CCW X-0.678456 Y0.573691 I-3.392286 J-3.323748 F10; 
  LI X0 Y-7.794879 Z0 F10; 
  CW X-0.678455 Y-0.393499 I-2.713829 J3.89744 F10; 
  LI X0 Y8.581879 Z0 F10; 
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  CCW X-0.678459 Y0.26029 I-2.035371 J-4.29094 F10; 
  LI X0 Y-9.102458 Z0 F10; 
  CW X-0.678459 Y-0.14926 I-1.356914 J4.551229 F10; 
  LI X0 Y9.400978 Z0 F10; 
  CCW X-0.678458 Y0.048711 I-0.678457 J-4.700489 F10; 
  LI X0 Y-9.4984 Z0 F10; 
  CW X-0.678457 Y0.048711 I0 J4.7492 F10; 
  LI X0 Y9.400978 Z0 F10; 
  CCW X-0.678456 Y-0.14926 I0.678457 J-4.700489 F10; 
  LI X0 Y-9.102458 Z0 F10; 
  CW X-0.678456 Y0.260289 I1.356914 J4.551229 F10; 
  LI X0 Y8.581879 Z0 F10; 
  CCW X-0.678455 Y-0.393499 I2.035371 J-4.29094 F10; 
  LI X0 Y-7.794879 Z0 F10; 
  CW X-0.678459 Y0.573694 I2.713829 J3.89744 F10; 
  LI X0 Y6.647495 Z0 F10; 
  CCW X-0.678458 Y-0.877537 I3.392286 J-3.323748 F10; 
  LI X0 Y-4.892424 Z0 F10; 
  VELOCITY OFF; skip 
  CW X-0.678457 Y2.446213 I4.070743 J2.446212 F10; 
 ;</End Filled Arc> 
;</End Layer 4> 
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SU :SY0Stop ; skip 
SU :SY1Stop ; skip 
SU :SY2Stop ; skip 
SU :SY0PlungerUp ; skip 
M2; signals the end of the program. 
;</BODY> 
;<TAIL> 
:SY0PlungerDown 
WA ON; skip 
LI U-1.3 F25; skip 
WA ON; skip 
DW 10; skip 
RETURN 
:SY0PlungerUp 
WA ON; skip 
LI U1.3 F25; skip 
WA ON; skip 
RETURN 
:SY0Start 
PL 2 
LI U SY0Stroke F  
SY0Speed ;skip 
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PL 1 
RETURN 
:SY0Stop 
WA ON; skip 
FR U0; skip 
RETURN 
:SY1PlungerDown 
WA ON; skip 
BO 2; skip 
LI X-1 F10; skip 
WA ON; skip 
BO 1; skip 
RETURN 
:SY1PlungerUp 
WA ON; skip 
BO 2; skip 
LI X1 F10; skip 
WA ON; skip 
BO 1; skip 
RETURN 
:SY1Start 
BO 2; skip 
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PL 2 
LI X SY1Stroke F  
SY1Speed ;skip 
BO 1; skip 
PL 1 
RETURN 
:SY1Stop 
WA ON; skip 
BO 2; skip 
FR X0; skip 
BO 1; skip 
RETURN 
:SY2PlungerDown 
WA ON; skip 
BO 2; skip 
LI Z-2 F30; skip 
WA ON; skip 
BO 1; skip 
RETURN 
:SY2PlungerUp 
WA ON; skip 
BO 2; skip 
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LI Z2 F30; skip 
WA ON; skip 
BO 1; skip 
RETURN 
:SY2Start 
BO 2; skip 
PL 2 
LI Z SY2Stroke F  
SY2Speed ;skip 
BO 1; skip 
PL 1 
RETURN 
:SY2Stop 
WA ON; skip 
BO 2; skip 
FR Z0; skip 
BO 1; skip 
RETURN 
;</TAIL> 
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APPENDIX B  SHRINKAGE 
The scaffolds were placed in a desiccator for a 24-hour period before being placed into 
the high temperature furnace electric furnace (Model LHT 02/17, Nabertherm GmbH, Lilienthal, 
Germany).  The furnace was programmed for three different firing protocols with maximum 
sintering temperatures of 900°C, 1100°C, and 1250°C for 4 hours.  Shrinkage due to sintering 
was measured by means of micro calipers (Mitutoyo, Tokyo, Japan) for each rod at pre- and post-
sintering conditions (n=10 per group).  The cylinder formula  
 V=π·r2·h (B.1) 
where, V is the volume, r the radius, and h the height of the scaffold was used to calculate the 
pre- and post-sintering volume.  Scaffold volume was calculated, pre and post sintering, using 
two different methods: (1) using microcalipers (Coolant Proof IP66, Mitutoyo America 
Corporation, IL, USA) and (2) Archimedes’ method.  For the later method the samples were 
weighed in air and subsequently in a liquid medium (EtOH), and derived using the following 
formula, where the correction factor for apparatus, α, was equal to 0.99985: 
 Vol=α
Wair-Wliquid
ρair-ρliquid
  (B.2). 
The pre- and post-sintering volumes were utilized to calculate the shrinkage percentage 
as: 
 Percent Shrinkage = 
VolGreen State - VolSintered
VolGreen State
  (B.3). 
Statistical analysis showed that both calcination and sintering temperatures presented a 
significant effect on shrinkage (both p<0.001) (Table B.1 and Figure B.1).  Significantly higher 
shrinkage (mean ± 95% confidence interval) was observed for scaffolds made of materials 
calcined at 975°C (18.58% ± 1.00) relative to 800°C (14.96% ± 1.05).  Concerning the different 
sintering temperatures, scaffolds sintered to 1100°C presented significantly higher shrinkage 
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relative to the ones sintered to 900°C and 1250°C at values of 22.25% ± 1.44, 14.48% ± 1.3, and 
13.58% ± 1.3, respectively. 
 
Calcination Temp. è 800°C 975°C 
Sintering Temp. ê Mean Lower Limit 
Upper 
Limit 
Mean Lower 
Limit 
Upper 
Limit 
900°C 13.87b 11.32 16.42 15.20b 12.91 17.49 
1100°C 20.01a,b 16.91 23.11 24.38a 20.16 28.60 
1250°C 11.12c 9.51 12.73 16.11b 13.90 18.32 
Table B.1: Percent shrinkage means ± 95% confidence interval for the different groups.  The 
letters  
 
Figure B.1: Percent shrinkage means ± 95% confidence interval for the different groups.  The 
number of asterisks depicts statistically homogeneous groups. 
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APPENDIX C  RADIAL DISTRUTION FUNCTION 
macro "Radial Distribution Function [f5]" { 
 run("Select None"); 
 doStack=false; 
 //User dialog 
 Dialog.create('RDF Options'); 
 Dialog.setInsets(0,0,0) 
 Dialog.addMessage("Radial Distribution Function Macro \nby Michael Schmid & Ajay 
Gopal \n(v.2011-08-21)"); 
 if (nSlices()>1) { 
  Dialog.addMessage("Selected file is a stack. \nUncheck below to analyze \nonly 
the current slice."); 
  Dialog.addCheckbox("Use all slices in stack?", true); 
 } 
 Dialog.addMessage("Particle Detection Noise Threshold \nHint: test image/s first with 
\nImageJ>Process>Find Maxima \nto verify that below threshold \ngives accurate particle 
centers."); 
 Dialog.addNumber("Noise Threshold", 10); 
 Dialog.addMessage("Default output is RDF plot with \noptions to list, save & copy data. 
\nCheck below to output extra \nwindow with RDF data table."); 
 Dialog.addCheckbox("Output RDF data table ", false); 
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Dialog.show; 
  //Preliminary checks 
 if (nSlices()>1) doStack _ Dialog.getCheckbox; 
 noiseThr = Dialog.getNumber; 
 showList = Dialog.getCheckbox; 
 setBatchMode(true); 
 firstSlice=getSliceNumber(); 
 lastSlice=getSliceNumber(); 
 if (doStack) { 
  firstSlice=1; 
  lastSlice=nSlices(); 
 } 
 width=getWidth; 
 height=getHeight; 
 //maxRadius may be modified, should not be larger than 0.3*minOf(width, height); 
 maxRadius=0.3*minOf(width, height); 
 minFFTsize=1.3*maxOf(width, height); 
 title=getTitle(); 
 size=4; 
 while(size<minFFTsize) size*=2; 
 //Main processing loop 
 for (slice=firstSlice; slice<=lastSlice; slice++) { 
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  //Make autocorrelation of particle positions 
  if (doStack) setSlice(slice); 
  run("Find Maxima...", "noise="+noiseThr+" output=[Single Points] light 
exclude");   
  tempID=getImageID(); 
  tempTitle="temp-"+random(); 
  rename(tempTitle); 
  run("Canvas Size...", "width="+ size+" height="+ size+" position=Center zero"); 
  run("FD Math...", "image1=["+tempTitle+"] operation=Correlate 
image2=["+tempTitle+"] result=AutoCorrelation do"); 
  psID=getImageID(); 
  selectImage(tempID); 
  close(); 
  //Make autocorrelation reference to correct finite image size effects 
  newImage("frame", "8-bit White", width, height, 1); 
  run("Set...", "value=255"); 
  tempID=getImageID(); 
  rename(tempTitle); 
  run("Canvas Size...", "width="+ size+" height="+ size+" position=Center zero"); 
  run("FD Math...", "image1=["+tempTitle+"] operation=Correlate 
image2=["+tempTitle+"] result=AutoCorrReference do"); 
  refID=getImageID(); 
  imageCalculator("Divide", psID,refID); 
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  selectImage(refID); 
  close(); 
  selectImage(tempID); 
  close(); 
  //Prepare normalized power spectrum for radial averaging 
  selectImage(psID); 
  makeRectangle(size/2, size/2, 1, 1); 
  run("Set...", "value=0"); 
  run("Select None"); 
  circleSize=2*floor(maxRadius)+1; 
  run("Specify...", "width="+circleSize+" height="+circleSize+" 
x="+(size/2+0.5)+" y="+(size/2+0.5)+" oval centered"); 
  getRawStatistics(nPixels, mean); 
  run("Select None"); 
  run("Divide...", "value="+mean); 
  run("Specify...", "width="+circleSize+" height="+circleSize+" 
x="+(size/2+0.5)+" y="+(size/2+0.5)+" oval centered"); 
  run("Radial Profile", "x="+(size/2+0.5)+" y="+(size/2+0.5)+" 
radius="+floor(maxRadius)-1); 
  rename("RDF of "+title); 
  rdfID=getImageID();  
  selectImage(psID);  
  close(); 
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  //Averaging of RDFs for stacks  
  if (doStack) { 
   selectImage(rdfID);    
   Plot.getValues(x, y); 
   if (slice==firstSlice) ySum = newArray(y.length); 
   for (i=0; i<y.length; i++) 
   ySum[i]+ = y[i] / lastSlice; 
   close(); 
  } 
 }//End Processing Loop  
 
 //Create output plots with annotated titles and options 
 if (doStack) { 
  Plot.create("RDF of "+title+" (stack)", "Distance (pixels)", "RDF", x, ySum); 
  if (showList) { 
   run("Clear Results"); 
   for (i=0; i<x.length; i++) { 
    setResult("R", i, x[i]); 
    setResult("RDF", i, ySum[i]); 
   } 
   updateResults(); 
  } 
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 }  
 else { 
  selectImage(rdfID); 
  Plot.getValues(x, y); 
  Plot.create("RDF of "+title+" (slice"+lastSlice+")", "Distance (pixels)", "RDF", x, 
y); 
  if (showList) { 
   run("Clear Results"); 
   for (i=0; i<x.length; i++) { 
    setResult("R", i, x[i]); 
    setResult("RDF", i, y[i]); 
   } 
   updateResults(); 
  } 
  close();   
 }//End Output 
 setBatchMode("exit and display");// Comment this out if you get duplicate RDF outputs 
} //End Macro 
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APPENDIX D CARBON BLACK OPTIMIZATION 
Dispersion of carbon black (CB) powder and its rheological behaviors have been 
extensively studied in organic solvents and polymer melts.  Rheological properties of aqueous 
carbon black dispersions have been investigated to a lesser extent; typically, with surfactants 
composed of hydrophobic anchoring groups and stabilizing polymeric chains [159].  The 
concentration of the colloidal gels used in this study is well above what has previously been 
reported in the literature for aqueous processing.  The materials involved are commercially 
available and easily obtained at low cost.   
The carbon black gel (CBG) formulation used an anionic dispersant in combination with 
a cationic flocculant molecule to control gel strength.  Carbon black (CB) (Monarch 120, Cabot 
Corporation, Billerica, MA) with manufacturer specified particle density in the range of 1.8 g/cm3 
and specific surface area of 31.25 m2/g, was selected for the particulate phase and was used 
without modification.  
For fabrication of the CBG, sulfonated naphthalene condensate, ammonium salt 
(NSC4AL) (AGNIQUE NSC4AL, Cognis, Cincinnati, OH), a 44% by weight of an ammonium 
neutralized derivative of sulfonic acid, containing a naphthalene functional unit, is used as an 
ionic dispersant to stabilize carbon black in water.  Nonlinear poly(ethylenimine) (ICN 
Biomedical, Aurora, OH) with Mw = 50 to 100 kDa (PEI50~100K) is prepared in aqueous stock 
solutions with 10% by weight polymer and is used as a flocculent.  While the DI water had a 
nominal conductivity 5×10-4 (Ω·cm)-1. 
To determine an ideal CBG formulation two series were fabricated.  The ‘A series’ gel 
did not incorporate the flocculent, cationic polyelectrolyte, poly(ethylenimine) (PEI).  ‘A series’ 
varied the weight % of the viscosifier, polyethylene glycol (PEG), with [PEG] = 0%, 2%, 6%, 
and 10%.  While the ‘B Series’ kept the [PEG] constant at 5%, the M[PEI] M[NSC], was varied, in 
0.1 increments, such that the ratios tested were 0.7, 0.8, and 0.9. 
The initial dispersion, ‘A series’, of CBG, has a relatively low viscosity and this behavior 
is evident in comparison to the ‘B series’ where the flocculent, PEI, is a component.
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Figure D.1(a) shows the oscillatory and steady flow behavior of the ‘A series’ CBG, comparing 
the 4 varying amounts of [PEG].  In Figure D.1(a), the elastic modulus (G') is graphed as a 
function of applied shear stress (τy) for each of the four groups.  The magnitude of G' for the A2 
and A3 materials were comparable to each other, whereas the A0 CBG was significantly lower 
across the entire stress amplitude range.  The A1 CBG was slightly lower than A2 and A3 but 
significantly greater than the A0 CBG which at no [PEG] and PEI.  Three parameters were used 
for comparison of the data: the plateau eleastic shear modulus (Geq
' ) is representative of the elastic 
nature of the colloidal gel network prior to rupture of the gel, the yield stress (τy) defined as the 
stress amplitude where G' Geq
' =0.9 and the yield strain (γy) defined as the strain amplitude when 
G' Geq
' =0.9 [160].  The G' Geq
'  was a more accurate representation of the process happening in 
robocasting where the CBG goes from rest in a reservoir and is extruded through a tip.  These 
parameters with corresponding values are reported in Table D.1.  The yield stress in the ‘A series’ 
increases when the amount [PEG] is increased from 2% to 6%, but when increasing the [PEG] to 
10% a slight decrease is observed in the yield stress (Figure C.1(b)).  After analyzing the ‘A 
series’ data, the ideal amount of [PEG] was chosen to be 5%, and for the ‘B series’ the [PEG] was 
held constant while the M[PEI] M[NSC] ratio was varied ([PEI] NSC  = 0.7, 0.8, 0.9 for B1, B2, 
and B3 respectively). As can be seen in Figure D.2(a) and Table D.1, the carbon black samples 
A2 and B1 not only have similar yield stress values (τy) but elastic shear modulus (Geq
' ) values.  
When comparing the ‘A series’ the similarity only is between A1-A3 and B1, the other two CBGs, 
B2 and B3, have values have properties an order of magnitude greater.  Figure D.2(b) indicates 
the relation of the “B series’ and the linear increase in shear stress (τy) when increasing the 
M[PEI] M[NSC] ratio.  The final CBG formulation was based on the B3 values with a few 
modifications, with the results reported in 5.4.1 Rheological properties of CB gel found on page 
101. 
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Figure D.1: (a) Rheology of ‘A series’ component CB gels, compared to each other with varying 
[PEG] amounts, describing the shear modulus as a function of shear stress.  (b) Graph comparing 
the 𝐺!"!  and 0.9 ∙ 𝐺!"! , of the three ‘A series’ gels. 
 
Figure D.2: (a) Rheology of ‘B series’ component CB gels, compared to each other with varying 
the ratio of M[PEI]/M[NSC], amounts, describing the shear modulus as a function of shear stress.  (b) 
Graph comparing the 𝜏! and 𝐺!"! , of the three ‘B series’ gels. 
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Series Sample 𝐺!"!  (Pa) (0.9)𝐺!"!  (Pa) τy [PEG] 𝑀[!"#]𝑀[!"#] ϕsolids 
A 
1 871.0 783.9 2.81 2% - 37.0% 
2 1233.0 1109.7 8.14 6% - 37.0% 
3 1040.0 936.0 6.55 10% - 37.0% 
B 
1 1697.9 1528.1 9.35 5% 0.7 37.0% 
2 11360.0 10224.0 19.74 5% 0.8 36.9% 
3 47303.0 42572.7 38.75 5% 0.9 36.9% 
Table D.1: Summary of results interpreted from Figure D.1 and Figure D.2, giving numerical 
values to go along with graphical representations.   
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